{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "g_H4lqos8Vd7"
      },
      "outputs": [],
      "source": [
        "import numpy as np\n",
        "import pandas as pd"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "8onD6USI8bqr"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "raw=pd.read_csv('MajorDatasetDischarge.csv')\n",
        "pd.set_option('display.max_colwidth', None)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "JV6cm7GXiw69"
      },
      "outputs": [],
      "source": [
        "#Concatenation of documents\n",
        "# concatenate documents\n",
        "grouped = raw.groupby('subject_id')\n",
        "\n",
        "concatenated_documents = []\n",
        "for group_name, group in grouped:\n",
        "    concatenated_document = ' '.join(group['text'].tolist())\n",
        "    concatenated_documents.append({'subject_id': group_name, 'text': concatenated_document})\n",
        "\n",
        "raw = pd.DataFrame(concatenated_documents)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Lrcjp_577GnR"
      },
      "outputs": [],
      "source": [
        "import nltk\n",
        "from nltk.tokenize import sent_tokenize\n",
        "\n",
        "def remove_redundant_sentences(df):\n",
        "    # Concatenate all the documents in the group\n",
        "    concatenated_document = ' '.join(df['text'].tolist())\n",
        "\n",
        "    # Tokenize the concatenated document into sentences\n",
        "    sentences = sent_tokenize(concatenated_document)\n",
        "\n",
        "    # Remove duplicate sentences\n",
        "    unique_sentences = set(sentences)\n",
        "\n",
        "    # Concatenate the unique sentences into a single document\n",
        "    unique_document = ' '.join(unique_sentences)\n",
        "    # Return a new DataFrame with the unique document\n",
        "    return pd.DataFrame({'subject_id': [df['subject_id'].iloc[0]], 'text': [unique_document]})"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "lBJNEJx9xACk"
      },
      "outputs": [],
      "source": [
        "raw = raw.groupby('subject_id').apply(remove_redundant_sentences)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "I386-R4Wcdkw",
        "outputId": "ab4de170-26d8-465f-b7b6-5c085c78e2e6"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Unzipping tokenizers/punkt.zip.\n"
          ]
        },
        {
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "execution_count": 4,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "import nltk\n",
        "nltk.download('punkt')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Ds6x69PM7Nw3"
      },
      "outputs": [],
      "source": [
        "raw = raw.groupby('subject_id').apply(remove_redundant_sentences)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "5NuclFl78d7S",
        "outputId": "333971c8-b62a-4e9b-b005-f2b376d99f5d"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "\n",
              "  <div id=\"df-85717776-ced3-40e7-a392-0304636be4d3\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Unnamed: 0</th>\n",
              "      <th>subject_id</th>\n",
              "      <th>text</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>0</td>\n",
              "      <td>10000032</td>\n",
              "      <td>Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: Chief Complaint: Worsening ABD distension and pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week. Pt reports self discontinuing lasix and spirnolactone weeks ago because she feels like they don t do anything and that she doesn t want to put more chemicals in her. She does not follow Na restricted diets. In the past week she notes that she has been having worsening abd distension and discomfort. She denies edema or SOB or orthopnea. She denies f/c/n/v d/c dysuria. She had food poisoning a week ago from eating stale cake n/v 20 min after food ingestion which resolved the same day. She denies other recent illness or sick contacts. She notes that she has been noticing gum bleeding while brushing her teeth in recent weeks. she denies easy bruising melena BRBPR hemetesis hemoptysis or hematuria. Because of her abd pain she went to OSH ED and was transferred to for further care. Per ED report pt has brief period of confusion she did not recall the ultrasound or bloodwork at osh. She denies recent drug use or alcohol use. She denies feeling confused but reports that she is forgetful at times. In the ED initial vitals were 98.4 70 106/63 16 97 RA Labs notable for ALT/AST/AP : Tbili1.6 WBC 5K platelet 77 INR 1.6 Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Her last alcohol consumption was one drink two months ago. No regular alcohol consumption. Last drug use years ago. She quit smoking a couple of years ago. Physical Exam: VS: 98.1 107/61 78 18 97RA General: in NAD HEENT: CTAB anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended mild diffuse tenderness flank dullness cannot percuss liver/spleen edge distension GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 converse normally able to recall 3 times after 5 minutes CN II XII intact Discharge: PHYSICAL EXAMINATION: VS: 98 105/70 95 General: in NAD HEENT: anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended but improved TTP in RUQ GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 CN II XII intact Pertinent Results: 10:25PM GLUCOSE 109 UREA N 25 CREAT 0.3 SODIUM 138 POTASSIUM 3.4 CHLORIDE 105 TOTAL CO2 27 ANION GAP 9 10:25PM estGFR Using this 10:25PM ALT SGPT 100 AST SGOT 114 ALK PHOS 114 TOT BILI 1.6 10:25PM LIPASE 77 10:25PM ALBUMIN 3.3 10:25PM WBC 5.0 RBC 4.29 HGB 14.3 HCT 42.6 MCV 99 MCH 33.3 MCHC 33.5 RDW 15.7 10:25PM NEUTS 70.3 LYMPHS 16.5 MONOS 8.1 EOS 4.2 BASOS 0.8 10:25PM PLT COUNT 71 10:25PM PTT 30.9 10:25PM . CXR: No acute cardiopulmonary process. U/S: 1. Nodular appearance of the liver compatible with cirrhosis. Signs of portal hypertension including small amount of ascites and splenomegaly. 2. Cholelithiasis. 3. Patent portal veins with normal hepatopetal flow. Diagnostic para attempted in the ED unsuccessful. On the floor pt c/o abd distension and discomfort. Brief Hospital Course: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week and confusion. Ascites p/w worsening abd distension and discomfort for last week. likely portal HTN given underlying liver disease though no ascitic fluid available on night of admission. No signs of heart failure noted on exam. This was to med non compliance and lack of diet restriction. SBP negative diuretics: Furosemide 40 mg PO DAILY Spironolactone 50 mg PO DAILY chosen over the usual 100mg dose d/t K of 4.5. CXR was wnl UA negative Urine culture blood culture negative. Pt was losing excess fluid appropriately with stable lytes on the above regimen. Pt was scheduled with current PCP for check upon discharge. Pt was scheduled for new PCP with Dr. at and follow up in Liver clinic to schedule outpatient screening EGD and . Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO DAILY 2. Spironolactone 50 mg PO DAILY 3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 4. Raltegravir 400 mg PO BID 5. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 6. Nicotine Patch 14 mg TD DAILY 7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Furosemide 40 mg PO DAILY RX furosemide 40 mg 1 tablet s by mouth Daily Disp 30 Tablet Refills: 3 4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB 5. Nicotine Patch 14 mg TD DAILY 6. Raltegravir 400 mg PO BID 7. Spironolactone 50 mg PO DAILY 8. Acetaminophen 500 mg PO Q6H:PRN pain Discharge Disposition: Home Discharge Diagnosis: Ascites from Portal HTN Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure taking care of you You came to us with stomach pain and worsening distension. While you were here we did a paracentesis to remove 1.5L of fluid from your belly. We also placed you on you 40 mg of Lasix and 50 mg of Aldactone to help you urinate the excess fluid still in your belly. As we discussed everyone has a different dose of lasix required to make them urinate and it s likely that you weren t taking a high enough dose. Please take these medications daily to keep excess fluid off and eat a low salt diet. You will follow up with Dr. in liver clinic and from there have your colonoscopy and EGD scheduled. Of course we are always here if you need us. We wish you all the best Your Team. Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet Attending: . Chief Complaint: abdominal fullness and discomfort Major Surgical or Invasive Procedure: diagnostic paracentesis therapeutic paracentesis History of Present Illness: with HIV on HAART COPD HCV cirrhosis complicated by ascites and HE admitted with abdominal distention and pain. She was admitted to for the same symptoms recently and had 3L fluid removed no SBP three days ago and felt better. Since discharge her abdomen has become increasingly distended with pain. This feels similar to prior episodes of ascites. Her diuretics were recently decreased on due to worsening hyponatremia 128 and hyperkalemia 5.1. Patient states she has been compliant with her HIV and diuretic medications but never filled out the lactulose prescription. She states she has had BMs daily at home. She has had some visual hallucinations and forgetfulness. Her appetite has been poor. In the ED initial vitals were 98.9 88 116/88 18 97 RA. CBC near baseline INR 1.4 Na 125 Cr 0.6. AST and ALT mildly above baseline 182 and 126 and albumin 2.8. Diagnostic para with 225 WBC 7 PMN total protein 0.3. UA with few bact 6 WBC mod leuk neg nitr but contaminated with 6 epi. CXR clear. RUQ US with no PV thrombus moderate ascites. She was given ondansetron 4mg IV and morphine 2.5mg IV x1 in the ED. On the floor she is feeling improved but still has abdominal distention and discomfort. ROS: Abdominal distention and pain. No black/bloody stools. No pain or swelling. No fevers or chills. Denies chest pain nausea vomiting. No dysuria or frequency. Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: VS: T98.1 105/57 79 20 97RA 44.6kg GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis DISCHARGE PE: VS: T 98.4 BP 95/55 SBP HR 80 RR 18 O2 95RA I/O 240/150 this am GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis Pertinent Results: LABS ON ADMISSION: 04:10PM BLOOD Plt 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:39PM BLOOD LABS ON DISCHARGE: 05:10AM BLOOD Plt 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD MICRO: 10:39 pm URINE Source: . FINAL REPORT URINE CULTURE Final : MIXED BACTERIAL FLORA 3 COLONY TYPES CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. Diagnositc Para: 07:00PM ASCITES 07:00PM ASCITES IMAGING: CXR No acute cardiopulmonary abnormality. RUQ US 1. Extremely coarse and nodular liver echotexture consistent with a history of cirrhosis. 2. Moderate ascites. 3. Patent portal vein. Brief Hospital Course: with HIV on HAART HCV cirrhosis with ascites and HE h/o IVDU COPD bipolar disorder presents with abdominal discomfort due to ascites. ASCITES. Now diuretic refractory given last tap was three days ago with 3L removed and she has already built up moderate ascites. Infectious workup negative with CXR clear UA contaminated but not grossly positive so will f/u culture diagnostic para with only 225 WBC RUQ US with no PV thrombus. Compliant with diuretics but not following low sodium diet or fluid restriction. Dr. discussed possible TIPS in the office but due to lung disease that was on hold pending further cardiac evaluation. Diuretics were recently decreased due to hyponatremia and hyperkalemia. Held spironolactone for now due to K 5.2 and increased lasix 20 40. No evidence of severe hyponatremia Na 120 or renal failure Cr 2.0 to stop diuretics at present. Diagnostic paracentesis negative for infection. Ascitic total protein 0.3 so warrants SBP prophylaxis 1.0 and fortunately already on Bactrim for PCP prophylaxis which would be appropriate for SBP ppx also. Patient did admit to eating pizza and some food prior to admission. She had therapeutic paracentesis with 4.3L removed and received 37.5G albumin IV post procedure. She felt much better with resolution of abdominal discomfort. Patient is scheduled for repeat paracentesis as outpatient on . HEPATIC ENCEPHALOPATHY. History of HE from Hep C cirrhosis. Now with mild encephalopathy hallucinations and forgetfulness due to medication noncompliance but not acutely encephalopathic and without asterixis on exam. Infectious workup negative thus far. Continue lactulose 30mL TID and titrate to 3 BMs daily and continue rifaximin 550mg BID. HYPONATREMIA. Na 125 on admission 128 four days ago and 135 one month ago. Likely due to third spacing from worsening ascites and fluid overload. 1.5L fluid restriction low salt diet. S/p therapeutic paracentesis with albumin replacement. CIRRHOSIS HEPATITIS C. MELD score of 10 and Child s class B on this admission. Now decompensated due to ascites. Hepatitis C genotype IIIB. Dr. starting and with patient in clinic and the insurance process was started by her office. No history of EGD needs this as outpatient for varices screening. NUTRITION. Unclear if truly compliant with low salt diet. Poor oral intake. Low albumin 2.8 on admission. Met with nutrition. COAGULOPATHY. INR 1.4 four days ago. No evidence of active bleeding. Very mild thrombocytopenia with plts 143. HIV. Most recent CD4 173. On HAART. No established ID provider. Continue Truvada and Isentress Bactrim DS daily for PCP . Needs outpatient ID appointment COPD. Stable. States she is on intermittent home O2 for comfort at night and with abdominal distentiom. Continued home COPD meds and home O2 as needed Transitional Issues Discontinued spironolactone elevated potassium Increased furosemide to 40mg daily Please recheck electrolytes at next visit Had paracentesis with 4.3 L removed received 37.5G albumin Needs outpatient ID provider needs more frequent paracentesis Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 2. Truvada 1 TAB PO DAILY 3. Furosemide 20 mg PO DAILY 4. Raltegravir 400 mg PO BID 5. Spironolactone 50 mg PO DAILY 6. Acetaminophen 500 mg PO Q6H:PRN pain fever 7. Tiotropium Bromide 1 CAP IH DAILY 8. Rifaximin 550 mg PO BID 9. Calcium Carbonate 1250 mg PO BID 10. Lactulose 15 mL PO TID 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Acetaminophen 500 mg PO Q6H:PRN pain fever 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 3. Calcium Carbonate 1250 mg PO BID 4. Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. Lactulose 15 mL PO TID 7. Raltegravir 400 mg PO BID 8. Rifaximin 550 mg PO BID 9. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 10. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: diuretic refractory ascites Secondary: HCV cirrhosis HIV hyponatremia COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear was a pleasure to take care of you at . You were admitted with abdominal fullness and pain from your ascites. You had a diagnostic and therapeutic paracentesis with 4.3 L removed. Your spironolactone was discontinued because your potassium was high. Your lasix was increased to 40mg daily. You are scheduled for another paracentesis on prior to your other appointments that day. Please call tomorrow to find out the time of the paracentesis. Please continue to follow a low sodium diet and fluid restriction. You should call your liver doctor or return to the emergency room if you have abdominal pain fever chills confusion or other concerning symptoms. Sincerely Your medical team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: Chief Complaint: altered mental status Major Surgical or Invasive Procedure: none History of Present Illness: Mrs. is a female with HIV on HAART COPD HCV cirrhosis complicated by ascites and hepatic encephalopathy who initially presented to the ED yesterday with hypotension after a paracentesis. The patient has had accelerated decompensation of her cirrhosis recently with worsening ascites and she is maintained on twice weekly paracentesis. She was at her regular session yesterday when she had hypotension to SBP and felt lightheadedness. Per the patient that s when her memory started to get fuzzy. She does not have much recollection of what happened since then. Her outpatient hepatologist saw her and recommended that she go to the ED. In the ED she was evaluated and deemed to have stable blood pressure. She was discharged home. At home she had worsening mental status with her daughter getting concerned and she returned to the ED. In the ED initial vitals were 98.7 77 96/50 16 98 RA. The patient was only oriented to person. Her labs were notable for Na 126 K 6.7 Cr 0.7 baseline 0.4 ALT 153 AST 275 TBili 1.9 Lip 66 INR 1.5. Initial EKG showed sinus rhythm with peaked T waves. Her head CT was negative for any acute processes. She received ceftriaxone 2gm x1 regular insulin 10U calcium gluconate 1g lactulose 30 mL x2 and 25g 5 albumin. On transfer vitals were 99.0 93 84/40 16 95 NC. On arrival to the MICU patient was more alert and conversant. She has no abdominal pain nausea vomiting chest pain or difficulty breathing. She has a chronic cough that is not much changed. She has not had any fever or chills. She reports taking all of her medications except for lactulose which she thinks taste disgusting. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals T: 98.7 BP: 84/48 P: 91 R: 24 O2: 98 NC on 2L GENERAL: Alert oriented no acute distress LUNGS: Decreased air movement on both sides scattered expiratory wheezes CV: Regular rate and rhythm normal S1 S2 no murmurs rubs gallops ABD: Soft non tender distended flank dullness bilaterally bowel sounds present EXT: Warm well perfused 2 pulses no cyanosis or edema DISCHARGE PHYSICAL EXAM: Vitals Tm 99.5 Tc 98.7 79 96/43 58 20 95 on 3L NC 7BM. General Cachectic appearing woman alert oriented no acute distress HEENT Sclera anicteric MMM oropharynx clear poor dentition with partial dentures Neck supple JVP not elevated no LAD Lungs Clear to auscultation bilaterally no wheezes rales ronchi CV Regular rate and rhythm normal S1 S2 no murmurs rubs gallops Abdomen Mildly distended and firm non tender bowel sounds present no rebound tenderness or guarding GU no foley Ext warm well perfused 2 pulses no clubbing cyanosis or edema Neuro AOx3 No asterixis. Pertinent Results: ADMISSION LABS: 06:39AM BLOOD WBC 6.9 RBC 3.98 Hgb 14.1 Hct 41.1 MCV 103 MCH 35.4 MCHC 34.3 RDW 15.8 Plt 06:39AM BLOOD Neuts 72.7 Lymphs 14.7 Monos 9.8 Eos 2.5 Baso 0.3 06:39AM BLOOD PTT 32.4 06:39AM BLOOD Glucose 102 UreaN 49 Creat 0.7 Na 126 K 6.7 Cl 95 HCO3 25 AnGap 13 06:39AM BLOOD ALT 153 AST 275 AlkPhos 114 TotBili 1.9 06:39AM BLOOD Albumin 3.6 IMAGING/STUDIES: CT HEAD: No evidence of acute intracranial process. The left zygomatic arch deformity is probably chronic as there is no associated soft tissue swelling. CXR: No acute intrathoracic process. DISCHARGE LABS: 04:45AM BLOOD WBC 4.8 RBC 3.15 Hgb 11.2 Hct 32.1 MCV 102 MCH 35.4 MCHC 34.8 RDW 15.8 Plt Ct 95 04:45AM BLOOD PTT 37.6 04:45AM BLOOD Glucose 121 UreaN 35 Creat 0.4 Na 130 K 5.2 Cl 97 HCO3 27 AnGap 11 04:45AM BLOOD ALT 96 AST 168 AlkPhos 69 TotBili 1.7 04:45AM BLOOD Calcium 8.6 Phos 2.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities w/ AMS hypotension and hyperkalemia. Altered mental status improved with lactulose. Hypotension was felt to be due to fluid shifts from paracentesis on the day prior to admission as well as low PO intake in the setting of AMS. Hypotension and resolved with IV albumin. Hyperkalemia resolved with insulin and kayexalate. Hypotension: Patient presented with SBP in and improved with albumin in the ED to . It was felt to be due to fluid shifts from paracentesis on as well as likely hypovolemia given AMS and decreased PO intake. No concern for bleeding or sepsis with baseline CBC and lack of fever. She continued to received IV albumin during her hospital course with which her SBP improved to and patient remained asymptomatic. Hyperkalemia: Patient presented with K 6.7 with EKG changes. Given low Na likely the result of low effective arterial volume leading to poor K excretion with likely exacerbation from . AM cortisol was normal. K improved with insulin and kayexalate and K was 5.2 on day of discharge. Bactrim was held during hospital course. : Patient presented with Cr 0.7 from baseline Cr is 0.3 0.4. It was felt to be likely due to volume shift from her paracentesis on the day prior to admission as well as now low effective arterial volume likely poor PO intake AMS. Cr improved to 0.4 with albumin administration. Furosemide and Bactrim were held during hospital course. GOC: The son HCP met with Dr. outpatient hepatologist during hospital course. They discussed that the patient is not a transplant candidate givenevere underlying lung disease FEV1 0.8 hypoxia RV dilation and very low BMI. A more conservative approach was recommended and the patient was transitioned to DNR/DNI. The patient agreed with this plan. She was treated with the goal of treating any any correctable issues. Social work met with the patient prior to discharge. The patient was interested in following up with palliative care for which an outpatient referral was made. Altered Mental Status: Patient presented with confusion that was most likely secondary to hepatic encephalopathy. Based on outpatient records patient has had steady decline in decompensated cirrhosis and mental status. No signs of infection and head CT was negative as well. Mental status improved with lactulose in the ED and patient reports that she has not been taking lactulose regularly at home. Patient was also continued on rifaximin. HCV Cirrhosis: Genotype 3a. Patient is decompensated with increasing ascites and worsening hepatic encephalopathy. She is dependent on twice weekly paracentesis. Spironolactone was recently stopped due to hyperkalemia. Patient is not a transplant candidate given her comorbidities COPD per outpatient hepatologist. The patient would like to continue biweekly paracenteses as an outpatient. HIV: Most recent CD4 count 173 on . HIV viral load on was undetectable. She was continued on her home regimen of raltegravir emtricitabine and tenofovir. Bactrim prophylaxis was held during admission because of hyperkalemia. COPD: Patient on 3L NC at home. She was continued on her home regimen. TRANSITIONAL ISSUES: Follow up with Palliative Care as outpatient Bactrim prophylaxis HIV was held during hospital course due to . Consider restarting as outpatient. Furosemide was held due to consider restarting as outpatient Follow up with hepatology Continue biweekly therapeurtic paracenteses Code status: DNR/DNI Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lactulose 15 mL PO TID 2. Tiotropium Bromide 1 CAP IH DAILY 3. Raltegravir 400 mg PO BID 4. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. TraMADOL Ultram 50 mg PO Q8H:PRN Pain 7. Fluticasone Propionate 110mcg 1 PUFF IH BID 8. Calcium Carbonate 500 mg PO BID 9. Rifaximin 550 mg PO BID 10. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: Hypotension Hyperkalemia Acute Kidney Injury Secondary: HIV Cirrhosis COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. You were admitted to because of confusion low blood pressure and a high potassium value. Your confusion improved with lactulose. Your blood pressure improved with extra fluids and your potassium improved as well. You also had small degree of kidney injury when you came to the hospital and this also improved with fluids. While you were here you discussed changing your goals of care to focusing on symptom management and treatment of reversible processes such as an infection. While you were in the hospital you were seen by one of our social workers. You will also follow up with Palliative Care in their clinic and will continue to have therapeutic paracenteses. It has been a pleasure taking care of you and we wish you all the best Your Care team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: . Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: w/ HIV on HAART COPD on 3L home O2 though sat ing fine on RA on admission HCV cirrhosis c/b ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening girth and abd pain. She d been having pain from her ascites and felt overdue for a paracentesis. She last had paracentesis on the . She reported that she began feeling worsening abdominal pain constant epigastric and radiates to back not a/w food on which increased in severity throughout the course of the day. She was brought to the ED by her son because of this pain. She had no confusion and was alert and oriented x3. The patient also reported she recently ran out of most of her home medications. She denied any fever chills shortness of breath cough dysuria. She reported loose stool a bit more than usual but attributed it to lactulose use. In the ED vitals were: 99.4 105 106/57 18 96 ra. Labs were significant for Na 127 K 5.3 lactate 2.1 INR 1.7. ALT 135 AST 244 AP 123. no leukocytosis. Ascitic fluid showed 220 WBC. She was given Morphine Sulfate 5 mg IV ONCE MR1 and a GI cocktail. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM Vitals T 97 BP 98/65 HR 103 RR 18 O2 94RA Glucose 128. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: distended fluid wave not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes DISCHARGE PHYSICAL EXAM Vitals Tm 98.6 Tc 98.2 BP 82 98/42 68 HR 80 95 RR O2 91 99 RA. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: soft decreased distension not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes Pertinent Results: ADMISSION LABS 09:20PM BLOOD WBC 8.2 RBC 3.48 Hgb 12.3 Hct 36.7 MCV 106 MCH 35.5 MCHC 33.6 RDW 16.5 Plt 09:28PM BLOOD PTT 31.8 09:20PM BLOOD Glucose 118 UreaN 33 Creat 0.6 Na 127 K 5.3 Cl 97 HCO3 24 AnGap 11 09:20PM BLOOD ALT 135 AST 244 AlkPhos 123 TotBili 1.3 09:20PM BLOOD Albumin 3.5 Calcium 8.3 Phos 3.3 Mg 2.3 09:27PM BLOOD Lactate 2.1 NOTABLE LABS 12:30AM ASCITES WBC 220 Polys 17 Lymphs 48 Monos 19 Mesothe 2 Macroph 12 Other 2 12:30AM ASCITES TotPro 0.7 Glucose 129 MICROBIOLOGY 12:30 am PERITONEAL FLUID GRAM STAIN Final : NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. VRE screen: No VRE isolated. IMAGING/STUDIES CXR No acute cardiopulmonary process. RUQUS Cirrhotic mild splenomegaly and ascites. A solid 3cm nodule in the left lobe of the liver is stable in size and appearance. DISCHARGE LABS 06:15AM BLOOD WBC 5.6 RBC 3.27 Hgb 11.6 Hct 33.5 MCV 103 MCH 35.5 MCHC 34.5 RDW 16.1 Plt 06:15AM BLOOD PTT 36.0 06:15AM BLOOD Glucose 87 UreaN 29 Creat 0.4 Na 123 K 5.4 Cl 93 HCO3 24 AnGap 11 06:15AM BLOOD ALT 112 AST 176 AlkPhos 101 TotBili 2.8 06:15AM BLOOD Albumin 3.5 Calcium 8.8 Phos 3.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening abd girth and pain. Goals of care: The patient expressed that her desire to let go and be at peace. She is tired of fighting her end stage liver disease and does not feel that she has a good quality of life. She wished to meet with a representative from hospice which we were able to arrange and she decided that she would like to go home with hospice. A conversation was held with the patient regarding code status. She noted that she would probably be DNR/DNI but would like to discuss it with her son HCP . Therefore at this time she remains full code. We also discussed the possibility of her getting a pleurex catheter placed because of her repeated paracenteses. She was discharged to home with hospice on . Decompensated HCV cirrhosis with ascites: The patient presented with worsening ascites. Her pain was initially managed with tramadol and morphine. She underwent paracentesis on with removal of 3.5L and she received albumin. Studies on the fluid were negative and she reported a significant improvement in her pain. Hyperkalemia: During her hospitalization it was noted that she had hyperkalemia 5.3 5.9 6.9 without EKG changes. After treatment with calcium gluconate 2gm x2 insulin and D50 x 2 and kayexelate her K downtrended to 5.4. Her K has been persistently elevated in the past and should continue to be monitored. Hepatic encephalopathy: The patient s mental status was A Ox3 on admission. She was continued on rifaximin and lactulose in house and at discharge. CHRONIC ISSUES Hyponatremia The patient has a history of asymptomatic hyponatremia. It is most likely hypervolemic hyponatremia related to underlying liver disease as well as aldosterone axis dysfunction related to liver disease. She remained asymptomatic through her hospitalization. Because she was also started on 10mg of furosemide to help prevent fluid re accumulation she will require BMPs twice weekly in the outpatient setting. HIV: Emtricitabine Tenofovir Truvada and Raltegravir were continued in house and at discharge. COPD: fluticasone tiotropium and albuterol were continued in house and at discharge. TRANSITIONAL ISSUES Follow up peritoneal fluid culture New/changed medications: Furosemide 10mg daily new For hyperkalemia and hyponatremia the patient should have biweekly BMPs script written . If K 5.3 she should be given kayexelate once weekly. Lab results will be faxed/sent to Dr. . Continue conversation regarding pleurex catheter placement and code status. She will continue to have twice weekly paracenteses Code: full Emergency Contact: on Admission: The Preadmission Medication list is accurate and complete. 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Medications: 1. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 2. Calcium Carbonate 500 mg PO BID 3. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 4. Fluticasone Propionate 110mcg 1 PUFF IH BID 5. Lactulose 30 mL PO TID 6. Raltegravir 400 mg PO BID 7. Rifaximin 550 mg PO BID 8. Tiotropium Bromide 1 CAP IH DAILY 9. TraMADOL Ultram mg PO Q6H:PRN pain 10. Furosemide 10 mg PO DAILY RX furosemide 20 mg 0.5 One half tablet s by mouth Please take 1 tablet daily. Disp 15 Tablet Refills: 0 11. Outpatient Lab Work Please obtain biweekly BMP to monitor K and Na. Please fax results to Dr. at the at . Discharge Disposition: Home With Service Facility: Discharge Diagnosis: PRIMARY DIAGNOSIS Decompensated HCV cirrhosis Hyperkalemia SECONDARY DIAGNOSES HIV COPD Hyponatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure caring for you during your stay at . You were admitted because of worsening abdominal pain. It is likely that this pain was due to increasing fluid in the abdomen from your cirrhosis. After a paracentesis in which much of this fluid was removed your pain improved significantly. You were noted to have a high potassium during your hospitalization which came down with treatment but this should continue to be followed as an outpatient. You also emphasized your desire to speak with a representative from hospice. Because of your repeated paracenteses we also discussed the possibility of a pleurex catheter placement. We arranged for you to meet with hospice coordinators and you will be discharged home with hospice. We wish you all the best Your care team Followup Instructions:</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>1</td>\n",
              "      <td>10000084</td>\n",
              "      <td>Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: . Chief Complaint: Visual hallucinations Major Surgical or Invasive Procedure: N/A History of Present Illness: male with disease dyslipidemia and a history of prostate cancer s/p prostatectomy who was referred to the ED by his neurologist for worsening gait falls and visual hallucinations. The following history is taken from chart review: The patient was seen by his neurologist on at which time he was noted to have visual hallucinations and worsening gait freezing. For his gait freezing his mirapex was increased by 0.125 mg every week to a goal dose of 0.75 mg t.i.d. He successfully up titrated the medicine to 0.75/0.625/0.625 but began to have visual hallucinations and confusion so on his neurologist recommended decreasing the dose to 0.625 TID. Despite the changes to his Mirapex the patient s daughter has noted progressive gait stiffness and increased difficulty standing. This has resulted in difficulty with simply getting to the bathroom leading to episodes of incontinence. A UA performed on was reassuring. On the day of presentation to the hospital the patient began to experience visual hallucinations of a motor cross race in his backyard. He subsequently had a fall while transferring from the couch to a chair. His wife was unable to get him off the floor. The fall was witnessed and there was no head strike. Per the patient s wife his gait has acutely worsened over the past 24 hours to the point where he has been unable to ambulate on his own. The patient s daughter called his neurologist who recommended presentation to the ED. In the ED the patient was afebrile HRs normotensive and SpO2 100 RA. On exam he was noted to have cogwheeling of upper extremities and decrease strength. Labs were remarkable for a negative urine and serum tox Na 132 K 5.8 hemolyzed and no EKG changes negative troponin normal LFTs unremarkable CBC. Chest Xray showed no acute process and CTH was reassuring. He was evaluated by neurology who recommended admission to medicine for failure to thrive to continue the patient s home medications and complete a toxo metabolic workup. The patient was given his home pramipexole and pravastatin before he was admitted. On arrival to the floor the patient is comfortable in bed. He is not accompanied by family on my interview. He knows that he is in the hospital and that it is . He is not sure why he is here and begins to tell me about a party in his house with a motor cross race in his backyard. When I asked him about his fall he mentions that he has not had a fall for years. He denies any fevers chills cough chest pain abdominal pain nausea diarrhea or dysuria. REVIEW OF SYSTEMS: Per HPI otherwise 10 point review of systems was within normal limits. Past Medical History: disease Body Dementia dyslipidemia prostate cancer s/p prostatectomy Social History: Family History: His mother died at age of old age. His father died of prostate cancer at . He has an older sister age and a younger sister age . He has a younger brother age . As noted he has 2 daughters. There is no family history of neurologic illness or dementia. There is no family history of neurodevelopmental mental disorders such as learning disability or ADHD. There is no family history of psychiatric problems. Physical Exam: ADMISSION PHYSICAL EXAM: VITALS: reviewed in OMR GENERAL: Alert and interactive. In no acute distress. HEENT: PERRL EOMI. Sclera anicteric and without injection. MMM. NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes rhonchi or rales. No increased work of breathing. BACK: No CVA tenderness. ABDOMEN: Normal bowels sounds non distended non tender to deep palpation in all four quadrants. No organomegaly. EXTREMITIES: No clubbing cyanosis or edema. Pulses DP/Radial 2 bilaterally. SKIN: Warm. Cap refill 2s. No rashes. NEUROLOGIC: AOx3. CN2 12 intact. cogwheel UE b/l. Increased tone in LEs strength b/l . Normal sensation. DISCHARGE PHYSICAL EXAM 24 HR Data last updated 2340 Temp: 97.7 Tm 98.4 BP: 130/80 130 153/80 90 HR: 80 80 104 RR: 18 O2 sat: 100 95 100 O2 delivery: Ra GENERAL: In no acute distress. Talking very quietly. CARDIAC: Regular rhythm normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes rhonchi or rales. No increased work of breathing. ABDOMEN: Normal bowels sounds non distended non tender to deep palpation in all four quadrants. EXTREMITIES: No clubbing cyanosis or edema. Pulses DP/Radial 2 bilaterally. SKIN: Warm. NEUROLOGIC: AOx3. CN2 12 intact. cogwheel UE b/l. Increased tone in LEs strength b/l . Normal sensation. Pertinent Results: ADMISSION LABS: 10:30PM BLOOD WBC 8.6 RBC 4.03 Hgb 12.8 Hct 38.2 MCV 95 MCH 31.8 MCHC 33.5 RDW 13.0 RDWSD 45.2 Plt 10:30PM BLOOD Neuts 48.1 Monos 15.9 Eos 2.0 Baso 0.6 Im AbsNeut 4.13 AbsLymp 2.86 AbsMono 1.36 AbsEos 0.17 AbsBaso 0.05 10:30PM BLOOD PTT 23.4 10:30PM BLOOD Glucose 100 UreaN 17 Creat 0.8 Na 132 K 5.8 Cl 98 HCO3 19 AnGap 15 10:30PM BLOOD ALT 18 AST 38 AlkPhos 39 TotBili 0.4 10:30PM BLOOD Lipase 47 10:30PM BLOOD cTropnT 0.01 10:30PM BLOOD Albumin 4.0 Calcium 9.9 Phos 3.7 Mg 2.0 10:30PM BLOOD VitB12 570 10:30PM BLOOD TSH 1.4 07:00AM BLOOD Trep Ab NEG 10:30PM BLOOD ASA NEG Ethanol NEG Acetmnp NEG Tricycl NEG IMAGING: Imaging CT HEAD W/O CONTRAST FINDINGS: There is no evidence of infarction hemorrhage edema or mass. There is prominence of the ventricles and sulci suggestive of involutional changes. There is no evidence of fracture. The visualized portion of the remaining paranasal sinuses and middle ear cavities are clear. The visualized portion of the orbits are unremarkable apart from bilateral lens replacements. IMPRESSION: 1. No acute intracranial abnormality. No hydrocephalus. Imaging CHEST PA LAT IMPRESSION: Mild atelectasis in the lung bases without focal consolidation. Age indeterminate moderate to severe compression deformity of a low thoracic vertebral body. DISCHARGE LABS: 06:21AM BLOOD WBC 7.0 RBC 4.02 Hgb 12.9 Hct 38.1 MCV 95 MCH 32.1 MCHC 33.9 RDW 12.8 RDWSD 44.4 Plt 06:21AM BLOOD Glucose 88 UreaN 10 Creat 0.7 Na 140 K 4.0 Cl 104 HCO3 24 AnGap 12 06:21AM BLOOD Calcium 9.5 Phos 3.2 Mg 1. male with disease dyslipidemia and a history of prostate cancer s/p prostatectomy who was referred to the ED by his neurologist for worsening gait falls and visual hallucinations concerning for progression of his neurologic disorder. ACUTE/ACTIVE ISSUES: disease Body Dementia Visual Hallucinations The patient appears to have acute on chronic progression of his disease. Unclear if this is disease progression or underlying medical cause. Continued mirapex rasagiline and rivastigmine. Neurology recommended started Seroquel for his hallucinations. He was evaluated by physical therapy who recommended rehab. This recommendation was discussed with the family who opted for discharge to home with home physical therapy as this was in line with the patient s goals of care. TRANSITIONAL ISSUES: f/u visual hallucination symptoms on Seroquel f/u physical therapy at home Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Rasagiline 1 mg PO DAILY 2. Pramipexole 0.625 mg PO TID 3. rivastigmine 9.5 mg/24 hr transdermal DAILY 4. Pravastatin 40 mg PO QPM 5. Cyanocobalamin Dose is Unknown PO DAILY 6. Loratadine 10 mg PO DAILY Discharge Medications: 1. QUEtiapine Fumarate 25 mg PO QHS RX quetiapine 25 mg 1 tablet s by mouth AT NIGHT Disp 30 Tablet Refills: 0 2. Loratadine 10 mg PO DAILY 3. Pramipexole 0.625 mg PO TID 4. Pravastatin 40 mg PO QPM 5. Rasagiline 1 mg PO DAILY 6. rivastigmine 9.5 mg/24 hr transdermal DAILY Discharge Disposition: Home With Service Facility: Discharge Diagnosis: Dementia Discharge Condition: Mental Status: Confused sometimes. Level of Consciousness: Alert and interactive. Discharge Instructions: Dear Mr. It was a privilege caring for you at . WHY WAS I IN THE HOSPITAL You were sent to the emergency room by your neurologist who was concerned that you were having visual hallucinations. WHAT HAPPENED TO ME IN THE HOSPITAL You were started on a new medication to help treat your symptoms. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL Continue to take all your medicines and keep your appointments. We wish you the best Sincerely Your Team Followup Instructions:</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>2</td>\n",
              "      <td>10000117</td>\n",
              "      <td>Sex: F Service: MEDICINE Allergies: omeprazole Attending: . Chief Complaint: dysphagia Major Surgical or Invasive Procedure: Upper endoscopy History of Present Illness: w/ anxiety and several years of dysphagia who p/w worsened foreign body sensation. She describes feeling as though food gets stuck in her neck when she eats. She put herself on a pureed diet to address this over the last 10 days. When she has food stuck in the throat she almost feels as though she cannot breath but she denies trouble breathing at any other time. She does not have any history of food allergies or skin rashes. In the ED initial vitals: 97.6 81 148/83 16 100 RA Imaging showed: CXR showed a prominent esophagus Consults: GI was consulted. Pt underwent EGD which showed a normal appearing esophagus. Biopsies were taken. Currently she endorses anxiety about eating. She would like to try eating here prior to leaving the hospital. Past Medical History: GERD Hypercholesterolemia Kidney stones Mitral valve prolapse Uterine fibroids Osteoporosis Migraine headaches Social History: Family History: HTN father Dementia father Physical Exam: ADMISSION/DISCHARGE EXAM VS: 97.9 PO 109 / 71 70 16 97 ra GEN: Thin anxious woman lying in bed no acute distress HEENT: Moist MM anicteric sclerae NCAT PERRL EOMI NECK: Supple without LAD no JVD PULM: CTABL no w/c/r COR: RRR S1/S2 no m/r/g ABD: Soft non tender non distended BS no HSM EXTREM: Warm well perfused no edema NEURO: CN II XII grossly intact motor function grossly normal sensation grossly intact Pertinent Results: ADMISSION LABS 08:27AM BLOOD WBC 5.0 RBC 4.82 Hgb 14.9 Hct 44.4 MCV 92 MCH 30.9 MCHC 33.6 RDW 12.1 RDWSD 41.3 Plt 08:27AM BLOOD PTT 28.6 08:27AM BLOOD Glucose 85 UreaN 8 Creat 0.9 Na 142 K 3.6 Cl 104 HCO3 22 AnGap 20 08:27AM BLOOD ALT 11 AST 16 LD LDH 154 AlkPhos 63 TotBili 1.0 08:27AM BLOOD Albumin 4.8 IMAGING CXR : IMPRESSION: Prominent esophagus on lateral view without air fluid level. Given the patient s history and radiographic appearance barium swallow is indicated either now or electively. NECK X ray : IMPRESSION: Within the limitation of plain radiography no evidence of prevertebral soft tissue swelling or soft tissue mass in the neck. EGD: Impression: Hiatal hernia Angioectasia in the stomach Angioectasia in the duodenum biopsy biopsy Otherwise normal EGD to third part of the duodenum Recommendations: no obvious anatomic cause for the patient s symptoms follow up biopsy results to rule out eosinophilic esophagitis follow up with Dr. if biopsies show eosinophilic esophagitis Brief Hospital Course: Ms. is a with history of GERD who presents with subacute worsening of dysphagia and foreign body sensation. This had worsened to the point where she placed herself on a pureed diet for the last 10 days. She underwent CXR which showed a prominent esophagus but was otherwise normal. She was evaluated by Gastroenterology and underwent an upper endoscopy on . This showed a normal appearing esophagus. Biopsies were taken. TRANSITIONAL ISSUES: f/u biopsies from EGD if results show eosinophilic esophagitis follow up with Dr. . for management pt should undergo barium swallow as an outpatient for further workup of her dysphagia f/u with ENT as planned Code: Full presumed Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Omeprazole 20 mg PO BID Discharge Medications: 1. Omeprazole 20 mg PO BID Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: dysphagia and foreign body sensation SECONDARY DIAGNOSIS: GERD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. You were hospitalized at . You came in due to difficulty swallowing. You had an endoscopy to look for any abnormalities in the esophagus. Thankfully this was normal. They took biopsies and you will be called with the results. You should have a test called a barium swallow as an outpatient. We wish you all the best Your Team Followup Instructions: Sex: F Service: ORTHOPAEDICS Allergies: omeprazole / Iodine and Iodide Containing Products / hallucinogens Attending: . Chief Complaint: Left hip pain Major Surgical or Invasive Procedure: Status post left CRPP History of Present Illness: REASON FOR CONSULT: Femur fracture HPI: female presents with the above fracture s/p mechanical fall. This morning pt was walking when dog pulled on leash. Pt fell on L hip. Immediate pain. with movement. Denies Head strike LOC or blood thinners. Denies numbness or weakness in the extremities. Past Medical History: GERD Hypercholesterolemia Kidney stones Mitral valve prolapse Uterine fibroids Osteoporosis Migraine headaches Social History: Family History: HTN father Dementia father Physical Exam: General: Well appearing female in no acute distress. Left Lower extremity: Skin intact No deformity edema ecchymosis erythema induration Soft non tender thigh and leg Full painless ROM knee and ankle Fires SILT S/S/SP/DP/T distributions 1 pulses WWP Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a left valgus impacted femoral neck fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on for left closed reduction and percutaneous pinning of hip which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications and progressed to a regular diet and oral medications by POD 1. The patient was given antibiotics and anticoagulation per routine. The patient s home medications were continued throughout this hospitalization. The patient worked with who determined that discharge to home with services was appropriate. The hospital course was otherwise unremarkable. At the time of discharge the patient s pain was well controlled with oral medications incisions were clean/dry/intact and the patient was voiding/moving bowels spontaneously. The patient is weightbearing as tolerated in the left lower extremity and will be discharged on Lovenox for DVT prophylaxis. The patient will follow up with Dr. routine. A thorough discussion was had with the patient regarding the diagnosis and expected post discharge course including reasons to call the office or return to the hospital and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow up care. The patient expressed readiness for discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lactaid lactase 3 000 unit oral DAILY:PRN 2. Calcium Citrate D calcium citrate vitamin D3 315 200 mg unit oral DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO Q6H:PRN Pain Mild/Fever 2. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 3. Docusate Sodium 100 mg PO BID 4. Enoxaparin Sodium 40 mg SC QHS RX enoxaparin 40 mg/0.4 mL 40 mg Subcutaneously Nightly Disp 30 Syringe Refills: 0 5. OxyCODONE Immediate Release mg PO Q4H:PRN Pain Moderate RX oxycodone 5 mg 1 tablet s by mouth q4 PRN Disp 25 Tablet Refills: 0 6. Senna 8.6 mg PO BID 7. Calcium Citrate D calcium citrate vitamin D3 315 200 mg unit oral DAILY 8. Lactaid lactase 3 000 unit oral DAILY:PRN 9. Multivitamins 1 TAB PO DAILY 10. Vitamin D 400 UNIT PO DAILY Discharge Disposition: Home With Service Facility: Discharge Diagnosis: Left valgus impacted femoral neck fracture Discharge Condition: AVSS NAD A Ox3 LLE: Incision well approximated. Dressing clean and dry. Fires FHL TA GCS. SILT n distributions. 1 DP pulse wwp distally. Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: You were in the hospital for orthopedic surgery. It is normal to feel tired or washed out after surgery and this feeling should improve over the first few days to week. Resume your regular activities as tolerated but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: Weightbearing as tolerated left lower extremity MEDICATIONS: 1 Take Tylenol every 6 hours around the clock. This is an over the counter medication. 2 Add oxycodone as needed for increased pain. Aim to wean off this medication in 1 week or sooner. This is an example on how to wean down: Take 1 tablet every 3 hours as needed x 1 day then 1 tablet every 4 hours as needed x 1 day then 1 tablet every 6 hours as needed x 1 day then 1 tablet every 8 hours as needed x 2 days then 1 tablet every 12 hours as needed x 1 day then 1 tablet every before bedtime as needed x 1 day. Then continue with Tylenol for pain. 3 Do not stop the Tylenol until you are off of the narcotic medication. 4 Per state regulations we are limited in the amount of narcotics we can prescribe. If you require more you must contact the office to set up an appointment because we cannot refill this type of pain medication over the phone. 5 Narcotic pain relievers can cause constipation so you should drink eight 8oz glasses of water daily and continue following the bowel regimen as stated on your medication prescription list. These meds senna colace miralax are over the counter and may be obtained at any pharmacy. 6 Do not drink alcohol drive a motor vehicle or operate machinery while taking narcotic pain relievers. 7 Please take all medications as prescribed by your physicians at discharge. 8 Continue all home medications unless specifically instructed to stop by your surgeon. ANTICOAGULATION: Please take Lovenox daily for 4 weeks Followup Instructions:</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>3</td>\n",
              "      <td>10000248</td>\n",
              "      <td>Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: . Chief Complaint: Right flank bruising and pain s/p fall Major Surgical or Invasive Procedure: None History of Present Illness: Mr. is a with history of factor VIII deficiency who presents with right neck swelling after snowboarding accident. The patient reports that he fell while snowboarding with loss of consciousness on . He was initially seen at where CT imaging of head/neck showed no intracranial hemorrhage. A CTA neck showed a thickened right platysma muscle with surrounding hematoma and a focus of active contrast extravasation within the right platysma muscle. He also developed a right shoulder hematoma although shoulder plain films didn t show acute abnormality. He was seen by Hematology and gave him one dose of DDAVP IV. A factor VIII assay was 139 and vW level was 200 per report. Per report his hemoglobin decreased from 13.2 on to 11.6 on . Repeat imaging in the morning showed stable injuries. The patient saw his hematologist on and was found to have a hemoglobin of 10.4. Because of the continued mild decrease the patient followed up with his PCP at which time his hemoglobin was 9.9. He was found to have an enlarging flank hematoma thus was referred given concern for retroperitoneal bleed. The patient has been using DDAVP intranasally intermittently since the accident. He denies lightheadedness or palpitations any increase in neck swelling over the course of the week. He does endorse pain in his right shoulder resting moving though this has improved over the course of the week. In the ED initial vital signs were 99.2 87 124/75 18 100 /RA. Initial labs demonstrated hemoglobin 10.6 though repeat was 9.7. Chemistries and coags were unremarkable. FVIII activity was 103. A CTAP was performed which demonstrated muscular hemorrhage along the flank but no retroperitoneal bleed on preliminary read. The patient s outpatient hematologist Dr. was contacted and it was decided to give the patient desmopressin 0.3mg/kg IV. The patient was then admitted for futher management. Per review of records the patient has a history of significant bleeding after his circumcision requiring blood transfusion. Throughout childhood he also had a tendency to bruise easily. He was tested and found to have disease. Later after wisdom tooth extraction the patient experienced late e.g. days later bleeding despite treatment with DDAVP. The patient was retested by a hematologist associated with the and was diagnosed with hemophilia A. His FVIII activity has been checked on multiple occasions sometimes testing normal though has been as low as 50. Upon arrival to the floor the patient is comfortable without complaint. Review of Systems: per HPI fever chills night sweats headache vision changes rhinorrhea congestion sore throat cough shortness of breath chest pain abdominal pain nausea vomiting diarrhea constipation BRBPR melena hematochezia dysuria hematuria. Past Medical History: Factor VIII deficiency mild Social History: Family History: The patient s mother had tendency to bleed. Physical Exam: ON ADMISSION VS:98 120/40 64 20 100RA GENERAL: lying flat in bed no acute distress HEENT: NCAT MMM OP clear NECK: Supple CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: Generally CTA b/l ABDOMEN: Soft non tender non distended EXTREMITIES: Warm well perfused PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact SKIN: Hematomas on right aspect of neck and flank ON DISCHARGE Vitals: 98.0 100 120/40 58 66 20 99 on RA GENERAL: lying flat in bed no acute distress HEENT: NCAT MMM OP clear NECK: Supple CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: Generally CTA b/l ABDOMEN: Soft non tender non distended EXTREMITIES: Warm well perfused PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact SKIN: Hematomas on right aspect of neck and flank Pertinent Results: ADMISSION DISCHARGE PERTINENT LABS: 07:03PM BLOOD WBC 6.6 RBC 3.58 Hgb 10.6 Hct 29.8 MCV 83 MCH 29.6 MCHC 35.6 RDW 14.7 Plt 07:03PM BLOOD Neuts 69.7 Monos 7.2 Eos 2.4 Baso 0.2 07:03PM BLOOD PTT 35.2 07:03PM BLOOD Plt 07:03PM BLOOD FacVIII 103 07:03PM BLOOD Glucose 93 UreaN 15 Creat 0.8 Na 139 K 4.1 Cl 101 HCO3 28 AnGap 14 11:00PM BLOOD WBC 6.6 RBC 3.30 Hgb 9.7 Hct 27.0 MCV 82 MCH 29.4 MCHC 36.0 RDW 14.7 Plt 07:25AM BLOOD WBC 5.2 RBC 3.14 Hgb 9.3 Hct 26.2 MCV 83 MCH 29.7 MCHC 35.7 RDW 14.6 Plt 03:25PM BLOOD WBC 6.3 RBC 3.27 Hgb 9.9 Hct 27.1 MCV 83 MCH 30.3 MCHC 36.5 RDW 14.7 Plt 07:50PM URINE Color Yellow Appear Clear Sp 07:50PM URINE Blood NEG Nitrite NEG Protein 30 Glucose NEG Ketone NEG Bilirub NEG Urobiln NEG pH 6.0 Leuks NEG 07:50PM URINE RBC 1 WBC 1 Bacteri FEW Yeast NONE Epi 0 07:50PM URINE Mucous RARE IMAGING/STUDIES: CT A/P Acute hemorrhage along right posterior flank musculature and probably layering over it only partly imaged and hard to distinguish musculature from hemorrhage. No active extravasation seen. Probable old hematoma along posterior left flank. Brief Hospital Course: Mr. is a with history of mild FVIII deficiency who presents after snowboarding accident with multiple hematomas and falling hemoglobin concerning for ongoing bleeding. FACTOR VIII DEFICIENCY MULTIPLE HEMATOMAS: Patient presented after recent snowboarding accident. At imaging was notable for neck and shoulder hematomas. Upon reevaluation by his PCP the patient was found to have a flank hematoma. Given falling hemoglobin there was concern for retroperitoneal bleed. CTAP in the ED demonstrated hematoma over his flank musculature but no active extravasation. He was given IV DDAVP but FVIII activity was 103 wnl . CBC remained stable and patient declined further inpatient monitoring. Atrius hematology recommended continued outpatient hemoglobin monitoring but did not think further DDAVP was indicated given normal FVIII level. TRANISTIONAL ISSUES: PCP CBC at Caution to avoid dangerous activity Code: presumed full Emergency Contact: wife Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Desmopressin Nasal mcg NAS PRN bleeding Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H pain 2. Desmopressin Nasal mcg NAS PRN bleeding 3. Outpatient Lab Work CBC on or . Last hemoglobin 9.9 . Discharge Disposition: Home Discharge Diagnosis: PRIMARY: Acute muscular hematoma right flank Hemophilia factor VIII deficiency Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Mr. It was our pleasure caring for you at . You were admitted with bruising on your right side and low blood counts after a snowboarding fall. With your history of hemophilia it was important to evaluate internal bleeding which did show a right muscular flank blood collection. Your facotr VIII level was 103 and you received IV DDAVP under our care. Your blood counts were stable to improved on the day of admission. It is important that you not participate in any dangerous activities given your recent bleed and your hemophilia. Bleeding in hemophiliacs has more potential to be life threatening. Please get your blood counts checked at site on either or . Follow up with your regular doctor early next week. Best wishes Your Care Team Followup Instructions:</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>4</td>\n",
              "      <td>10000560</td>\n",
              "      <td>Sex: F Service: UROLOGY Allergies: Patient recorded as having No Known Allergies to Drugs Attending: . Chief Complaint: renal mass Major Surgical or Invasive Procedure: right laparascopic radical nephrectomy Dr. Dr. History of Present Illness: y/o healthy female with incidental finding of right renal mass suspicious for RCC following MRI on . Past Medical History: PMH: nonspecific right axis deviation PSH cesarean section ALL NKDA Social History: Family History: no history of RCC Pertinent Results: 07:15AM BLOOD WBC 7.6 RBC 3.82 Hgb 11.9 Hct 33.8 MCV 89 MCH 31.2 MCHC 35.2 RDW 12.8 Plt 07:15AM BLOOD Glucose 150 UreaN 10 Creat 0.9 Na 138 K 3.8 Cl 104 HCO3 27 AnGap 11 Brief Hospital Course: Patient was admitted to Urology after undergoing laparoscopic right radical nephrectomy. No concerning intraoperative events occurred please see dictated operative note for details. The patient received perioperative antibiotic prophylaxis. The patient was transferred to the floor from the PACU in stable condition. On POD0 pain was well controlled on PCA hydrated for urine output 30cc/hour provided with pneumoboots and incentive spirometry for prophylaxis and ambulated once. On POD1 foley was removed without difficulty basic metabolic panel and complete blood count were checked pain control was transitioned from PCA to oral analgesics diet was advanced to a clears/toast and crackers diet. On POD2 diet was advanced as tolerated. The remainder of the hospital course was relatively unremarkable. The patient was discharged in stable condition eating well ambulating independently voiding without difficulty and with pain control on oral analgesics. On exam incision was clean dry and intact with no evidence of hematoma collection or infection. The patient was given explicit instructions to follow up in clinic with in 3 weeks. Medications on Admission: none Discharge Medications: 1. Hydrocodone Acetaminophen mg Tablet Sig: Tablets PO Q6H every 6 hours as needed for break through pain only score 4 . Disp: 60 Tablet s Refills: 0 2. Docusate Sodium 100 mg Capsule Sig: One 1 Capsule PO BID 2 times a day . Disp: 60 Capsule s Refills: 2 Discharge Disposition: Home Discharge Diagnosis: renal cell carcinoma Discharge Condition: stable Discharge Instructions: You may shower but do not bathe swim or immerse your incision. Do not eat constipating foods for weeks drink plenty of fluids Do not lift anything heavier than a phone book 10 pounds or drive until you are seen by your Urologist in follow up Tylenol should be used as your first line pain medication. If your pain is not well controlled on Tylenol you have been prescribed a narcotic pain medication. Use in place of Tylenol. Do not exceed 4 gms of Tylenol in total daily Do not drive or drink alcohol while taking narcotics Resume all of your home medications except hold NSAID aspirin advil motrin ibuprofen until you see your urologist in follow up If you have fevers 101.5 F vomiting or increased redness swelling or discharge from your incision call your doctor or go to the nearest ER Call Dr. to set up follow up appointment and if you have any urological questions. Followup Instructions:</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-85717776-ced3-40e7-a392-0304636be4d3')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-85717776-ced3-40e7-a392-0304636be4d3 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-85717776-ced3-40e7-a392-0304636be4d3');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ],
            "text/plain": [
              "   Unnamed: 0  subject_id  \\\n",
              "0           0    10000032   \n",
              "1           1    10000084   \n",
              "2           2    10000117   \n",
              "3           3    10000248   \n",
              "4           4    10000560   \n",
              "\n",
              "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      text  \n",
              "0  Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: Chief Complaint: Worsening ABD distension and pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week. Pt reports self discontinuing lasix and spirnolactone weeks ago because she feels like they don t do anything and that she doesn t want to put more chemicals in her. She does not follow Na restricted diets. In the past week she notes that she has been having worsening abd distension and discomfort. She denies edema or SOB or orthopnea. She denies f/c/n/v d/c dysuria. She had food poisoning a week ago from eating stale cake n/v 20 min after food ingestion which resolved the same day. She denies other recent illness or sick contacts. She notes that she has been noticing gum bleeding while brushing her teeth in recent weeks. she denies easy bruising melena BRBPR hemetesis hemoptysis or hematuria. Because of her abd pain she went to OSH ED and was transferred to for further care. Per ED report pt has brief period of confusion she did not recall the ultrasound or bloodwork at osh. She denies recent drug use or alcohol use. She denies feeling confused but reports that she is forgetful at times. In the ED initial vitals were 98.4 70 106/63 16 97 RA Labs notable for ALT/AST/AP : Tbili1.6 WBC 5K platelet 77 INR 1.6 Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Her last alcohol consumption was one drink two months ago. No regular alcohol consumption. Last drug use years ago. She quit smoking a couple of years ago. Physical Exam: VS: 98.1 107/61 78 18 97RA General: in NAD HEENT: CTAB anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended mild diffuse tenderness flank dullness cannot percuss liver/spleen edge distension GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 converse normally able to recall 3 times after 5 minutes CN II XII intact Discharge: PHYSICAL EXAMINATION: VS: 98 105/70 95 General: in NAD HEENT: anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended but improved TTP in RUQ GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 CN II XII intact Pertinent Results: 10:25PM GLUCOSE 109 UREA N 25 CREAT 0.3 SODIUM 138 POTASSIUM 3.4 CHLORIDE 105 TOTAL CO2 27 ANION GAP 9 10:25PM estGFR Using this 10:25PM ALT SGPT 100 AST SGOT 114 ALK PHOS 114 TOT BILI 1.6 10:25PM LIPASE 77 10:25PM ALBUMIN 3.3 10:25PM WBC 5.0 RBC 4.29 HGB 14.3 HCT 42.6 MCV 99 MCH 33.3 MCHC 33.5 RDW 15.7 10:25PM NEUTS 70.3 LYMPHS 16.5 MONOS 8.1 EOS 4.2 BASOS 0.8 10:25PM PLT COUNT 71 10:25PM PTT 30.9 10:25PM . CXR: No acute cardiopulmonary process. U/S: 1. Nodular appearance of the liver compatible with cirrhosis. Signs of portal hypertension including small amount of ascites and splenomegaly. 2. Cholelithiasis. 3. Patent portal veins with normal hepatopetal flow. Diagnostic para attempted in the ED unsuccessful. On the floor pt c/o abd distension and discomfort. Brief Hospital Course: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week and confusion. Ascites p/w worsening abd distension and discomfort for last week. likely portal HTN given underlying liver disease though no ascitic fluid available on night of admission. No signs of heart failure noted on exam. This was to med non compliance and lack of diet restriction. SBP negative diuretics: Furosemide 40 mg PO DAILY Spironolactone 50 mg PO DAILY chosen over the usual 100mg dose d/t K of 4.5. CXR was wnl UA negative Urine culture blood culture negative. Pt was losing excess fluid appropriately with stable lytes on the above regimen. Pt was scheduled with current PCP for check upon discharge. Pt was scheduled for new PCP with Dr. at and follow up in Liver clinic to schedule outpatient screening EGD and . Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO DAILY 2. Spironolactone 50 mg PO DAILY 3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 4. Raltegravir 400 mg PO BID 5. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 6. Nicotine Patch 14 mg TD DAILY 7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Furosemide 40 mg PO DAILY RX furosemide 40 mg 1 tablet s by mouth Daily Disp 30 Tablet Refills: 3 4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB 5. Nicotine Patch 14 mg TD DAILY 6. Raltegravir 400 mg PO BID 7. Spironolactone 50 mg PO DAILY 8. Acetaminophen 500 mg PO Q6H:PRN pain Discharge Disposition: Home Discharge Diagnosis: Ascites from Portal HTN Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure taking care of you You came to us with stomach pain and worsening distension. While you were here we did a paracentesis to remove 1.5L of fluid from your belly. We also placed you on you 40 mg of Lasix and 50 mg of Aldactone to help you urinate the excess fluid still in your belly. As we discussed everyone has a different dose of lasix required to make them urinate and it s likely that you weren t taking a high enough dose. Please take these medications daily to keep excess fluid off and eat a low salt diet. You will follow up with Dr. in liver clinic and from there have your colonoscopy and EGD scheduled. Of course we are always here if you need us. We wish you all the best Your Team. Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet Attending: . Chief Complaint: abdominal fullness and discomfort Major Surgical or Invasive Procedure: diagnostic paracentesis therapeutic paracentesis History of Present Illness: with HIV on HAART COPD HCV cirrhosis complicated by ascites and HE admitted with abdominal distention and pain. She was admitted to for the same symptoms recently and had 3L fluid removed no SBP three days ago and felt better. Since discharge her abdomen has become increasingly distended with pain. This feels similar to prior episodes of ascites. Her diuretics were recently decreased on due to worsening hyponatremia 128 and hyperkalemia 5.1. Patient states she has been compliant with her HIV and diuretic medications but never filled out the lactulose prescription. She states she has had BMs daily at home. She has had some visual hallucinations and forgetfulness. Her appetite has been poor. In the ED initial vitals were 98.9 88 116/88 18 97 RA. CBC near baseline INR 1.4 Na 125 Cr 0.6. AST and ALT mildly above baseline 182 and 126 and albumin 2.8. Diagnostic para with 225 WBC 7 PMN total protein 0.3. UA with few bact 6 WBC mod leuk neg nitr but contaminated with 6 epi. CXR clear. RUQ US with no PV thrombus moderate ascites. She was given ondansetron 4mg IV and morphine 2.5mg IV x1 in the ED. On the floor she is feeling improved but still has abdominal distention and discomfort. ROS: Abdominal distention and pain. No black/bloody stools. No pain or swelling. No fevers or chills. Denies chest pain nausea vomiting. No dysuria or frequency. Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: VS: T98.1 105/57 79 20 97RA 44.6kg GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis DISCHARGE PE: VS: T 98.4 BP 95/55 SBP HR 80 RR 18 O2 95RA I/O 240/150 this am GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis Pertinent Results: LABS ON ADMISSION: 04:10PM BLOOD Plt 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:39PM BLOOD LABS ON DISCHARGE: 05:10AM BLOOD Plt 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD MICRO: 10:39 pm URINE Source: . FINAL REPORT URINE CULTURE Final : MIXED BACTERIAL FLORA 3 COLONY TYPES CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. Diagnositc Para: 07:00PM ASCITES 07:00PM ASCITES IMAGING: CXR No acute cardiopulmonary abnormality. RUQ US 1. Extremely coarse and nodular liver echotexture consistent with a history of cirrhosis. 2. Moderate ascites. 3. Patent portal vein. Brief Hospital Course: with HIV on HAART HCV cirrhosis with ascites and HE h/o IVDU COPD bipolar disorder presents with abdominal discomfort due to ascites. ASCITES. Now diuretic refractory given last tap was three days ago with 3L removed and she has already built up moderate ascites. Infectious workup negative with CXR clear UA contaminated but not grossly positive so will f/u culture diagnostic para with only 225 WBC RUQ US with no PV thrombus. Compliant with diuretics but not following low sodium diet or fluid restriction. Dr. discussed possible TIPS in the office but due to lung disease that was on hold pending further cardiac evaluation. Diuretics were recently decreased due to hyponatremia and hyperkalemia. Held spironolactone for now due to K 5.2 and increased lasix 20 40. No evidence of severe hyponatremia Na 120 or renal failure Cr 2.0 to stop diuretics at present. Diagnostic paracentesis negative for infection. Ascitic total protein 0.3 so warrants SBP prophylaxis 1.0 and fortunately already on Bactrim for PCP prophylaxis which would be appropriate for SBP ppx also. Patient did admit to eating pizza and some food prior to admission. She had therapeutic paracentesis with 4.3L removed and received 37.5G albumin IV post procedure. She felt much better with resolution of abdominal discomfort. Patient is scheduled for repeat paracentesis as outpatient on . HEPATIC ENCEPHALOPATHY. History of HE from Hep C cirrhosis. Now with mild encephalopathy hallucinations and forgetfulness due to medication noncompliance but not acutely encephalopathic and without asterixis on exam. Infectious workup negative thus far. Continue lactulose 30mL TID and titrate to 3 BMs daily and continue rifaximin 550mg BID. HYPONATREMIA. Na 125 on admission 128 four days ago and 135 one month ago. Likely due to third spacing from worsening ascites and fluid overload. 1.5L fluid restriction low salt diet. S/p therapeutic paracentesis with albumin replacement. CIRRHOSIS HEPATITIS C. MELD score of 10 and Child s class B on this admission. Now decompensated due to ascites. Hepatitis C genotype IIIB. Dr. starting and with patient in clinic and the insurance process was started by her office. No history of EGD needs this as outpatient for varices screening. NUTRITION. Unclear if truly compliant with low salt diet. Poor oral intake. Low albumin 2.8 on admission. Met with nutrition. COAGULOPATHY. INR 1.4 four days ago. No evidence of active bleeding. Very mild thrombocytopenia with plts 143. HIV. Most recent CD4 173. On HAART. No established ID provider. Continue Truvada and Isentress Bactrim DS daily for PCP . Needs outpatient ID appointment COPD. Stable. States she is on intermittent home O2 for comfort at night and with abdominal distentiom. Continued home COPD meds and home O2 as needed Transitional Issues Discontinued spironolactone elevated potassium Increased furosemide to 40mg daily Please recheck electrolytes at next visit Had paracentesis with 4.3 L removed received 37.5G albumin Needs outpatient ID provider needs more frequent paracentesis Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 2. Truvada 1 TAB PO DAILY 3. Furosemide 20 mg PO DAILY 4. Raltegravir 400 mg PO BID 5. Spironolactone 50 mg PO DAILY 6. Acetaminophen 500 mg PO Q6H:PRN pain fever 7. Tiotropium Bromide 1 CAP IH DAILY 8. Rifaximin 550 mg PO BID 9. Calcium Carbonate 1250 mg PO BID 10. Lactulose 15 mL PO TID 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Acetaminophen 500 mg PO Q6H:PRN pain fever 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 3. Calcium Carbonate 1250 mg PO BID 4. Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. Lactulose 15 mL PO TID 7. Raltegravir 400 mg PO BID 8. Rifaximin 550 mg PO BID 9. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 10. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: diuretic refractory ascites Secondary: HCV cirrhosis HIV hyponatremia COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear was a pleasure to take care of you at . You were admitted with abdominal fullness and pain from your ascites. You had a diagnostic and therapeutic paracentesis with 4.3 L removed. Your spironolactone was discontinued because your potassium was high. Your lasix was increased to 40mg daily. You are scheduled for another paracentesis on prior to your other appointments that day. Please call tomorrow to find out the time of the paracentesis. Please continue to follow a low sodium diet and fluid restriction. You should call your liver doctor or return to the emergency room if you have abdominal pain fever chills confusion or other concerning symptoms. Sincerely Your medical team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: Chief Complaint: altered mental status Major Surgical or Invasive Procedure: none History of Present Illness: Mrs. is a female with HIV on HAART COPD HCV cirrhosis complicated by ascites and hepatic encephalopathy who initially presented to the ED yesterday with hypotension after a paracentesis. The patient has had accelerated decompensation of her cirrhosis recently with worsening ascites and she is maintained on twice weekly paracentesis. She was at her regular session yesterday when she had hypotension to SBP and felt lightheadedness. Per the patient that s when her memory started to get fuzzy. She does not have much recollection of what happened since then. Her outpatient hepatologist saw her and recommended that she go to the ED. In the ED she was evaluated and deemed to have stable blood pressure. She was discharged home. At home she had worsening mental status with her daughter getting concerned and she returned to the ED. In the ED initial vitals were 98.7 77 96/50 16 98 RA. The patient was only oriented to person. Her labs were notable for Na 126 K 6.7 Cr 0.7 baseline 0.4 ALT 153 AST 275 TBili 1.9 Lip 66 INR 1.5. Initial EKG showed sinus rhythm with peaked T waves. Her head CT was negative for any acute processes. She received ceftriaxone 2gm x1 regular insulin 10U calcium gluconate 1g lactulose 30 mL x2 and 25g 5 albumin. On transfer vitals were 99.0 93 84/40 16 95 NC. On arrival to the MICU patient was more alert and conversant. She has no abdominal pain nausea vomiting chest pain or difficulty breathing. She has a chronic cough that is not much changed. She has not had any fever or chills. She reports taking all of her medications except for lactulose which she thinks taste disgusting. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals T: 98.7 BP: 84/48 P: 91 R: 24 O2: 98 NC on 2L GENERAL: Alert oriented no acute distress LUNGS: Decreased air movement on both sides scattered expiratory wheezes CV: Regular rate and rhythm normal S1 S2 no murmurs rubs gallops ABD: Soft non tender distended flank dullness bilaterally bowel sounds present EXT: Warm well perfused 2 pulses no cyanosis or edema DISCHARGE PHYSICAL EXAM: Vitals Tm 99.5 Tc 98.7 79 96/43 58 20 95 on 3L NC 7BM. General Cachectic appearing woman alert oriented no acute distress HEENT Sclera anicteric MMM oropharynx clear poor dentition with partial dentures Neck supple JVP not elevated no LAD Lungs Clear to auscultation bilaterally no wheezes rales ronchi CV Regular rate and rhythm normal S1 S2 no murmurs rubs gallops Abdomen Mildly distended and firm non tender bowel sounds present no rebound tenderness or guarding GU no foley Ext warm well perfused 2 pulses no clubbing cyanosis or edema Neuro AOx3 No asterixis. Pertinent Results: ADMISSION LABS: 06:39AM BLOOD WBC 6.9 RBC 3.98 Hgb 14.1 Hct 41.1 MCV 103 MCH 35.4 MCHC 34.3 RDW 15.8 Plt 06:39AM BLOOD Neuts 72.7 Lymphs 14.7 Monos 9.8 Eos 2.5 Baso 0.3 06:39AM BLOOD PTT 32.4 06:39AM BLOOD Glucose 102 UreaN 49 Creat 0.7 Na 126 K 6.7 Cl 95 HCO3 25 AnGap 13 06:39AM BLOOD ALT 153 AST 275 AlkPhos 114 TotBili 1.9 06:39AM BLOOD Albumin 3.6 IMAGING/STUDIES: CT HEAD: No evidence of acute intracranial process. The left zygomatic arch deformity is probably chronic as there is no associated soft tissue swelling. CXR: No acute intrathoracic process. DISCHARGE LABS: 04:45AM BLOOD WBC 4.8 RBC 3.15 Hgb 11.2 Hct 32.1 MCV 102 MCH 35.4 MCHC 34.8 RDW 15.8 Plt Ct 95 04:45AM BLOOD PTT 37.6 04:45AM BLOOD Glucose 121 UreaN 35 Creat 0.4 Na 130 K 5.2 Cl 97 HCO3 27 AnGap 11 04:45AM BLOOD ALT 96 AST 168 AlkPhos 69 TotBili 1.7 04:45AM BLOOD Calcium 8.6 Phos 2.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities w/ AMS hypotension and hyperkalemia. Altered mental status improved with lactulose. Hypotension was felt to be due to fluid shifts from paracentesis on the day prior to admission as well as low PO intake in the setting of AMS. Hypotension and resolved with IV albumin. Hyperkalemia resolved with insulin and kayexalate. Hypotension: Patient presented with SBP in and improved with albumin in the ED to . It was felt to be due to fluid shifts from paracentesis on as well as likely hypovolemia given AMS and decreased PO intake. No concern for bleeding or sepsis with baseline CBC and lack of fever. She continued to received IV albumin during her hospital course with which her SBP improved to and patient remained asymptomatic. Hyperkalemia: Patient presented with K 6.7 with EKG changes. Given low Na likely the result of low effective arterial volume leading to poor K excretion with likely exacerbation from . AM cortisol was normal. K improved with insulin and kayexalate and K was 5.2 on day of discharge. Bactrim was held during hospital course. : Patient presented with Cr 0.7 from baseline Cr is 0.3 0.4. It was felt to be likely due to volume shift from her paracentesis on the day prior to admission as well as now low effective arterial volume likely poor PO intake AMS. Cr improved to 0.4 with albumin administration. Furosemide and Bactrim were held during hospital course. GOC: The son HCP met with Dr. outpatient hepatologist during hospital course. They discussed that the patient is not a transplant candidate givenevere underlying lung disease FEV1 0.8 hypoxia RV dilation and very low BMI. A more conservative approach was recommended and the patient was transitioned to DNR/DNI. The patient agreed with this plan. She was treated with the goal of treating any any correctable issues. Social work met with the patient prior to discharge. The patient was interested in following up with palliative care for which an outpatient referral was made. Altered Mental Status: Patient presented with confusion that was most likely secondary to hepatic encephalopathy. Based on outpatient records patient has had steady decline in decompensated cirrhosis and mental status. No signs of infection and head CT was negative as well. Mental status improved with lactulose in the ED and patient reports that she has not been taking lactulose regularly at home. Patient was also continued on rifaximin. HCV Cirrhosis: Genotype 3a. Patient is decompensated with increasing ascites and worsening hepatic encephalopathy. She is dependent on twice weekly paracentesis. Spironolactone was recently stopped due to hyperkalemia. Patient is not a transplant candidate given her comorbidities COPD per outpatient hepatologist. The patient would like to continue biweekly paracenteses as an outpatient. HIV: Most recent CD4 count 173 on . HIV viral load on was undetectable. She was continued on her home regimen of raltegravir emtricitabine and tenofovir. Bactrim prophylaxis was held during admission because of hyperkalemia. COPD: Patient on 3L NC at home. She was continued on her home regimen. TRANSITIONAL ISSUES: Follow up with Palliative Care as outpatient Bactrim prophylaxis HIV was held during hospital course due to . Consider restarting as outpatient. Furosemide was held due to consider restarting as outpatient Follow up with hepatology Continue biweekly therapeurtic paracenteses Code status: DNR/DNI Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lactulose 15 mL PO TID 2. Tiotropium Bromide 1 CAP IH DAILY 3. Raltegravir 400 mg PO BID 4. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. TraMADOL Ultram 50 mg PO Q8H:PRN Pain 7. Fluticasone Propionate 110mcg 1 PUFF IH BID 8. Calcium Carbonate 500 mg PO BID 9. Rifaximin 550 mg PO BID 10. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: Hypotension Hyperkalemia Acute Kidney Injury Secondary: HIV Cirrhosis COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. You were admitted to because of confusion low blood pressure and a high potassium value. Your confusion improved with lactulose. Your blood pressure improved with extra fluids and your potassium improved as well. You also had small degree of kidney injury when you came to the hospital and this also improved with fluids. While you were here you discussed changing your goals of care to focusing on symptom management and treatment of reversible processes such as an infection. While you were in the hospital you were seen by one of our social workers. You will also follow up with Palliative Care in their clinic and will continue to have therapeutic paracenteses. It has been a pleasure taking care of you and we wish you all the best Your Care team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: . Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: w/ HIV on HAART COPD on 3L home O2 though sat ing fine on RA on admission HCV cirrhosis c/b ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening girth and abd pain. She d been having pain from her ascites and felt overdue for a paracentesis. She last had paracentesis on the . She reported that she began feeling worsening abdominal pain constant epigastric and radiates to back not a/w food on which increased in severity throughout the course of the day. She was brought to the ED by her son because of this pain. She had no confusion and was alert and oriented x3. The patient also reported she recently ran out of most of her home medications. She denied any fever chills shortness of breath cough dysuria. She reported loose stool a bit more than usual but attributed it to lactulose use. In the ED vitals were: 99.4 105 106/57 18 96 ra. Labs were significant for Na 127 K 5.3 lactate 2.1 INR 1.7. ALT 135 AST 244 AP 123. no leukocytosis. Ascitic fluid showed 220 WBC. She was given Morphine Sulfate 5 mg IV ONCE MR1 and a GI cocktail. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM Vitals T 97 BP 98/65 HR 103 RR 18 O2 94RA Glucose 128. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: distended fluid wave not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes DISCHARGE PHYSICAL EXAM Vitals Tm 98.6 Tc 98.2 BP 82 98/42 68 HR 80 95 RR O2 91 99 RA. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: soft decreased distension not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes Pertinent Results: ADMISSION LABS 09:20PM BLOOD WBC 8.2 RBC 3.48 Hgb 12.3 Hct 36.7 MCV 106 MCH 35.5 MCHC 33.6 RDW 16.5 Plt 09:28PM BLOOD PTT 31.8 09:20PM BLOOD Glucose 118 UreaN 33 Creat 0.6 Na 127 K 5.3 Cl 97 HCO3 24 AnGap 11 09:20PM BLOOD ALT 135 AST 244 AlkPhos 123 TotBili 1.3 09:20PM BLOOD Albumin 3.5 Calcium 8.3 Phos 3.3 Mg 2.3 09:27PM BLOOD Lactate 2.1 NOTABLE LABS 12:30AM ASCITES WBC 220 Polys 17 Lymphs 48 Monos 19 Mesothe 2 Macroph 12 Other 2 12:30AM ASCITES TotPro 0.7 Glucose 129 MICROBIOLOGY 12:30 am PERITONEAL FLUID GRAM STAIN Final : NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. VRE screen: No VRE isolated. IMAGING/STUDIES CXR No acute cardiopulmonary process. RUQUS Cirrhotic mild splenomegaly and ascites. A solid 3cm nodule in the left lobe of the liver is stable in size and appearance. DISCHARGE LABS 06:15AM BLOOD WBC 5.6 RBC 3.27 Hgb 11.6 Hct 33.5 MCV 103 MCH 35.5 MCHC 34.5 RDW 16.1 Plt 06:15AM BLOOD PTT 36.0 06:15AM BLOOD Glucose 87 UreaN 29 Creat 0.4 Na 123 K 5.4 Cl 93 HCO3 24 AnGap 11 06:15AM BLOOD ALT 112 AST 176 AlkPhos 101 TotBili 2.8 06:15AM BLOOD Albumin 3.5 Calcium 8.8 Phos 3.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening abd girth and pain. Goals of care: The patient expressed that her desire to let go and be at peace. She is tired of fighting her end stage liver disease and does not feel that she has a good quality of life. She wished to meet with a representative from hospice which we were able to arrange and she decided that she would like to go home with hospice. A conversation was held with the patient regarding code status. She noted that she would probably be DNR/DNI but would like to discuss it with her son HCP . Therefore at this time she remains full code. We also discussed the possibility of her getting a pleurex catheter placed because of her repeated paracenteses. She was discharged to home with hospice on . Decompensated HCV cirrhosis with ascites: The patient presented with worsening ascites. Her pain was initially managed with tramadol and morphine. She underwent paracentesis on with removal of 3.5L and she received albumin. Studies on the fluid were negative and she reported a significant improvement in her pain. Hyperkalemia: During her hospitalization it was noted that she had hyperkalemia 5.3 5.9 6.9 without EKG changes. After treatment with calcium gluconate 2gm x2 insulin and D50 x 2 and kayexelate her K downtrended to 5.4. Her K has been persistently elevated in the past and should continue to be monitored. Hepatic encephalopathy: The patient s mental status was A Ox3 on admission. She was continued on rifaximin and lactulose in house and at discharge. CHRONIC ISSUES Hyponatremia The patient has a history of asymptomatic hyponatremia. It is most likely hypervolemic hyponatremia related to underlying liver disease as well as aldosterone axis dysfunction related to liver disease. She remained asymptomatic through her hospitalization. Because she was also started on 10mg of furosemide to help prevent fluid re accumulation she will require BMPs twice weekly in the outpatient setting. HIV: Emtricitabine Tenofovir Truvada and Raltegravir were continued in house and at discharge. COPD: fluticasone tiotropium and albuterol were continued in house and at discharge. TRANSITIONAL ISSUES Follow up peritoneal fluid culture New/changed medications: Furosemide 10mg daily new For hyperkalemia and hyponatremia the patient should have biweekly BMPs script written . If K 5.3 she should be given kayexelate once weekly. Lab results will be faxed/sent to Dr. . Continue conversation regarding pleurex catheter placement and code status. She will continue to have twice weekly paracenteses Code: full Emergency Contact: on Admission: The Preadmission Medication list is accurate and complete. 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Medications: 1. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 2. Calcium Carbonate 500 mg PO BID 3. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 4. Fluticasone Propionate 110mcg 1 PUFF IH BID 5. Lactulose 30 mL PO TID 6. Raltegravir 400 mg PO BID 7. Rifaximin 550 mg PO BID 8. Tiotropium Bromide 1 CAP IH DAILY 9. TraMADOL Ultram mg PO Q6H:PRN pain 10. Furosemide 10 mg PO DAILY RX furosemide 20 mg 0.5 One half tablet s by mouth Please take 1 tablet daily. Disp 15 Tablet Refills: 0 11. Outpatient Lab Work Please obtain biweekly BMP to monitor K and Na. Please fax results to Dr. at the at . Discharge Disposition: Home With Service Facility: Discharge Diagnosis: PRIMARY DIAGNOSIS Decompensated HCV cirrhosis Hyperkalemia SECONDARY DIAGNOSES HIV COPD Hyponatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure caring for you during your stay at . You were admitted because of worsening abdominal pain. It is likely that this pain was due to increasing fluid in the abdomen from your cirrhosis. After a paracentesis in which much of this fluid was removed your pain improved significantly. You were noted to have a high potassium during your hospitalization which came down with treatment but this should continue to be followed as an outpatient. You also emphasized your desire to speak with a representative from hospice. Because of your repeated paracenteses we also discussed the possibility of a pleurex catheter placement. We arranged for you to meet with hospice coordinators and you will be discharged home with hospice. We wish you all the best Your care team Followup Instructions:  \n",
              "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: . Chief Complaint: Visual hallucinations Major Surgical or Invasive Procedure: N/A History of Present Illness: male with disease dyslipidemia and a history of prostate cancer s/p prostatectomy who was referred to the ED by his neurologist for worsening gait falls and visual hallucinations. The following history is taken from chart review: The patient was seen by his neurologist on at which time he was noted to have visual hallucinations and worsening gait freezing. For his gait freezing his mirapex was increased by 0.125 mg every week to a goal dose of 0.75 mg t.i.d. He successfully up titrated the medicine to 0.75/0.625/0.625 but began to have visual hallucinations and confusion so on his neurologist recommended decreasing the dose to 0.625 TID. Despite the changes to his Mirapex the patient s daughter has noted progressive gait stiffness and increased difficulty standing. This has resulted in difficulty with simply getting to the bathroom leading to episodes of incontinence. A UA performed on was reassuring. On the day of presentation to the hospital the patient began to experience visual hallucinations of a motor cross race in his backyard. He subsequently had a fall while transferring from the couch to a chair. His wife was unable to get him off the floor. The fall was witnessed and there was no head strike. Per the patient s wife his gait has acutely worsened over the past 24 hours to the point where he has been unable to ambulate on his own. The patient s daughter called his neurologist who recommended presentation to the ED. In the ED the patient was afebrile HRs normotensive and SpO2 100 RA. On exam he was noted to have cogwheeling of upper extremities and decrease strength. Labs were remarkable for a negative urine and serum tox Na 132 K 5.8 hemolyzed and no EKG changes negative troponin normal LFTs unremarkable CBC. Chest Xray showed no acute process and CTH was reassuring. He was evaluated by neurology who recommended admission to medicine for failure to thrive to continue the patient s home medications and complete a toxo metabolic workup. The patient was given his home pramipexole and pravastatin before he was admitted. On arrival to the floor the patient is comfortable in bed. He is not accompanied by family on my interview. He knows that he is in the hospital and that it is . He is not sure why he is here and begins to tell me about a party in his house with a motor cross race in his backyard. When I asked him about his fall he mentions that he has not had a fall for years. He denies any fevers chills cough chest pain abdominal pain nausea diarrhea or dysuria. REVIEW OF SYSTEMS: Per HPI otherwise 10 point review of systems was within normal limits. Past Medical History: disease Body Dementia dyslipidemia prostate cancer s/p prostatectomy Social History: Family History: His mother died at age of old age. His father died of prostate cancer at . He has an older sister age and a younger sister age . He has a younger brother age . As noted he has 2 daughters. There is no family history of neurologic illness or dementia. There is no family history of neurodevelopmental mental disorders such as learning disability or ADHD. There is no family history of psychiatric problems. Physical Exam: ADMISSION PHYSICAL EXAM: VITALS: reviewed in OMR GENERAL: Alert and interactive. In no acute distress. HEENT: PERRL EOMI. Sclera anicteric and without injection. MMM. NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes rhonchi or rales. No increased work of breathing. BACK: No CVA tenderness. ABDOMEN: Normal bowels sounds non distended non tender to deep palpation in all four quadrants. No organomegaly. EXTREMITIES: No clubbing cyanosis or edema. Pulses DP/Radial 2 bilaterally. SKIN: Warm. Cap refill 2s. No rashes. NEUROLOGIC: AOx3. CN2 12 intact. cogwheel UE b/l. Increased tone in LEs strength b/l . Normal sensation. DISCHARGE PHYSICAL EXAM 24 HR Data last updated 2340 Temp: 97.7 Tm 98.4 BP: 130/80 130 153/80 90 HR: 80 80 104 RR: 18 O2 sat: 100 95 100 O2 delivery: Ra GENERAL: In no acute distress. Talking very quietly. CARDIAC: Regular rhythm normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes rhonchi or rales. No increased work of breathing. ABDOMEN: Normal bowels sounds non distended non tender to deep palpation in all four quadrants. EXTREMITIES: No clubbing cyanosis or edema. Pulses DP/Radial 2 bilaterally. SKIN: Warm. NEUROLOGIC: AOx3. CN2 12 intact. cogwheel UE b/l. Increased tone in LEs strength b/l . Normal sensation. Pertinent Results: ADMISSION LABS: 10:30PM BLOOD WBC 8.6 RBC 4.03 Hgb 12.8 Hct 38.2 MCV 95 MCH 31.8 MCHC 33.5 RDW 13.0 RDWSD 45.2 Plt 10:30PM BLOOD Neuts 48.1 Monos 15.9 Eos 2.0 Baso 0.6 Im AbsNeut 4.13 AbsLymp 2.86 AbsMono 1.36 AbsEos 0.17 AbsBaso 0.05 10:30PM BLOOD PTT 23.4 10:30PM BLOOD Glucose 100 UreaN 17 Creat 0.8 Na 132 K 5.8 Cl 98 HCO3 19 AnGap 15 10:30PM BLOOD ALT 18 AST 38 AlkPhos 39 TotBili 0.4 10:30PM BLOOD Lipase 47 10:30PM BLOOD cTropnT 0.01 10:30PM BLOOD Albumin 4.0 Calcium 9.9 Phos 3.7 Mg 2.0 10:30PM BLOOD VitB12 570 10:30PM BLOOD TSH 1.4 07:00AM BLOOD Trep Ab NEG 10:30PM BLOOD ASA NEG Ethanol NEG Acetmnp NEG Tricycl NEG IMAGING: Imaging CT HEAD W/O CONTRAST FINDINGS: There is no evidence of infarction hemorrhage edema or mass. There is prominence of the ventricles and sulci suggestive of involutional changes. There is no evidence of fracture. The visualized portion of the remaining paranasal sinuses and middle ear cavities are clear. The visualized portion of the orbits are unremarkable apart from bilateral lens replacements. IMPRESSION: 1. No acute intracranial abnormality. No hydrocephalus. Imaging CHEST PA LAT IMPRESSION: Mild atelectasis in the lung bases without focal consolidation. Age indeterminate moderate to severe compression deformity of a low thoracic vertebral body. DISCHARGE LABS: 06:21AM BLOOD WBC 7.0 RBC 4.02 Hgb 12.9 Hct 38.1 MCV 95 MCH 32.1 MCHC 33.9 RDW 12.8 RDWSD 44.4 Plt 06:21AM BLOOD Glucose 88 UreaN 10 Creat 0.7 Na 140 K 4.0 Cl 104 HCO3 24 AnGap 12 06:21AM BLOOD Calcium 9.5 Phos 3.2 Mg 1. male with disease dyslipidemia and a history of prostate cancer s/p prostatectomy who was referred to the ED by his neurologist for worsening gait falls and visual hallucinations concerning for progression of his neurologic disorder. ACUTE/ACTIVE ISSUES: disease Body Dementia Visual Hallucinations The patient appears to have acute on chronic progression of his disease. Unclear if this is disease progression or underlying medical cause. Continued mirapex rasagiline and rivastigmine. Neurology recommended started Seroquel for his hallucinations. He was evaluated by physical therapy who recommended rehab. This recommendation was discussed with the family who opted for discharge to home with home physical therapy as this was in line with the patient s goals of care. TRANSITIONAL ISSUES: f/u visual hallucination symptoms on Seroquel f/u physical therapy at home Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Rasagiline 1 mg PO DAILY 2. Pramipexole 0.625 mg PO TID 3. rivastigmine 9.5 mg/24 hr transdermal DAILY 4. Pravastatin 40 mg PO QPM 5. Cyanocobalamin Dose is Unknown PO DAILY 6. Loratadine 10 mg PO DAILY Discharge Medications: 1. QUEtiapine Fumarate 25 mg PO QHS RX quetiapine 25 mg 1 tablet s by mouth AT NIGHT Disp 30 Tablet Refills: 0 2. Loratadine 10 mg PO DAILY 3. Pramipexole 0.625 mg PO TID 4. Pravastatin 40 mg PO QPM 5. Rasagiline 1 mg PO DAILY 6. rivastigmine 9.5 mg/24 hr transdermal DAILY Discharge Disposition: Home With Service Facility: Discharge Diagnosis: Dementia Discharge Condition: Mental Status: Confused sometimes. Level of Consciousness: Alert and interactive. Discharge Instructions: Dear Mr. It was a privilege caring for you at . WHY WAS I IN THE HOSPITAL You were sent to the emergency room by your neurologist who was concerned that you were having visual hallucinations. WHAT HAPPENED TO ME IN THE HOSPITAL You were started on a new medication to help treat your symptoms. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL Continue to take all your medicines and keep your appointments. We wish you the best Sincerely Your Team Followup Instructions:  \n",
              "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sex: F Service: MEDICINE Allergies: omeprazole Attending: . Chief Complaint: dysphagia Major Surgical or Invasive Procedure: Upper endoscopy History of Present Illness: w/ anxiety and several years of dysphagia who p/w worsened foreign body sensation. She describes feeling as though food gets stuck in her neck when she eats. She put herself on a pureed diet to address this over the last 10 days. When she has food stuck in the throat she almost feels as though she cannot breath but she denies trouble breathing at any other time. She does not have any history of food allergies or skin rashes. In the ED initial vitals: 97.6 81 148/83 16 100 RA Imaging showed: CXR showed a prominent esophagus Consults: GI was consulted. Pt underwent EGD which showed a normal appearing esophagus. Biopsies were taken. Currently she endorses anxiety about eating. She would like to try eating here prior to leaving the hospital. Past Medical History: GERD Hypercholesterolemia Kidney stones Mitral valve prolapse Uterine fibroids Osteoporosis Migraine headaches Social History: Family History: HTN father Dementia father Physical Exam: ADMISSION/DISCHARGE EXAM VS: 97.9 PO 109 / 71 70 16 97 ra GEN: Thin anxious woman lying in bed no acute distress HEENT: Moist MM anicteric sclerae NCAT PERRL EOMI NECK: Supple without LAD no JVD PULM: CTABL no w/c/r COR: RRR S1/S2 no m/r/g ABD: Soft non tender non distended BS no HSM EXTREM: Warm well perfused no edema NEURO: CN II XII grossly intact motor function grossly normal sensation grossly intact Pertinent Results: ADMISSION LABS 08:27AM BLOOD WBC 5.0 RBC 4.82 Hgb 14.9 Hct 44.4 MCV 92 MCH 30.9 MCHC 33.6 RDW 12.1 RDWSD 41.3 Plt 08:27AM BLOOD PTT 28.6 08:27AM BLOOD Glucose 85 UreaN 8 Creat 0.9 Na 142 K 3.6 Cl 104 HCO3 22 AnGap 20 08:27AM BLOOD ALT 11 AST 16 LD LDH 154 AlkPhos 63 TotBili 1.0 08:27AM BLOOD Albumin 4.8 IMAGING CXR : IMPRESSION: Prominent esophagus on lateral view without air fluid level. Given the patient s history and radiographic appearance barium swallow is indicated either now or electively. NECK X ray : IMPRESSION: Within the limitation of plain radiography no evidence of prevertebral soft tissue swelling or soft tissue mass in the neck. EGD: Impression: Hiatal hernia Angioectasia in the stomach Angioectasia in the duodenum biopsy biopsy Otherwise normal EGD to third part of the duodenum Recommendations: no obvious anatomic cause for the patient s symptoms follow up biopsy results to rule out eosinophilic esophagitis follow up with Dr. if biopsies show eosinophilic esophagitis Brief Hospital Course: Ms. is a with history of GERD who presents with subacute worsening of dysphagia and foreign body sensation. This had worsened to the point where she placed herself on a pureed diet for the last 10 days. She underwent CXR which showed a prominent esophagus but was otherwise normal. She was evaluated by Gastroenterology and underwent an upper endoscopy on . This showed a normal appearing esophagus. Biopsies were taken. TRANSITIONAL ISSUES: f/u biopsies from EGD if results show eosinophilic esophagitis follow up with Dr. . for management pt should undergo barium swallow as an outpatient for further workup of her dysphagia f/u with ENT as planned Code: Full presumed Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Omeprazole 20 mg PO BID Discharge Medications: 1. Omeprazole 20 mg PO BID Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: dysphagia and foreign body sensation SECONDARY DIAGNOSIS: GERD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. You were hospitalized at . You came in due to difficulty swallowing. You had an endoscopy to look for any abnormalities in the esophagus. Thankfully this was normal. They took biopsies and you will be called with the results. You should have a test called a barium swallow as an outpatient. We wish you all the best Your Team Followup Instructions: Sex: F Service: ORTHOPAEDICS Allergies: omeprazole / Iodine and Iodide Containing Products / hallucinogens Attending: . Chief Complaint: Left hip pain Major Surgical or Invasive Procedure: Status post left CRPP History of Present Illness: REASON FOR CONSULT: Femur fracture HPI: female presents with the above fracture s/p mechanical fall. This morning pt was walking when dog pulled on leash. Pt fell on L hip. Immediate pain. with movement. Denies Head strike LOC or blood thinners. Denies numbness or weakness in the extremities. Past Medical History: GERD Hypercholesterolemia Kidney stones Mitral valve prolapse Uterine fibroids Osteoporosis Migraine headaches Social History: Family History: HTN father Dementia father Physical Exam: General: Well appearing female in no acute distress. Left Lower extremity: Skin intact No deformity edema ecchymosis erythema induration Soft non tender thigh and leg Full painless ROM knee and ankle Fires SILT S/S/SP/DP/T distributions 1 pulses WWP Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a left valgus impacted femoral neck fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on for left closed reduction and percutaneous pinning of hip which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications and progressed to a regular diet and oral medications by POD 1. The patient was given antibiotics and anticoagulation per routine. The patient s home medications were continued throughout this hospitalization. The patient worked with who determined that discharge to home with services was appropriate. The hospital course was otherwise unremarkable. At the time of discharge the patient s pain was well controlled with oral medications incisions were clean/dry/intact and the patient was voiding/moving bowels spontaneously. The patient is weightbearing as tolerated in the left lower extremity and will be discharged on Lovenox for DVT prophylaxis. The patient will follow up with Dr. routine. A thorough discussion was had with the patient regarding the diagnosis and expected post discharge course including reasons to call the office or return to the hospital and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow up care. The patient expressed readiness for discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lactaid lactase 3 000 unit oral DAILY:PRN 2. Calcium Citrate D calcium citrate vitamin D3 315 200 mg unit oral DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO Q6H:PRN Pain Mild/Fever 2. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 3. Docusate Sodium 100 mg PO BID 4. Enoxaparin Sodium 40 mg SC QHS RX enoxaparin 40 mg/0.4 mL 40 mg Subcutaneously Nightly Disp 30 Syringe Refills: 0 5. OxyCODONE Immediate Release mg PO Q4H:PRN Pain Moderate RX oxycodone 5 mg 1 tablet s by mouth q4 PRN Disp 25 Tablet Refills: 0 6. Senna 8.6 mg PO BID 7. Calcium Citrate D calcium citrate vitamin D3 315 200 mg unit oral DAILY 8. Lactaid lactase 3 000 unit oral DAILY:PRN 9. Multivitamins 1 TAB PO DAILY 10. Vitamin D 400 UNIT PO DAILY Discharge Disposition: Home With Service Facility: Discharge Diagnosis: Left valgus impacted femoral neck fracture Discharge Condition: AVSS NAD A Ox3 LLE: Incision well approximated. Dressing clean and dry. Fires FHL TA GCS. SILT n distributions. 1 DP pulse wwp distally. Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: You were in the hospital for orthopedic surgery. It is normal to feel tired or washed out after surgery and this feeling should improve over the first few days to week. Resume your regular activities as tolerated but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: Weightbearing as tolerated left lower extremity MEDICATIONS: 1 Take Tylenol every 6 hours around the clock. This is an over the counter medication. 2 Add oxycodone as needed for increased pain. Aim to wean off this medication in 1 week or sooner. This is an example on how to wean down: Take 1 tablet every 3 hours as needed x 1 day then 1 tablet every 4 hours as needed x 1 day then 1 tablet every 6 hours as needed x 1 day then 1 tablet every 8 hours as needed x 2 days then 1 tablet every 12 hours as needed x 1 day then 1 tablet every before bedtime as needed x 1 day. Then continue with Tylenol for pain. 3 Do not stop the Tylenol until you are off of the narcotic medication. 4 Per state regulations we are limited in the amount of narcotics we can prescribe. If you require more you must contact the office to set up an appointment because we cannot refill this type of pain medication over the phone. 5 Narcotic pain relievers can cause constipation so you should drink eight 8oz glasses of water daily and continue following the bowel regimen as stated on your medication prescription list. These meds senna colace miralax are over the counter and may be obtained at any pharmacy. 6 Do not drink alcohol drive a motor vehicle or operate machinery while taking narcotic pain relievers. 7 Please take all medications as prescribed by your physicians at discharge. 8 Continue all home medications unless specifically instructed to stop by your surgeon. ANTICOAGULATION: Please take Lovenox daily for 4 weeks Followup Instructions:  \n",
              "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: . Chief Complaint: Right flank bruising and pain s/p fall Major Surgical or Invasive Procedure: None History of Present Illness: Mr. is a with history of factor VIII deficiency who presents with right neck swelling after snowboarding accident. The patient reports that he fell while snowboarding with loss of consciousness on . He was initially seen at where CT imaging of head/neck showed no intracranial hemorrhage. A CTA neck showed a thickened right platysma muscle with surrounding hematoma and a focus of active contrast extravasation within the right platysma muscle. He also developed a right shoulder hematoma although shoulder plain films didn t show acute abnormality. He was seen by Hematology and gave him one dose of DDAVP IV. A factor VIII assay was 139 and vW level was 200 per report. Per report his hemoglobin decreased from 13.2 on to 11.6 on . Repeat imaging in the morning showed stable injuries. The patient saw his hematologist on and was found to have a hemoglobin of 10.4. Because of the continued mild decrease the patient followed up with his PCP at which time his hemoglobin was 9.9. He was found to have an enlarging flank hematoma thus was referred given concern for retroperitoneal bleed. The patient has been using DDAVP intranasally intermittently since the accident. He denies lightheadedness or palpitations any increase in neck swelling over the course of the week. He does endorse pain in his right shoulder resting moving though this has improved over the course of the week. In the ED initial vital signs were 99.2 87 124/75 18 100 /RA. Initial labs demonstrated hemoglobin 10.6 though repeat was 9.7. Chemistries and coags were unremarkable. FVIII activity was 103. A CTAP was performed which demonstrated muscular hemorrhage along the flank but no retroperitoneal bleed on preliminary read. The patient s outpatient hematologist Dr. was contacted and it was decided to give the patient desmopressin 0.3mg/kg IV. The patient was then admitted for futher management. Per review of records the patient has a history of significant bleeding after his circumcision requiring blood transfusion. Throughout childhood he also had a tendency to bruise easily. He was tested and found to have disease. Later after wisdom tooth extraction the patient experienced late e.g. days later bleeding despite treatment with DDAVP. The patient was retested by a hematologist associated with the and was diagnosed with hemophilia A. His FVIII activity has been checked on multiple occasions sometimes testing normal though has been as low as 50. Upon arrival to the floor the patient is comfortable without complaint. Review of Systems: per HPI fever chills night sweats headache vision changes rhinorrhea congestion sore throat cough shortness of breath chest pain abdominal pain nausea vomiting diarrhea constipation BRBPR melena hematochezia dysuria hematuria. Past Medical History: Factor VIII deficiency mild Social History: Family History: The patient s mother had tendency to bleed. Physical Exam: ON ADMISSION VS:98 120/40 64 20 100RA GENERAL: lying flat in bed no acute distress HEENT: NCAT MMM OP clear NECK: Supple CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: Generally CTA b/l ABDOMEN: Soft non tender non distended EXTREMITIES: Warm well perfused PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact SKIN: Hematomas on right aspect of neck and flank ON DISCHARGE Vitals: 98.0 100 120/40 58 66 20 99 on RA GENERAL: lying flat in bed no acute distress HEENT: NCAT MMM OP clear NECK: Supple CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: Generally CTA b/l ABDOMEN: Soft non tender non distended EXTREMITIES: Warm well perfused PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact SKIN: Hematomas on right aspect of neck and flank Pertinent Results: ADMISSION DISCHARGE PERTINENT LABS: 07:03PM BLOOD WBC 6.6 RBC 3.58 Hgb 10.6 Hct 29.8 MCV 83 MCH 29.6 MCHC 35.6 RDW 14.7 Plt 07:03PM BLOOD Neuts 69.7 Monos 7.2 Eos 2.4 Baso 0.2 07:03PM BLOOD PTT 35.2 07:03PM BLOOD Plt 07:03PM BLOOD FacVIII 103 07:03PM BLOOD Glucose 93 UreaN 15 Creat 0.8 Na 139 K 4.1 Cl 101 HCO3 28 AnGap 14 11:00PM BLOOD WBC 6.6 RBC 3.30 Hgb 9.7 Hct 27.0 MCV 82 MCH 29.4 MCHC 36.0 RDW 14.7 Plt 07:25AM BLOOD WBC 5.2 RBC 3.14 Hgb 9.3 Hct 26.2 MCV 83 MCH 29.7 MCHC 35.7 RDW 14.6 Plt 03:25PM BLOOD WBC 6.3 RBC 3.27 Hgb 9.9 Hct 27.1 MCV 83 MCH 30.3 MCHC 36.5 RDW 14.7 Plt 07:50PM URINE Color Yellow Appear Clear Sp 07:50PM URINE Blood NEG Nitrite NEG Protein 30 Glucose NEG Ketone NEG Bilirub NEG Urobiln NEG pH 6.0 Leuks NEG 07:50PM URINE RBC 1 WBC 1 Bacteri FEW Yeast NONE Epi 0 07:50PM URINE Mucous RARE IMAGING/STUDIES: CT A/P Acute hemorrhage along right posterior flank musculature and probably layering over it only partly imaged and hard to distinguish musculature from hemorrhage. No active extravasation seen. Probable old hematoma along posterior left flank. Brief Hospital Course: Mr. is a with history of mild FVIII deficiency who presents after snowboarding accident with multiple hematomas and falling hemoglobin concerning for ongoing bleeding. FACTOR VIII DEFICIENCY MULTIPLE HEMATOMAS: Patient presented after recent snowboarding accident. At imaging was notable for neck and shoulder hematomas. Upon reevaluation by his PCP the patient was found to have a flank hematoma. Given falling hemoglobin there was concern for retroperitoneal bleed. CTAP in the ED demonstrated hematoma over his flank musculature but no active extravasation. He was given IV DDAVP but FVIII activity was 103 wnl . CBC remained stable and patient declined further inpatient monitoring. Atrius hematology recommended continued outpatient hemoglobin monitoring but did not think further DDAVP was indicated given normal FVIII level. TRANISTIONAL ISSUES: PCP CBC at Caution to avoid dangerous activity Code: presumed full Emergency Contact: wife Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Desmopressin Nasal mcg NAS PRN bleeding Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H pain 2. Desmopressin Nasal mcg NAS PRN bleeding 3. Outpatient Lab Work CBC on or . Last hemoglobin 9.9 . Discharge Disposition: Home Discharge Diagnosis: PRIMARY: Acute muscular hematoma right flank Hemophilia factor VIII deficiency Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Mr. It was our pleasure caring for you at . You were admitted with bruising on your right side and low blood counts after a snowboarding fall. With your history of hemophilia it was important to evaluate internal bleeding which did show a right muscular flank blood collection. Your facotr VIII level was 103 and you received IV DDAVP under our care. Your blood counts were stable to improved on the day of admission. It is important that you not participate in any dangerous activities given your recent bleed and your hemophilia. Bleeding in hemophiliacs has more potential to be life threatening. Please get your blood counts checked at site on either or . Follow up with your regular doctor early next week. Best wishes Your Care Team Followup Instructions:  \n",
              "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sex: F Service: UROLOGY Allergies: Patient recorded as having No Known Allergies to Drugs Attending: . Chief Complaint: renal mass Major Surgical or Invasive Procedure: right laparascopic radical nephrectomy Dr. Dr. History of Present Illness: y/o healthy female with incidental finding of right renal mass suspicious for RCC following MRI on . Past Medical History: PMH: nonspecific right axis deviation PSH cesarean section ALL NKDA Social History: Family History: no history of RCC Pertinent Results: 07:15AM BLOOD WBC 7.6 RBC 3.82 Hgb 11.9 Hct 33.8 MCV 89 MCH 31.2 MCHC 35.2 RDW 12.8 Plt 07:15AM BLOOD Glucose 150 UreaN 10 Creat 0.9 Na 138 K 3.8 Cl 104 HCO3 27 AnGap 11 Brief Hospital Course: Patient was admitted to Urology after undergoing laparoscopic right radical nephrectomy. No concerning intraoperative events occurred please see dictated operative note for details. The patient received perioperative antibiotic prophylaxis. The patient was transferred to the floor from the PACU in stable condition. On POD0 pain was well controlled on PCA hydrated for urine output 30cc/hour provided with pneumoboots and incentive spirometry for prophylaxis and ambulated once. On POD1 foley was removed without difficulty basic metabolic panel and complete blood count were checked pain control was transitioned from PCA to oral analgesics diet was advanced to a clears/toast and crackers diet. On POD2 diet was advanced as tolerated. The remainder of the hospital course was relatively unremarkable. The patient was discharged in stable condition eating well ambulating independently voiding without difficulty and with pain control on oral analgesics. On exam incision was clean dry and intact with no evidence of hematoma collection or infection. The patient was given explicit instructions to follow up in clinic with in 3 weeks. Medications on Admission: none Discharge Medications: 1. Hydrocodone Acetaminophen mg Tablet Sig: Tablets PO Q6H every 6 hours as needed for break through pain only score 4 . Disp: 60 Tablet s Refills: 0 2. Docusate Sodium 100 mg Capsule Sig: One 1 Capsule PO BID 2 times a day . Disp: 60 Capsule s Refills: 2 Discharge Disposition: Home Discharge Diagnosis: renal cell carcinoma Discharge Condition: stable Discharge Instructions: You may shower but do not bathe swim or immerse your incision. Do not eat constipating foods for weeks drink plenty of fluids Do not lift anything heavier than a phone book 10 pounds or drive until you are seen by your Urologist in follow up Tylenol should be used as your first line pain medication. If your pain is not well controlled on Tylenol you have been prescribed a narcotic pain medication. Use in place of Tylenol. Do not exceed 4 gms of Tylenol in total daily Do not drive or drink alcohol while taking narcotics Resume all of your home medications except hold NSAID aspirin advil motrin ibuprofen until you see your urologist in follow up If you have fevers 101.5 F vomiting or increased redness swelling or discharge from your incision call your doctor or go to the nearest ER Call Dr. to set up follow up appointment and if you have any urological questions. Followup Instructions:  "
            ]
          },
          "execution_count": 5,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "pd.set_option('display.max_colwidth', None)\n",
        "raw.head(5)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "HdFe2pD6B2fC"
      },
      "outputs": [],
      "source": [
        "raw=raw.drop(columns=['Unnamed: 0' ])"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "t7T8966z8iLV"
      },
      "outputs": [],
      "source": [
        "raw=raw.head(50000)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GHgFOmmb8muD",
        "outputId": "351c3d33-f9d6-4399-9c19-e131731ffd33"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "(50000, 2)"
            ]
          },
          "execution_count": 7,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "raw.shape"
      ]
    },
    {
      "attachments": {},
      "cell_type": "markdown",
      "metadata": {
        "id": "4LTLPYBWWvWH"
      },
      "source": [
        "#Visualise data"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Jyx_gdNMgMwa",
        "outputId": "175dca00-5578-42f5-e1f8-3e9abf429379"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "10000032\n",
            "13449593\n"
          ]
        }
      ],
      "source": [
        "subject_id_min = raw['subject_id'].min()\n",
        "subject_id_max = raw['subject_id'].max()\n",
        "print(subject_id_min)\n",
        "print(subject_id_max)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "uwDPsk1WWui-"
      },
      "outputs": [],
      "source": [
        "unique_counts = raw['subject_id'].nunique()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 506
        },
        "id": "VLMUdxmsX1oJ",
        "outputId": "07094882-7ef4-4201-e1e3-2171afd08a92"
      },
      "outputs": [
        {
          "data": {
            "image/png": "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",
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "document_counts = raw.groupby('subject_id').count()\n",
        "top_counts = document_counts.sort_values(by='subject_id', ascending=False).head(20)\n",
        "top_counts.plot(kind='bar', color='#EE6E9C')\n",
        "plt.xlabel('Subject ID')\n",
        "plt.ylabel('Number of Documents')\n",
        "#plt.title('Number of Documents per Subject ID (Top 20)')\n",
        "plt.show()\n",
        "\n"
      ]
    },
    {
      "attachments": {},
      "cell_type": "markdown",
      "metadata": {
        "id": "8mB3i8Vb_OmG"
      },
      "source": [
        "### Preprocessing"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "sXXCtCENldfG"
      },
      "outputs": [],
      "source": [
        "raw['text'] = raw['text'].replace('\\n', ' ', regex=True)\n",
        "raw['text'] = raw['text'].replace('_', ' ', regex=True)\n",
        "raw['text'] =raw['text'].replace('=', ' ', regex=True)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "b5MRKem_4cjb",
        "outputId": "7b4ac827-e6e6-4d86-e60a-386633d25352"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "0    Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: Chief Complaint: Worsening ABD distension and pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week. Pt reports self discontinuing lasix and spirnolactone weeks ago because she feels like they don t do anything and that she doesn t want to put more chemicals in her. She does not follow Na restricted diets. In the past week she notes that she has been having worsening abd distension and discomfort. She denies edema or SOB or orthopnea. She denies f/c/n/v d/c dysuria. She had food poisoning a week ago from eating stale cake n/v 20 min after food ingestion which resolved the same day. She denies other recent illness or sick contacts. She notes that she has been noticing gum bleeding while brushing her teeth in recent weeks. she denies easy bruising melena BRBPR hemetesis hemoptysis or hematuria. Because of her abd pain she went to OSH ED and was transferred to for further care. Per ED report pt has brief period of confusion she did not recall the ultrasound or bloodwork at osh. She denies recent drug use or alcohol use. She denies feeling confused but reports that she is forgetful at times. In the ED initial vitals were 98.4 70 106/63 16 97 RA Labs notable for ALT/AST/AP : Tbili1.6 WBC 5K platelet 77 INR 1.6 Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Her last alcohol consumption was one drink two months ago. No regular alcohol consumption. Last drug use years ago. She quit smoking a couple of years ago. Physical Exam: VS: 98.1 107/61 78 18 97RA General: in NAD HEENT: CTAB anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended mild diffuse tenderness flank dullness cannot percuss liver/spleen edge distension GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 converse normally able to recall 3 times after 5 minutes CN II XII intact Discharge: PHYSICAL EXAMINATION: VS: 98 105/70 95 General: in NAD HEENT: anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended but improved TTP in RUQ GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 CN II XII intact Pertinent Results: 10:25PM GLUCOSE 109 UREA N 25 CREAT 0.3 SODIUM 138 POTASSIUM 3.4 CHLORIDE 105 TOTAL CO2 27 ANION GAP 9 10:25PM estGFR Using this 10:25PM ALT SGPT 100 AST SGOT 114 ALK PHOS 114 TOT BILI 1.6 10:25PM LIPASE 77 10:25PM ALBUMIN 3.3 10:25PM WBC 5.0 RBC 4.29 HGB 14.3 HCT 42.6 MCV 99 MCH 33.3 MCHC 33.5 RDW 15.7 10:25PM NEUTS 70.3 LYMPHS 16.5 MONOS 8.1 EOS 4.2 BASOS 0.8 10:25PM PLT COUNT 71 10:25PM PTT 30.9 10:25PM . CXR: No acute cardiopulmonary process. U/S: 1. Nodular appearance of the liver compatible with cirrhosis. Signs of portal hypertension including small amount of ascites and splenomegaly. 2. Cholelithiasis. 3. Patent portal veins with normal hepatopetal flow. Diagnostic para attempted in the ED unsuccessful. On the floor pt c/o abd distension and discomfort. Brief Hospital Course: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week and confusion. Ascites p/w worsening abd distension and discomfort for last week. likely portal HTN given underlying liver disease though no ascitic fluid available on night of admission. No signs of heart failure noted on exam. This was to med non compliance and lack of diet restriction. SBP negative diuretics: Furosemide 40 mg PO DAILY Spironolactone 50 mg PO DAILY chosen over the usual 100mg dose d/t K of 4.5. CXR was wnl UA negative Urine culture blood culture negative. Pt was losing excess fluid appropriately with stable lytes on the above regimen. Pt was scheduled with current PCP for check upon discharge. Pt was scheduled for new PCP with Dr. at and follow up in Liver clinic to schedule outpatient screening EGD and . Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO DAILY 2. Spironolactone 50 mg PO DAILY 3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 4. Raltegravir 400 mg PO BID 5. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 6. Nicotine Patch 14 mg TD DAILY 7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Furosemide 40 mg PO DAILY RX furosemide 40 mg 1 tablet s by mouth Daily Disp 30 Tablet Refills: 3 4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB 5. Nicotine Patch 14 mg TD DAILY 6. Raltegravir 400 mg PO BID 7. Spironolactone 50 mg PO DAILY 8. Acetaminophen 500 mg PO Q6H:PRN pain Discharge Disposition: Home Discharge Diagnosis: Ascites from Portal HTN Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure taking care of you You came to us with stomach pain and worsening distension. While you were here we did a paracentesis to remove 1.5L of fluid from your belly. We also placed you on you 40 mg of Lasix and 50 mg of Aldactone to help you urinate the excess fluid still in your belly. As we discussed everyone has a different dose of lasix required to make them urinate and it s likely that you weren t taking a high enough dose. Please take these medications daily to keep excess fluid off and eat a low salt diet. You will follow up with Dr. in liver clinic and from there have your colonoscopy and EGD scheduled. Of course we are always here if you need us. We wish you all the best Your Team. Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet Attending: . Chief Complaint: abdominal fullness and discomfort Major Surgical or Invasive Procedure: diagnostic paracentesis therapeutic paracentesis History of Present Illness: with HIV on HAART COPD HCV cirrhosis complicated by ascites and HE admitted with abdominal distention and pain. She was admitted to for the same symptoms recently and had 3L fluid removed no SBP three days ago and felt better. Since discharge her abdomen has become increasingly distended with pain. This feels similar to prior episodes of ascites. Her diuretics were recently decreased on due to worsening hyponatremia 128 and hyperkalemia 5.1. Patient states she has been compliant with her HIV and diuretic medications but never filled out the lactulose prescription. She states she has had BMs daily at home. She has had some visual hallucinations and forgetfulness. Her appetite has been poor. In the ED initial vitals were 98.9 88 116/88 18 97 RA. CBC near baseline INR 1.4 Na 125 Cr 0.6. AST and ALT mildly above baseline 182 and 126 and albumin 2.8. Diagnostic para with 225 WBC 7 PMN total protein 0.3. UA with few bact 6 WBC mod leuk neg nitr but contaminated with 6 epi. CXR clear. RUQ US with no PV thrombus moderate ascites. She was given ondansetron 4mg IV and morphine 2.5mg IV x1 in the ED. On the floor she is feeling improved but still has abdominal distention and discomfort. ROS: Abdominal distention and pain. No black/bloody stools. No pain or swelling. No fevers or chills. Denies chest pain nausea vomiting. No dysuria or frequency. Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: VS: T98.1 105/57 79 20 97RA 44.6kg GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis DISCHARGE PE: VS: T 98.4 BP 95/55 SBP HR 80 RR 18 O2 95RA I/O 240/150 this am GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis Pertinent Results: LABS ON ADMISSION: 04:10PM BLOOD Plt 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:39PM BLOOD LABS ON DISCHARGE: 05:10AM BLOOD Plt 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD MICRO: 10:39 pm URINE Source: . FINAL REPORT URINE CULTURE Final : MIXED BACTERIAL FLORA 3 COLONY TYPES CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. Diagnositc Para: 07:00PM ASCITES 07:00PM ASCITES IMAGING: CXR No acute cardiopulmonary abnormality. RUQ US 1. Extremely coarse and nodular liver echotexture consistent with a history of cirrhosis. 2. Moderate ascites. 3. Patent portal vein. Brief Hospital Course: with HIV on HAART HCV cirrhosis with ascites and HE h/o IVDU COPD bipolar disorder presents with abdominal discomfort due to ascites. ASCITES. Now diuretic refractory given last tap was three days ago with 3L removed and she has already built up moderate ascites. Infectious workup negative with CXR clear UA contaminated but not grossly positive so will f/u culture diagnostic para with only 225 WBC RUQ US with no PV thrombus. Compliant with diuretics but not following low sodium diet or fluid restriction. Dr. discussed possible TIPS in the office but due to lung disease that was on hold pending further cardiac evaluation. Diuretics were recently decreased due to hyponatremia and hyperkalemia. Held spironolactone for now due to K 5.2 and increased lasix 20 40. No evidence of severe hyponatremia Na 120 or renal failure Cr 2.0 to stop diuretics at present. Diagnostic paracentesis negative for infection. Ascitic total protein 0.3 so warrants SBP prophylaxis 1.0 and fortunately already on Bactrim for PCP prophylaxis which would be appropriate for SBP ppx also. Patient did admit to eating pizza and some food prior to admission. She had therapeutic paracentesis with 4.3L removed and received 37.5G albumin IV post procedure. She felt much better with resolution of abdominal discomfort. Patient is scheduled for repeat paracentesis as outpatient on . HEPATIC ENCEPHALOPATHY. History of HE from Hep C cirrhosis. Now with mild encephalopathy hallucinations and forgetfulness due to medication noncompliance but not acutely encephalopathic and without asterixis on exam. Infectious workup negative thus far. Continue lactulose 30mL TID and titrate to 3 BMs daily and continue rifaximin 550mg BID. HYPONATREMIA. Na 125 on admission 128 four days ago and 135 one month ago. Likely due to third spacing from worsening ascites and fluid overload. 1.5L fluid restriction low salt diet. S/p therapeutic paracentesis with albumin replacement. CIRRHOSIS HEPATITIS C. MELD score of 10 and Child s class B on this admission. Now decompensated due to ascites. Hepatitis C genotype IIIB. Dr. starting and with patient in clinic and the insurance process was started by her office. No history of EGD needs this as outpatient for varices screening. NUTRITION. Unclear if truly compliant with low salt diet. Poor oral intake. Low albumin 2.8 on admission. Met with nutrition. COAGULOPATHY. INR 1.4 four days ago. No evidence of active bleeding. Very mild thrombocytopenia with plts 143. HIV. Most recent CD4 173. On HAART. No established ID provider. Continue Truvada and Isentress Bactrim DS daily for PCP . Needs outpatient ID appointment COPD. Stable. States she is on intermittent home O2 for comfort at night and with abdominal distentiom. Continued home COPD meds and home O2 as needed Transitional Issues Discontinued spironolactone elevated potassium Increased furosemide to 40mg daily Please recheck electrolytes at next visit Had paracentesis with 4.3 L removed received 37.5G albumin Needs outpatient ID provider needs more frequent paracentesis Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 2. Truvada 1 TAB PO DAILY 3. Furosemide 20 mg PO DAILY 4. Raltegravir 400 mg PO BID 5. Spironolactone 50 mg PO DAILY 6. Acetaminophen 500 mg PO Q6H:PRN pain fever 7. Tiotropium Bromide 1 CAP IH DAILY 8. Rifaximin 550 mg PO BID 9. Calcium Carbonate 1250 mg PO BID 10. Lactulose 15 mL PO TID 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Acetaminophen 500 mg PO Q6H:PRN pain fever 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 3. Calcium Carbonate 1250 mg PO BID 4. Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. Lactulose 15 mL PO TID 7. Raltegravir 400 mg PO BID 8. Rifaximin 550 mg PO BID 9. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 10. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: diuretic refractory ascites Secondary: HCV cirrhosis HIV hyponatremia COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear was a pleasure to take care of you at . You were admitted with abdominal fullness and pain from your ascites. You had a diagnostic and therapeutic paracentesis with 4.3 L removed. Your spironolactone was discontinued because your potassium was high. Your lasix was increased to 40mg daily. You are scheduled for another paracentesis on prior to your other appointments that day. Please call tomorrow to find out the time of the paracentesis. Please continue to follow a low sodium diet and fluid restriction. You should call your liver doctor or return to the emergency room if you have abdominal pain fever chills confusion or other concerning symptoms. Sincerely Your medical team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: Chief Complaint: altered mental status Major Surgical or Invasive Procedure: none History of Present Illness: Mrs. is a female with HIV on HAART COPD HCV cirrhosis complicated by ascites and hepatic encephalopathy who initially presented to the ED yesterday with hypotension after a paracentesis. The patient has had accelerated decompensation of her cirrhosis recently with worsening ascites and she is maintained on twice weekly paracentesis. She was at her regular session yesterday when she had hypotension to SBP and felt lightheadedness. Per the patient that s when her memory started to get fuzzy. She does not have much recollection of what happened since then. Her outpatient hepatologist saw her and recommended that she go to the ED. In the ED she was evaluated and deemed to have stable blood pressure. She was discharged home. At home she had worsening mental status with her daughter getting concerned and she returned to the ED. In the ED initial vitals were 98.7 77 96/50 16 98 RA. The patient was only oriented to person. Her labs were notable for Na 126 K 6.7 Cr 0.7 baseline 0.4 ALT 153 AST 275 TBili 1.9 Lip 66 INR 1.5. Initial EKG showed sinus rhythm with peaked T waves. Her head CT was negative for any acute processes. She received ceftriaxone 2gm x1 regular insulin 10U calcium gluconate 1g lactulose 30 mL x2 and 25g 5 albumin. On transfer vitals were 99.0 93 84/40 16 95 NC. On arrival to the MICU patient was more alert and conversant. She has no abdominal pain nausea vomiting chest pain or difficulty breathing. She has a chronic cough that is not much changed. She has not had any fever or chills. She reports taking all of her medications except for lactulose which she thinks taste disgusting. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals T: 98.7 BP: 84/48 P: 91 R: 24 O2: 98 NC on 2L GENERAL: Alert oriented no acute distress LUNGS: Decreased air movement on both sides scattered expiratory wheezes CV: Regular rate and rhythm normal S1 S2 no murmurs rubs gallops ABD: Soft non tender distended flank dullness bilaterally bowel sounds present EXT: Warm well perfused 2 pulses no cyanosis or edema DISCHARGE PHYSICAL EXAM: Vitals Tm 99.5 Tc 98.7 79 96/43 58 20 95 on 3L NC 7BM. General Cachectic appearing woman alert oriented no acute distress HEENT Sclera anicteric MMM oropharynx clear poor dentition with partial dentures Neck supple JVP not elevated no LAD Lungs Clear to auscultation bilaterally no wheezes rales ronchi CV Regular rate and rhythm normal S1 S2 no murmurs rubs gallops Abdomen Mildly distended and firm non tender bowel sounds present no rebound tenderness or guarding GU no foley Ext warm well perfused 2 pulses no clubbing cyanosis or edema Neuro AOx3 No asterixis. Pertinent Results: ADMISSION LABS: 06:39AM BLOOD WBC 6.9 RBC 3.98 Hgb 14.1 Hct 41.1 MCV 103 MCH 35.4 MCHC 34.3 RDW 15.8 Plt 06:39AM BLOOD Neuts 72.7 Lymphs 14.7 Monos 9.8 Eos 2.5 Baso 0.3 06:39AM BLOOD PTT 32.4 06:39AM BLOOD Glucose 102 UreaN 49 Creat 0.7 Na 126 K 6.7 Cl 95 HCO3 25 AnGap 13 06:39AM BLOOD ALT 153 AST 275 AlkPhos 114 TotBili 1.9 06:39AM BLOOD Albumin 3.6 IMAGING/STUDIES: CT HEAD: No evidence of acute intracranial process. The left zygomatic arch deformity is probably chronic as there is no associated soft tissue swelling. CXR: No acute intrathoracic process. DISCHARGE LABS: 04:45AM BLOOD WBC 4.8 RBC 3.15 Hgb 11.2 Hct 32.1 MCV 102 MCH 35.4 MCHC 34.8 RDW 15.8 Plt Ct 95 04:45AM BLOOD PTT 37.6 04:45AM BLOOD Glucose 121 UreaN 35 Creat 0.4 Na 130 K 5.2 Cl 97 HCO3 27 AnGap 11 04:45AM BLOOD ALT 96 AST 168 AlkPhos 69 TotBili 1.7 04:45AM BLOOD Calcium 8.6 Phos 2.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities w/ AMS hypotension and hyperkalemia. Altered mental status improved with lactulose. Hypotension was felt to be due to fluid shifts from paracentesis on the day prior to admission as well as low PO intake in the setting of AMS. Hypotension and resolved with IV albumin. Hyperkalemia resolved with insulin and kayexalate. Hypotension: Patient presented with SBP in and improved with albumin in the ED to . It was felt to be due to fluid shifts from paracentesis on as well as likely hypovolemia given AMS and decreased PO intake. No concern for bleeding or sepsis with baseline CBC and lack of fever. She continued to received IV albumin during her hospital course with which her SBP improved to and patient remained asymptomatic. Hyperkalemia: Patient presented with K 6.7 with EKG changes. Given low Na likely the result of low effective arterial volume leading to poor K excretion with likely exacerbation from . AM cortisol was normal. K improved with insulin and kayexalate and K was 5.2 on day of discharge. Bactrim was held during hospital course. : Patient presented with Cr 0.7 from baseline Cr is 0.3 0.4. It was felt to be likely due to volume shift from her paracentesis on the day prior to admission as well as now low effective arterial volume likely poor PO intake AMS. Cr improved to 0.4 with albumin administration. Furosemide and Bactrim were held during hospital course. GOC: The son HCP met with Dr. outpatient hepatologist during hospital course. They discussed that the patient is not a transplant candidate givenevere underlying lung disease FEV1 0.8 hypoxia RV dilation and very low BMI. A more conservative approach was recommended and the patient was transitioned to DNR/DNI. The patient agreed with this plan. She was treated with the goal of treating any any correctable issues. Social work met with the patient prior to discharge. The patient was interested in following up with palliative care for which an outpatient referral was made. Altered Mental Status: Patient presented with confusion that was most likely secondary to hepatic encephalopathy. Based on outpatient records patient has had steady decline in decompensated cirrhosis and mental status. No signs of infection and head CT was negative as well. Mental status improved with lactulose in the ED and patient reports that she has not been taking lactulose regularly at home. Patient was also continued on rifaximin. HCV Cirrhosis: Genotype 3a. Patient is decompensated with increasing ascites and worsening hepatic encephalopathy. She is dependent on twice weekly paracentesis. Spironolactone was recently stopped due to hyperkalemia. Patient is not a transplant candidate given her comorbidities COPD per outpatient hepatologist. The patient would like to continue biweekly paracenteses as an outpatient. HIV: Most recent CD4 count 173 on . HIV viral load on was undetectable. She was continued on her home regimen of raltegravir emtricitabine and tenofovir. Bactrim prophylaxis was held during admission because of hyperkalemia. COPD: Patient on 3L NC at home. She was continued on her home regimen. TRANSITIONAL ISSUES: Follow up with Palliative Care as outpatient Bactrim prophylaxis HIV was held during hospital course due to . Consider restarting as outpatient. Furosemide was held due to consider restarting as outpatient Follow up with hepatology Continue biweekly therapeurtic paracenteses Code status: DNR/DNI Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lactulose 15 mL PO TID 2. Tiotropium Bromide 1 CAP IH DAILY 3. Raltegravir 400 mg PO BID 4. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. TraMADOL Ultram 50 mg PO Q8H:PRN Pain 7. Fluticasone Propionate 110mcg 1 PUFF IH BID 8. Calcium Carbonate 500 mg PO BID 9. Rifaximin 550 mg PO BID 10. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: Hypotension Hyperkalemia Acute Kidney Injury Secondary: HIV Cirrhosis COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. You were admitted to because of confusion low blood pressure and a high potassium value. Your confusion improved with lactulose. Your blood pressure improved with extra fluids and your potassium improved as well. You also had small degree of kidney injury when you came to the hospital and this also improved with fluids. While you were here you discussed changing your goals of care to focusing on symptom management and treatment of reversible processes such as an infection. While you were in the hospital you were seen by one of our social workers. You will also follow up with Palliative Care in their clinic and will continue to have therapeutic paracenteses. It has been a pleasure taking care of you and we wish you all the best Your Care team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: . Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: w/ HIV on HAART COPD on 3L home O2 though sat ing fine on RA on admission HCV cirrhosis c/b ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening girth and abd pain. She d been having pain from her ascites and felt overdue for a paracentesis. She last had paracentesis on the . She reported that she began feeling worsening abdominal pain constant epigastric and radiates to back not a/w food on which increased in severity throughout the course of the day. She was brought to the ED by her son because of this pain. She had no confusion and was alert and oriented x3. The patient also reported she recently ran out of most of her home medications. She denied any fever chills shortness of breath cough dysuria. She reported loose stool a bit more than usual but attributed it to lactulose use. In the ED vitals were: 99.4 105 106/57 18 96 ra. Labs were significant for Na 127 K 5.3 lactate 2.1 INR 1.7. ALT 135 AST 244 AP 123. no leukocytosis. Ascitic fluid showed 220 WBC. She was given Morphine Sulfate 5 mg IV ONCE MR1 and a GI cocktail. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM Vitals T 97 BP 98/65 HR 103 RR 18 O2 94RA Glucose 128. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: distended fluid wave not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes DISCHARGE PHYSICAL EXAM Vitals Tm 98.6 Tc 98.2 BP 82 98/42 68 HR 80 95 RR O2 91 99 RA. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: soft decreased distension not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes Pertinent Results: ADMISSION LABS 09:20PM BLOOD WBC 8.2 RBC 3.48 Hgb 12.3 Hct 36.7 MCV 106 MCH 35.5 MCHC 33.6 RDW 16.5 Plt 09:28PM BLOOD PTT 31.8 09:20PM BLOOD Glucose 118 UreaN 33 Creat 0.6 Na 127 K 5.3 Cl 97 HCO3 24 AnGap 11 09:20PM BLOOD ALT 135 AST 244 AlkPhos 123 TotBili 1.3 09:20PM BLOOD Albumin 3.5 Calcium 8.3 Phos 3.3 Mg 2.3 09:27PM BLOOD Lactate 2.1 NOTABLE LABS 12:30AM ASCITES WBC 220 Polys 17 Lymphs 48 Monos 19 Mesothe 2 Macroph 12 Other 2 12:30AM ASCITES TotPro 0.7 Glucose 129 MICROBIOLOGY 12:30 am PERITONEAL FLUID GRAM STAIN Final : NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. VRE screen: No VRE isolated. IMAGING/STUDIES CXR No acute cardiopulmonary process. RUQUS Cirrhotic mild splenomegaly and ascites. A solid 3cm nodule in the left lobe of the liver is stable in size and appearance. DISCHARGE LABS 06:15AM BLOOD WBC 5.6 RBC 3.27 Hgb 11.6 Hct 33.5 MCV 103 MCH 35.5 MCHC 34.5 RDW 16.1 Plt 06:15AM BLOOD PTT 36.0 06:15AM BLOOD Glucose 87 UreaN 29 Creat 0.4 Na 123 K 5.4 Cl 93 HCO3 24 AnGap 11 06:15AM BLOOD ALT 112 AST 176 AlkPhos 101 TotBili 2.8 06:15AM BLOOD Albumin 3.5 Calcium 8.8 Phos 3.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening abd girth and pain. Goals of care: The patient expressed that her desire to let go and be at peace. She is tired of fighting her end stage liver disease and does not feel that she has a good quality of life. She wished to meet with a representative from hospice which we were able to arrange and she decided that she would like to go home with hospice. A conversation was held with the patient regarding code status. She noted that she would probably be DNR/DNI but would like to discuss it with her son HCP . Therefore at this time she remains full code. We also discussed the possibility of her getting a pleurex catheter placed because of her repeated paracenteses. She was discharged to home with hospice on . Decompensated HCV cirrhosis with ascites: The patient presented with worsening ascites. Her pain was initially managed with tramadol and morphine. She underwent paracentesis on with removal of 3.5L and she received albumin. Studies on the fluid were negative and she reported a significant improvement in her pain. Hyperkalemia: During her hospitalization it was noted that she had hyperkalemia 5.3 5.9 6.9 without EKG changes. After treatment with calcium gluconate 2gm x2 insulin and D50 x 2 and kayexelate her K downtrended to 5.4. Her K has been persistently elevated in the past and should continue to be monitored. Hepatic encephalopathy: The patient s mental status was A Ox3 on admission. She was continued on rifaximin and lactulose in house and at discharge. CHRONIC ISSUES Hyponatremia The patient has a history of asymptomatic hyponatremia. It is most likely hypervolemic hyponatremia related to underlying liver disease as well as aldosterone axis dysfunction related to liver disease. She remained asymptomatic through her hospitalization. Because she was also started on 10mg of furosemide to help prevent fluid re accumulation she will require BMPs twice weekly in the outpatient setting. HIV: Emtricitabine Tenofovir Truvada and Raltegravir were continued in house and at discharge. COPD: fluticasone tiotropium and albuterol were continued in house and at discharge. TRANSITIONAL ISSUES Follow up peritoneal fluid culture New/changed medications: Furosemide 10mg daily new For hyperkalemia and hyponatremia the patient should have biweekly BMPs script written . If K 5.3 she should be given kayexelate once weekly. Lab results will be faxed/sent to Dr. . Continue conversation regarding pleurex catheter placement and code status. She will continue to have twice weekly paracenteses Code: full Emergency Contact: on Admission: The Preadmission Medication list is accurate and complete. 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Medications: 1. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 2. Calcium Carbonate 500 mg PO BID 3. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 4. Fluticasone Propionate 110mcg 1 PUFF IH BID 5. Lactulose 30 mL PO TID 6. Raltegravir 400 mg PO BID 7. Rifaximin 550 mg PO BID 8. Tiotropium Bromide 1 CAP IH DAILY 9. TraMADOL Ultram mg PO Q6H:PRN pain 10. Furosemide 10 mg PO DAILY RX furosemide 20 mg 0.5 One half tablet s by mouth Please take 1 tablet daily. Disp 15 Tablet Refills: 0 11. Outpatient Lab Work Please obtain biweekly BMP to monitor K and Na. Please fax results to Dr. at the at . Discharge Disposition: Home With Service Facility: Discharge Diagnosis: PRIMARY DIAGNOSIS Decompensated HCV cirrhosis Hyperkalemia SECONDARY DIAGNOSES HIV COPD Hyponatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure caring for you during your stay at . You were admitted because of worsening abdominal pain. It is likely that this pain was due to increasing fluid in the abdomen from your cirrhosis. After a paracentesis in which much of this fluid was removed your pain improved significantly. You were noted to have a high potassium during your hospitalization which came down with treatment but this should continue to be followed as an outpatient. You also emphasized your desire to speak with a representative from hospice. Because of your repeated paracenteses we also discussed the possibility of a pleurex catheter placement. We arranged for you to meet with hospice coordinators and you will be discharged home with hospice. We wish you all the best Your care team Followup Instructions:\n",
              "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: . Chief Complaint: Visual hallucinations Major Surgical or Invasive Procedure: N/A History of Present Illness: male with disease dyslipidemia and a history of prostate cancer s/p prostatectomy who was referred to the ED by his neurologist for worsening gait falls and visual hallucinations. The following history is taken from chart review: The patient was seen by his neurologist on at which time he was noted to have visual hallucinations and worsening gait freezing. For his gait freezing his mirapex was increased by 0.125 mg every week to a goal dose of 0.75 mg t.i.d. He successfully up titrated the medicine to 0.75/0.625/0.625 but began to have visual hallucinations and confusion so on his neurologist recommended decreasing the dose to 0.625 TID. Despite the changes to his Mirapex the patient s daughter has noted progressive gait stiffness and increased difficulty standing. This has resulted in difficulty with simply getting to the bathroom leading to episodes of incontinence. A UA performed on was reassuring. On the day of presentation to the hospital the patient began to experience visual hallucinations of a motor cross race in his backyard. He subsequently had a fall while transferring from the couch to a chair. His wife was unable to get him off the floor. The fall was witnessed and there was no head strike. Per the patient s wife his gait has acutely worsened over the past 24 hours to the point where he has been unable to ambulate on his own. The patient s daughter called his neurologist who recommended presentation to the ED. In the ED the patient was afebrile HRs normotensive and SpO2 100 RA. On exam he was noted to have cogwheeling of upper extremities and decrease strength. Labs were remarkable for a negative urine and serum tox Na 132 K 5.8 hemolyzed and no EKG changes negative troponin normal LFTs unremarkable CBC. Chest Xray showed no acute process and CTH was reassuring. He was evaluated by neurology who recommended admission to medicine for failure to thrive to continue the patient s home medications and complete a toxo metabolic workup. The patient was given his home pramipexole and pravastatin before he was admitted. On arrival to the floor the patient is comfortable in bed. He is not accompanied by family on my interview. He knows that he is in the hospital and that it is . He is not sure why he is here and begins to tell me about a party in his house with a motor cross race in his backyard. When I asked him about his fall he mentions that he has not had a fall for years. He denies any fevers chills cough chest pain abdominal pain nausea diarrhea or dysuria. REVIEW OF SYSTEMS: Per HPI otherwise 10 point review of systems was within normal limits. Past Medical History: disease Body Dementia dyslipidemia prostate cancer s/p prostatectomy Social History: Family History: His mother died at age of old age. His father died of prostate cancer at . He has an older sister age and a younger sister age . He has a younger brother age . As noted he has 2 daughters. There is no family history of neurologic illness or dementia. There is no family history of neurodevelopmental mental disorders such as learning disability or ADHD. There is no family history of psychiatric problems. Physical Exam: ADMISSION PHYSICAL EXAM: VITALS: reviewed in OMR GENERAL: Alert and interactive. In no acute distress. HEENT: PERRL EOMI. Sclera anicteric and without injection. MMM. NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes rhonchi or rales. No increased work of breathing. BACK: No CVA tenderness. ABDOMEN: Normal bowels sounds non distended non tender to deep palpation in all four quadrants. No organomegaly. EXTREMITIES: No clubbing cyanosis or edema. Pulses DP/Radial 2 bilaterally. SKIN: Warm. Cap refill 2s. No rashes. NEUROLOGIC: AOx3. CN2 12 intact. cogwheel UE b/l. Increased tone in LEs strength b/l . Normal sensation. DISCHARGE PHYSICAL EXAM 24 HR Data last updated 2340 Temp: 97.7 Tm 98.4 BP: 130/80 130 153/80 90 HR: 80 80 104 RR: 18 O2 sat: 100 95 100 O2 delivery: Ra GENERAL: In no acute distress. Talking very quietly. CARDIAC: Regular rhythm normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes rhonchi or rales. No increased work of breathing. ABDOMEN: Normal bowels sounds non distended non tender to deep palpation in all four quadrants. EXTREMITIES: No clubbing cyanosis or edema. Pulses DP/Radial 2 bilaterally. SKIN: Warm. NEUROLOGIC: AOx3. CN2 12 intact. cogwheel UE b/l. Increased tone in LEs strength b/l . Normal sensation. Pertinent Results: ADMISSION LABS: 10:30PM BLOOD WBC 8.6 RBC 4.03 Hgb 12.8 Hct 38.2 MCV 95 MCH 31.8 MCHC 33.5 RDW 13.0 RDWSD 45.2 Plt 10:30PM BLOOD Neuts 48.1 Monos 15.9 Eos 2.0 Baso 0.6 Im AbsNeut 4.13 AbsLymp 2.86 AbsMono 1.36 AbsEos 0.17 AbsBaso 0.05 10:30PM BLOOD PTT 23.4 10:30PM BLOOD Glucose 100 UreaN 17 Creat 0.8 Na 132 K 5.8 Cl 98 HCO3 19 AnGap 15 10:30PM BLOOD ALT 18 AST 38 AlkPhos 39 TotBili 0.4 10:30PM BLOOD Lipase 47 10:30PM BLOOD cTropnT 0.01 10:30PM BLOOD Albumin 4.0 Calcium 9.9 Phos 3.7 Mg 2.0 10:30PM BLOOD VitB12 570 10:30PM BLOOD TSH 1.4 07:00AM BLOOD Trep Ab NEG 10:30PM BLOOD ASA NEG Ethanol NEG Acetmnp NEG Tricycl NEG IMAGING: Imaging CT HEAD W/O CONTRAST FINDINGS: There is no evidence of infarction hemorrhage edema or mass. There is prominence of the ventricles and sulci suggestive of involutional changes. There is no evidence of fracture. The visualized portion of the remaining paranasal sinuses and middle ear cavities are clear. The visualized portion of the orbits are unremarkable apart from bilateral lens replacements. IMPRESSION: 1. No acute intracranial abnormality. No hydrocephalus. Imaging CHEST PA LAT IMPRESSION: Mild atelectasis in the lung bases without focal consolidation. Age indeterminate moderate to severe compression deformity of a low thoracic vertebral body. DISCHARGE LABS: 06:21AM BLOOD WBC 7.0 RBC 4.02 Hgb 12.9 Hct 38.1 MCV 95 MCH 32.1 MCHC 33.9 RDW 12.8 RDWSD 44.4 Plt 06:21AM BLOOD Glucose 88 UreaN 10 Creat 0.7 Na 140 K 4.0 Cl 104 HCO3 24 AnGap 12 06:21AM BLOOD Calcium 9.5 Phos 3.2 Mg 1. male with disease dyslipidemia and a history of prostate cancer s/p prostatectomy who was referred to the ED by his neurologist for worsening gait falls and visual hallucinations concerning for progression of his neurologic disorder. ACUTE/ACTIVE ISSUES: disease Body Dementia Visual Hallucinations The patient appears to have acute on chronic progression of his disease. Unclear if this is disease progression or underlying medical cause. Continued mirapex rasagiline and rivastigmine. Neurology recommended started Seroquel for his hallucinations. He was evaluated by physical therapy who recommended rehab. This recommendation was discussed with the family who opted for discharge to home with home physical therapy as this was in line with the patient s goals of care. TRANSITIONAL ISSUES: f/u visual hallucination symptoms on Seroquel f/u physical therapy at home Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Rasagiline 1 mg PO DAILY 2. Pramipexole 0.625 mg PO TID 3. rivastigmine 9.5 mg/24 hr transdermal DAILY 4. Pravastatin 40 mg PO QPM 5. Cyanocobalamin Dose is Unknown PO DAILY 6. Loratadine 10 mg PO DAILY Discharge Medications: 1. QUEtiapine Fumarate 25 mg PO QHS RX quetiapine 25 mg 1 tablet s by mouth AT NIGHT Disp 30 Tablet Refills: 0 2. Loratadine 10 mg PO DAILY 3. Pramipexole 0.625 mg PO TID 4. Pravastatin 40 mg PO QPM 5. Rasagiline 1 mg PO DAILY 6. rivastigmine 9.5 mg/24 hr transdermal DAILY Discharge Disposition: Home With Service Facility: Discharge Diagnosis: Dementia Discharge Condition: Mental Status: Confused sometimes. Level of Consciousness: Alert and interactive. Discharge Instructions: Dear Mr. It was a privilege caring for you at . WHY WAS I IN THE HOSPITAL You were sent to the emergency room by your neurologist who was concerned that you were having visual hallucinations. WHAT HAPPENED TO ME IN THE HOSPITAL You were started on a new medication to help treat your symptoms. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL Continue to take all your medicines and keep your appointments. We wish you the best Sincerely Your Team Followup Instructions:\n",
              "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Sex: F Service: MEDICINE Allergies: omeprazole Attending: . Chief Complaint: dysphagia Major Surgical or Invasive Procedure: Upper endoscopy History of Present Illness: w/ anxiety and several years of dysphagia who p/w worsened foreign body sensation. She describes feeling as though food gets stuck in her neck when she eats. She put herself on a pureed diet to address this over the last 10 days. When she has food stuck in the throat she almost feels as though she cannot breath but she denies trouble breathing at any other time. She does not have any history of food allergies or skin rashes. In the ED initial vitals: 97.6 81 148/83 16 100 RA Imaging showed: CXR showed a prominent esophagus Consults: GI was consulted. Pt underwent EGD which showed a normal appearing esophagus. Biopsies were taken. Currently she endorses anxiety about eating. She would like to try eating here prior to leaving the hospital. Past Medical History: GERD Hypercholesterolemia Kidney stones Mitral valve prolapse Uterine fibroids Osteoporosis Migraine headaches Social History: Family History: HTN father Dementia father Physical Exam: ADMISSION/DISCHARGE EXAM VS: 97.9 PO 109 / 71 70 16 97 ra GEN: Thin anxious woman lying in bed no acute distress HEENT: Moist MM anicteric sclerae NCAT PERRL EOMI NECK: Supple without LAD no JVD PULM: CTABL no w/c/r COR: RRR S1/S2 no m/r/g ABD: Soft non tender non distended BS no HSM EXTREM: Warm well perfused no edema NEURO: CN II XII grossly intact motor function grossly normal sensation grossly intact Pertinent Results: ADMISSION LABS 08:27AM BLOOD WBC 5.0 RBC 4.82 Hgb 14.9 Hct 44.4 MCV 92 MCH 30.9 MCHC 33.6 RDW 12.1 RDWSD 41.3 Plt 08:27AM BLOOD PTT 28.6 08:27AM BLOOD Glucose 85 UreaN 8 Creat 0.9 Na 142 K 3.6 Cl 104 HCO3 22 AnGap 20 08:27AM BLOOD ALT 11 AST 16 LD LDH 154 AlkPhos 63 TotBili 1.0 08:27AM BLOOD Albumin 4.8 IMAGING CXR : IMPRESSION: Prominent esophagus on lateral view without air fluid level. Given the patient s history and radiographic appearance barium swallow is indicated either now or electively. NECK X ray : IMPRESSION: Within the limitation of plain radiography no evidence of prevertebral soft tissue swelling or soft tissue mass in the neck. EGD: Impression: Hiatal hernia Angioectasia in the stomach Angioectasia in the duodenum biopsy biopsy Otherwise normal EGD to third part of the duodenum Recommendations: no obvious anatomic cause for the patient s symptoms follow up biopsy results to rule out eosinophilic esophagitis follow up with Dr. if biopsies show eosinophilic esophagitis Brief Hospital Course: Ms. is a with history of GERD who presents with subacute worsening of dysphagia and foreign body sensation. This had worsened to the point where she placed herself on a pureed diet for the last 10 days. She underwent CXR which showed a prominent esophagus but was otherwise normal. She was evaluated by Gastroenterology and underwent an upper endoscopy on . This showed a normal appearing esophagus. Biopsies were taken. TRANSITIONAL ISSUES: f/u biopsies from EGD if results show eosinophilic esophagitis follow up with Dr. . for management pt should undergo barium swallow as an outpatient for further workup of her dysphagia f/u with ENT as planned Code: Full presumed Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Omeprazole 20 mg PO BID Discharge Medications: 1. Omeprazole 20 mg PO BID Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: dysphagia and foreign body sensation SECONDARY DIAGNOSIS: GERD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. You were hospitalized at . You came in due to difficulty swallowing. You had an endoscopy to look for any abnormalities in the esophagus. Thankfully this was normal. They took biopsies and you will be called with the results. You should have a test called a barium swallow as an outpatient. We wish you all the best Your Team Followup Instructions: Sex: F Service: ORTHOPAEDICS Allergies: omeprazole / Iodine and Iodide Containing Products / hallucinogens Attending: . Chief Complaint: Left hip pain Major Surgical or Invasive Procedure: Status post left CRPP History of Present Illness: REASON FOR CONSULT: Femur fracture HPI: female presents with the above fracture s/p mechanical fall. This morning pt was walking when dog pulled on leash. Pt fell on L hip. Immediate pain. with movement. Denies Head strike LOC or blood thinners. Denies numbness or weakness in the extremities. Past Medical History: GERD Hypercholesterolemia Kidney stones Mitral valve prolapse Uterine fibroids Osteoporosis Migraine headaches Social History: Family History: HTN father Dementia father Physical Exam: General: Well appearing female in no acute distress. Left Lower extremity: Skin intact No deformity edema ecchymosis erythema induration Soft non tender thigh and leg Full painless ROM knee and ankle Fires SILT S/S/SP/DP/T distributions 1 pulses WWP Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a left valgus impacted femoral neck fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on for left closed reduction and percutaneous pinning of hip which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications and progressed to a regular diet and oral medications by POD 1. The patient was given antibiotics and anticoagulation per routine. The patient s home medications were continued throughout this hospitalization. The patient worked with who determined that discharge to home with services was appropriate. The hospital course was otherwise unremarkable. At the time of discharge the patient s pain was well controlled with oral medications incisions were clean/dry/intact and the patient was voiding/moving bowels spontaneously. The patient is weightbearing as tolerated in the left lower extremity and will be discharged on Lovenox for DVT prophylaxis. The patient will follow up with Dr. routine. A thorough discussion was had with the patient regarding the diagnosis and expected post discharge course including reasons to call the office or return to the hospital and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow up care. The patient expressed readiness for discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lactaid lactase 3 000 unit oral DAILY:PRN 2. Calcium Citrate D calcium citrate vitamin D3 315 200 mg unit oral DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO Q6H:PRN Pain Mild/Fever 2. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 3. Docusate Sodium 100 mg PO BID 4. Enoxaparin Sodium 40 mg SC QHS RX enoxaparin 40 mg/0.4 mL 40 mg Subcutaneously Nightly Disp 30 Syringe Refills: 0 5. OxyCODONE Immediate Release mg PO Q4H:PRN Pain Moderate RX oxycodone 5 mg 1 tablet s by mouth q4 PRN Disp 25 Tablet Refills: 0 6. Senna 8.6 mg PO BID 7. Calcium Citrate D calcium citrate vitamin D3 315 200 mg unit oral DAILY 8. Lactaid lactase 3 000 unit oral DAILY:PRN 9. Multivitamins 1 TAB PO DAILY 10. Vitamin D 400 UNIT PO DAILY Discharge Disposition: Home With Service Facility: Discharge Diagnosis: Left valgus impacted femoral neck fracture Discharge Condition: AVSS NAD A Ox3 LLE: Incision well approximated. Dressing clean and dry. Fires FHL TA GCS. SILT n distributions. 1 DP pulse wwp distally. Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: You were in the hospital for orthopedic surgery. It is normal to feel tired or washed out after surgery and this feeling should improve over the first few days to week. Resume your regular activities as tolerated but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: Weightbearing as tolerated left lower extremity MEDICATIONS: 1 Take Tylenol every 6 hours around the clock. This is an over the counter medication. 2 Add oxycodone as needed for increased pain. Aim to wean off this medication in 1 week or sooner. This is an example on how to wean down: Take 1 tablet every 3 hours as needed x 1 day then 1 tablet every 4 hours as needed x 1 day then 1 tablet every 6 hours as needed x 1 day then 1 tablet every 8 hours as needed x 2 days then 1 tablet every 12 hours as needed x 1 day then 1 tablet every before bedtime as needed x 1 day. Then continue with Tylenol for pain. 3 Do not stop the Tylenol until you are off of the narcotic medication. 4 Per state regulations we are limited in the amount of narcotics we can prescribe. If you require more you must contact the office to set up an appointment because we cannot refill this type of pain medication over the phone. 5 Narcotic pain relievers can cause constipation so you should drink eight 8oz glasses of water daily and continue following the bowel regimen as stated on your medication prescription list. These meds senna colace miralax are over the counter and may be obtained at any pharmacy. 6 Do not drink alcohol drive a motor vehicle or operate machinery while taking narcotic pain relievers. 7 Please take all medications as prescribed by your physicians at discharge. 8 Continue all home medications unless specifically instructed to stop by your surgeon. ANTICOAGULATION: Please take Lovenox daily for 4 weeks Followup Instructions:\n",
              "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: . Chief Complaint: Right flank bruising and pain s/p fall Major Surgical or Invasive Procedure: None History of Present Illness: Mr. is a with history of factor VIII deficiency who presents with right neck swelling after snowboarding accident. The patient reports that he fell while snowboarding with loss of consciousness on . He was initially seen at where CT imaging of head/neck showed no intracranial hemorrhage. A CTA neck showed a thickened right platysma muscle with surrounding hematoma and a focus of active contrast extravasation within the right platysma muscle. He also developed a right shoulder hematoma although shoulder plain films didn t show acute abnormality. He was seen by Hematology and gave him one dose of DDAVP IV. A factor VIII assay was 139 and vW level was 200 per report. Per report his hemoglobin decreased from 13.2 on to 11.6 on . Repeat imaging in the morning showed stable injuries. The patient saw his hematologist on and was found to have a hemoglobin of 10.4. Because of the continued mild decrease the patient followed up with his PCP at which time his hemoglobin was 9.9. He was found to have an enlarging flank hematoma thus was referred given concern for retroperitoneal bleed. The patient has been using DDAVP intranasally intermittently since the accident. He denies lightheadedness or palpitations any increase in neck swelling over the course of the week. He does endorse pain in his right shoulder resting moving though this has improved over the course of the week. In the ED initial vital signs were 99.2 87 124/75 18 100 /RA. Initial labs demonstrated hemoglobin 10.6 though repeat was 9.7. Chemistries and coags were unremarkable. FVIII activity was 103. A CTAP was performed which demonstrated muscular hemorrhage along the flank but no retroperitoneal bleed on preliminary read. The patient s outpatient hematologist Dr. was contacted and it was decided to give the patient desmopressin 0.3mg/kg IV. The patient was then admitted for futher management. Per review of records the patient has a history of significant bleeding after his circumcision requiring blood transfusion. Throughout childhood he also had a tendency to bruise easily. He was tested and found to have disease. Later after wisdom tooth extraction the patient experienced late e.g. days later bleeding despite treatment with DDAVP. The patient was retested by a hematologist associated with the and was diagnosed with hemophilia A. His FVIII activity has been checked on multiple occasions sometimes testing normal though has been as low as 50. Upon arrival to the floor the patient is comfortable without complaint. Review of Systems: per HPI fever chills night sweats headache vision changes rhinorrhea congestion sore throat cough shortness of breath chest pain abdominal pain nausea vomiting diarrhea constipation BRBPR melena hematochezia dysuria hematuria. Past Medical History: Factor VIII deficiency mild Social History: Family History: The patient s mother had tendency to bleed. Physical Exam: ON ADMISSION VS:98 120/40 64 20 100RA GENERAL: lying flat in bed no acute distress HEENT: NCAT MMM OP clear NECK: Supple CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: Generally CTA b/l ABDOMEN: Soft non tender non distended EXTREMITIES: Warm well perfused PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact SKIN: Hematomas on right aspect of neck and flank ON DISCHARGE Vitals: 98.0 100 120/40 58 66 20 99 on RA GENERAL: lying flat in bed no acute distress HEENT: NCAT MMM OP clear NECK: Supple CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: Generally CTA b/l ABDOMEN: Soft non tender non distended EXTREMITIES: Warm well perfused PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact SKIN: Hematomas on right aspect of neck and flank Pertinent Results: ADMISSION DISCHARGE PERTINENT LABS: 07:03PM BLOOD WBC 6.6 RBC 3.58 Hgb 10.6 Hct 29.8 MCV 83 MCH 29.6 MCHC 35.6 RDW 14.7 Plt 07:03PM BLOOD Neuts 69.7 Monos 7.2 Eos 2.4 Baso 0.2 07:03PM BLOOD PTT 35.2 07:03PM BLOOD Plt 07:03PM BLOOD FacVIII 103 07:03PM BLOOD Glucose 93 UreaN 15 Creat 0.8 Na 139 K 4.1 Cl 101 HCO3 28 AnGap 14 11:00PM BLOOD WBC 6.6 RBC 3.30 Hgb 9.7 Hct 27.0 MCV 82 MCH 29.4 MCHC 36.0 RDW 14.7 Plt 07:25AM BLOOD WBC 5.2 RBC 3.14 Hgb 9.3 Hct 26.2 MCV 83 MCH 29.7 MCHC 35.7 RDW 14.6 Plt 03:25PM BLOOD WBC 6.3 RBC 3.27 Hgb 9.9 Hct 27.1 MCV 83 MCH 30.3 MCHC 36.5 RDW 14.7 Plt 07:50PM URINE Color Yellow Appear Clear Sp 07:50PM URINE Blood NEG Nitrite NEG Protein 30 Glucose NEG Ketone NEG Bilirub NEG Urobiln NEG pH 6.0 Leuks NEG 07:50PM URINE RBC 1 WBC 1 Bacteri FEW Yeast NONE Epi 0 07:50PM URINE Mucous RARE IMAGING/STUDIES: CT A/P Acute hemorrhage along right posterior flank musculature and probably layering over it only partly imaged and hard to distinguish musculature from hemorrhage. No active extravasation seen. Probable old hematoma along posterior left flank. Brief Hospital Course: Mr. is a with history of mild FVIII deficiency who presents after snowboarding accident with multiple hematomas and falling hemoglobin concerning for ongoing bleeding. FACTOR VIII DEFICIENCY MULTIPLE HEMATOMAS: Patient presented after recent snowboarding accident. At imaging was notable for neck and shoulder hematomas. Upon reevaluation by his PCP the patient was found to have a flank hematoma. Given falling hemoglobin there was concern for retroperitoneal bleed. CTAP in the ED demonstrated hematoma over his flank musculature but no active extravasation. He was given IV DDAVP but FVIII activity was 103 wnl . CBC remained stable and patient declined further inpatient monitoring. Atrius hematology recommended continued outpatient hemoglobin monitoring but did not think further DDAVP was indicated given normal FVIII level. TRANISTIONAL ISSUES: PCP CBC at Caution to avoid dangerous activity Code: presumed full Emergency Contact: wife Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Desmopressin Nasal mcg NAS PRN bleeding Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H pain 2. Desmopressin Nasal mcg NAS PRN bleeding 3. Outpatient Lab Work CBC on or . Last hemoglobin 9.9 . Discharge Disposition: Home Discharge Diagnosis: PRIMARY: Acute muscular hematoma right flank Hemophilia factor VIII deficiency Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Mr. It was our pleasure caring for you at . You were admitted with bruising on your right side and low blood counts after a snowboarding fall. With your history of hemophilia it was important to evaluate internal bleeding which did show a right muscular flank blood collection. Your facotr VIII level was 103 and you received IV DDAVP under our care. Your blood counts were stable to improved on the day of admission. It is important that you not participate in any dangerous activities given your recent bleed and your hemophilia. Bleeding in hemophiliacs has more potential to be life threatening. Please get your blood counts checked at site on either or . Follow up with your regular doctor early next week. Best wishes Your Care Team Followup Instructions:\n",
              "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Sex: F Service: UROLOGY Allergies: Patient recorded as having No Known Allergies to Drugs Attending: . Chief Complaint: renal mass Major Surgical or Invasive Procedure: right laparascopic radical nephrectomy Dr. Dr. History of Present Illness: y/o healthy female with incidental finding of right renal mass suspicious for RCC following MRI on . Past Medical History: PMH: nonspecific right axis deviation PSH cesarean section ALL NKDA Social History: Family History: no history of RCC Pertinent Results: 07:15AM BLOOD WBC 7.6 RBC 3.82 Hgb 11.9 Hct 33.8 MCV 89 MCH 31.2 MCHC 35.2 RDW 12.8 Plt 07:15AM BLOOD Glucose 150 UreaN 10 Creat 0.9 Na 138 K 3.8 Cl 104 HCO3 27 AnGap 11 Brief Hospital Course: Patient was admitted to Urology after undergoing laparoscopic right radical nephrectomy. No concerning intraoperative events occurred please see dictated operative note for details. The patient received perioperative antibiotic prophylaxis. The patient was transferred to the floor from the PACU in stable condition. On POD0 pain was well controlled on PCA hydrated for urine output 30cc/hour provided with pneumoboots and incentive spirometry for prophylaxis and ambulated once. On POD1 foley was removed without difficulty basic metabolic panel and complete blood count were checked pain control was transitioned from PCA to oral analgesics diet was advanced to a clears/toast and crackers diet. On POD2 diet was advanced as tolerated. The remainder of the hospital course was relatively unremarkable. The patient was discharged in stable condition eating well ambulating independently voiding without difficulty and with pain control on oral analgesics. On exam incision was clean dry and intact with no evidence of hematoma collection or infection. The patient was given explicit instructions to follow up in clinic with in 3 weeks. Medications on Admission: none Discharge Medications: 1. Hydrocodone Acetaminophen mg Tablet Sig: Tablets PO Q6H every 6 hours as needed for break through pain only score 4 . Disp: 60 Tablet s Refills: 0 2. Docusate Sodium 100 mg Capsule Sig: One 1 Capsule PO BID 2 times a day . Disp: 60 Capsule s Refills: 2 Discharge Disposition: Home Discharge Diagnosis: renal cell carcinoma Discharge Condition: stable Discharge Instructions: You may shower but do not bathe swim or immerse your incision. Do not eat constipating foods for weeks drink plenty of fluids Do not lift anything heavier than a phone book 10 pounds or drive until you are seen by your Urologist in follow up Tylenol should be used as your first line pain medication. If your pain is not well controlled on Tylenol you have been prescribed a narcotic pain medication. Use in place of Tylenol. Do not exceed 4 gms of Tylenol in total daily Do not drive or drink alcohol while taking narcotics Resume all of your home medications except hold NSAID aspirin advil motrin ibuprofen until you see your urologist in follow up If you have fevers 101.5 F vomiting or increased redness swelling or discharge from your incision call your doctor or go to the nearest ER Call Dr. to set up follow up appointment and if you have any urological questions. Followup Instructions:\n",
              "Name: text, dtype: object"
            ]
          },
          "execution_count": 9,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "import re\n",
        "def preprocess_text(text):\n",
        "    # Remove the sentence from start of text\n",
        "    prefix = 'Name: Unit No: Admission Date: Discharge Date: Date of Birth: '\n",
        "    #if text.startswith(prefix):\n",
        "        #text = text[len(prefix):].strip()\n",
        "    text = text.replace(prefix, '').strip()\n",
        "    # Remove extra spaces\n",
        "    text = re.sub(' +', ' ', text)\n",
        "    #text = \" \".join(text.split())\n",
        "    # Remove special characters\n",
        "    #text = re.sub('[^A-Za-z0-9 ./ :/]+', '', text)\n",
        "    text = re.sub('[^A-Za-z0-9 ./:/ ]+', ' ', text)\n",
        "    #text = re.sub('[^A-Za-z0-9 ./,:-]+', ' ', text)\n",
        "\n",
        "\n",
        "    #text = re.sub('[^A-Za-z0-9 /]+', '', text)\n",
        "    #text=text.lower()\n",
        "    return text\n",
        "raw['text'] = raw['text'].apply(preprocess_text)\n",
        "raw['text'].head(5)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "VziWrbaD8o5Z",
        "outputId": "027b0fad-4cc1-4632-b02c-67f18e57306f"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "   subject_id  \\\n",
            "0    10000032   \n",
            "1    10000084   \n",
            "\n",
            "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      text  \n",
            "0  Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: Chief Complaint: Worsening ABD distension and pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week. Pt reports self discontinuing lasix and spirnolactone weeks ago because she feels like they don t do anything and that she doesn t want to put more chemicals in her. She does not follow Na restricted diets. In the past week she notes that she has been having worsening abd distension and discomfort. She denies edema or SOB or orthopnea. She denies f/c/n/v d/c dysuria. She had food poisoning a week ago from eating stale cake n/v 20 min after food ingestion which resolved the same day. She denies other recent illness or sick contacts. She notes that she has been noticing gum bleeding while brushing her teeth in recent weeks. she denies easy bruising melena BRBPR hemetesis hemoptysis or hematuria. Because of her abd pain she went to OSH ED and was transferred to for further care. Per ED report pt has brief period of confusion she did not recall the ultrasound or bloodwork at osh. She denies recent drug use or alcohol use. She denies feeling confused but reports that she is forgetful at times. In the ED initial vitals were 98.4 70 106/63 16 97 RA Labs notable for ALT/AST/AP : Tbili1.6 WBC 5K platelet 77 INR 1.6 Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Her last alcohol consumption was one drink two months ago. No regular alcohol consumption. Last drug use years ago. She quit smoking a couple of years ago. Physical Exam: VS: 98.1 107/61 78 18 97RA General: in NAD HEENT: CTAB anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended mild diffuse tenderness flank dullness cannot percuss liver/spleen edge distension GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 converse normally able to recall 3 times after 5 minutes CN II XII intact Discharge: PHYSICAL EXAMINATION: VS: 98 105/70 95 General: in NAD HEENT: anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended but improved TTP in RUQ GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 CN II XII intact Pertinent Results: 10:25PM GLUCOSE 109 UREA N 25 CREAT 0.3 SODIUM 138 POTASSIUM 3.4 CHLORIDE 105 TOTAL CO2 27 ANION GAP 9 10:25PM estGFR Using this 10:25PM ALT SGPT 100 AST SGOT 114 ALK PHOS 114 TOT BILI 1.6 10:25PM LIPASE 77 10:25PM ALBUMIN 3.3 10:25PM WBC 5.0 RBC 4.29 HGB 14.3 HCT 42.6 MCV 99 MCH 33.3 MCHC 33.5 RDW 15.7 10:25PM NEUTS 70.3 LYMPHS 16.5 MONOS 8.1 EOS 4.2 BASOS 0.8 10:25PM PLT COUNT 71 10:25PM PTT 30.9 10:25PM . CXR: No acute cardiopulmonary process. U/S: 1. Nodular appearance of the liver compatible with cirrhosis. Signs of portal hypertension including small amount of ascites and splenomegaly. 2. Cholelithiasis. 3. Patent portal veins with normal hepatopetal flow. Diagnostic para attempted in the ED unsuccessful. On the floor pt c/o abd distension and discomfort. Brief Hospital Course: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week and confusion. Ascites p/w worsening abd distension and discomfort for last week. likely portal HTN given underlying liver disease though no ascitic fluid available on night of admission. No signs of heart failure noted on exam. This was to med non compliance and lack of diet restriction. SBP negative diuretics: Furosemide 40 mg PO DAILY Spironolactone 50 mg PO DAILY chosen over the usual 100mg dose d/t K of 4.5. CXR was wnl UA negative Urine culture blood culture negative. Pt was losing excess fluid appropriately with stable lytes on the above regimen. Pt was scheduled with current PCP for check upon discharge. Pt was scheduled for new PCP with Dr. at and follow up in Liver clinic to schedule outpatient screening EGD and . Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO DAILY 2. Spironolactone 50 mg PO DAILY 3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 4. Raltegravir 400 mg PO BID 5. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 6. Nicotine Patch 14 mg TD DAILY 7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Furosemide 40 mg PO DAILY RX furosemide 40 mg 1 tablet s by mouth Daily Disp 30 Tablet Refills: 3 4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB 5. Nicotine Patch 14 mg TD DAILY 6. Raltegravir 400 mg PO BID 7. Spironolactone 50 mg PO DAILY 8. Acetaminophen 500 mg PO Q6H:PRN pain Discharge Disposition: Home Discharge Diagnosis: Ascites from Portal HTN Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure taking care of you You came to us with stomach pain and worsening distension. While you were here we did a paracentesis to remove 1.5L of fluid from your belly. We also placed you on you 40 mg of Lasix and 50 mg of Aldactone to help you urinate the excess fluid still in your belly. As we discussed everyone has a different dose of lasix required to make them urinate and it s likely that you weren t taking a high enough dose. Please take these medications daily to keep excess fluid off and eat a low salt diet. You will follow up with Dr. in liver clinic and from there have your colonoscopy and EGD scheduled. Of course we are always here if you need us. We wish you all the best Your Team. Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet Attending: . Chief Complaint: abdominal fullness and discomfort Major Surgical or Invasive Procedure: diagnostic paracentesis therapeutic paracentesis History of Present Illness: with HIV on HAART COPD HCV cirrhosis complicated by ascites and HE admitted with abdominal distention and pain. She was admitted to for the same symptoms recently and had 3L fluid removed no SBP three days ago and felt better. Since discharge her abdomen has become increasingly distended with pain. This feels similar to prior episodes of ascites. Her diuretics were recently decreased on due to worsening hyponatremia 128 and hyperkalemia 5.1. Patient states she has been compliant with her HIV and diuretic medications but never filled out the lactulose prescription. She states she has had BMs daily at home. She has had some visual hallucinations and forgetfulness. Her appetite has been poor. In the ED initial vitals were 98.9 88 116/88 18 97 RA. CBC near baseline INR 1.4 Na 125 Cr 0.6. AST and ALT mildly above baseline 182 and 126 and albumin 2.8. Diagnostic para with 225 WBC 7 PMN total protein 0.3. UA with few bact 6 WBC mod leuk neg nitr but contaminated with 6 epi. CXR clear. RUQ US with no PV thrombus moderate ascites. She was given ondansetron 4mg IV and morphine 2.5mg IV x1 in the ED. On the floor she is feeling improved but still has abdominal distention and discomfort. ROS: Abdominal distention and pain. No black/bloody stools. No pain or swelling. No fevers or chills. Denies chest pain nausea vomiting. No dysuria or frequency. Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: VS: T98.1 105/57 79 20 97RA 44.6kg GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis DISCHARGE PE: VS: T 98.4 BP 95/55 SBP HR 80 RR 18 O2 95RA I/O 240/150 this am GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis Pertinent Results: LABS ON ADMISSION: 04:10PM BLOOD Plt 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:39PM BLOOD LABS ON DISCHARGE: 05:10AM BLOOD Plt 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD MICRO: 10:39 pm URINE Source: . FINAL REPORT URINE CULTURE Final : MIXED BACTERIAL FLORA 3 COLONY TYPES CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. Diagnositc Para: 07:00PM ASCITES 07:00PM ASCITES IMAGING: CXR No acute cardiopulmonary abnormality. RUQ US 1. Extremely coarse and nodular liver echotexture consistent with a history of cirrhosis. 2. Moderate ascites. 3. Patent portal vein. Brief Hospital Course: with HIV on HAART HCV cirrhosis with ascites and HE h/o IVDU COPD bipolar disorder presents with abdominal discomfort due to ascites. ASCITES. Now diuretic refractory given last tap was three days ago with 3L removed and she has already built up moderate ascites. Infectious workup negative with CXR clear UA contaminated but not grossly positive so will f/u culture diagnostic para with only 225 WBC RUQ US with no PV thrombus. Compliant with diuretics but not following low sodium diet or fluid restriction. Dr. discussed possible TIPS in the office but due to lung disease that was on hold pending further cardiac evaluation. Diuretics were recently decreased due to hyponatremia and hyperkalemia. Held spironolactone for now due to K 5.2 and increased lasix 20 40. No evidence of severe hyponatremia Na 120 or renal failure Cr 2.0 to stop diuretics at present. Diagnostic paracentesis negative for infection. Ascitic total protein 0.3 so warrants SBP prophylaxis 1.0 and fortunately already on Bactrim for PCP prophylaxis which would be appropriate for SBP ppx also. Patient did admit to eating pizza and some food prior to admission. She had therapeutic paracentesis with 4.3L removed and received 37.5G albumin IV post procedure. She felt much better with resolution of abdominal discomfort. Patient is scheduled for repeat paracentesis as outpatient on . HEPATIC ENCEPHALOPATHY. History of HE from Hep C cirrhosis. Now with mild encephalopathy hallucinations and forgetfulness due to medication noncompliance but not acutely encephalopathic and without asterixis on exam. Infectious workup negative thus far. Continue lactulose 30mL TID and titrate to 3 BMs daily and continue rifaximin 550mg BID. HYPONATREMIA. Na 125 on admission 128 four days ago and 135 one month ago. Likely due to third spacing from worsening ascites and fluid overload. 1.5L fluid restriction low salt diet. S/p therapeutic paracentesis with albumin replacement. CIRRHOSIS HEPATITIS C. MELD score of 10 and Child s class B on this admission. Now decompensated due to ascites. Hepatitis C genotype IIIB. Dr. starting and with patient in clinic and the insurance process was started by her office. No history of EGD needs this as outpatient for varices screening. NUTRITION. Unclear if truly compliant with low salt diet. Poor oral intake. Low albumin 2.8 on admission. Met with nutrition. COAGULOPATHY. INR 1.4 four days ago. No evidence of active bleeding. Very mild thrombocytopenia with plts 143. HIV. Most recent CD4 173. On HAART. No established ID provider. Continue Truvada and Isentress Bactrim DS daily for PCP . Needs outpatient ID appointment COPD. Stable. States she is on intermittent home O2 for comfort at night and with abdominal distentiom. Continued home COPD meds and home O2 as needed Transitional Issues Discontinued spironolactone elevated potassium Increased furosemide to 40mg daily Please recheck electrolytes at next visit Had paracentesis with 4.3 L removed received 37.5G albumin Needs outpatient ID provider needs more frequent paracentesis Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 2. Truvada 1 TAB PO DAILY 3. Furosemide 20 mg PO DAILY 4. Raltegravir 400 mg PO BID 5. Spironolactone 50 mg PO DAILY 6. Acetaminophen 500 mg PO Q6H:PRN pain fever 7. Tiotropium Bromide 1 CAP IH DAILY 8. Rifaximin 550 mg PO BID 9. Calcium Carbonate 1250 mg PO BID 10. Lactulose 15 mL PO TID 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Acetaminophen 500 mg PO Q6H:PRN pain fever 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 3. Calcium Carbonate 1250 mg PO BID 4. Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. Lactulose 15 mL PO TID 7. Raltegravir 400 mg PO BID 8. Rifaximin 550 mg PO BID 9. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 10. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: diuretic refractory ascites Secondary: HCV cirrhosis HIV hyponatremia COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear was a pleasure to take care of you at . You were admitted with abdominal fullness and pain from your ascites. You had a diagnostic and therapeutic paracentesis with 4.3 L removed. Your spironolactone was discontinued because your potassium was high. Your lasix was increased to 40mg daily. You are scheduled for another paracentesis on prior to your other appointments that day. Please call tomorrow to find out the time of the paracentesis. Please continue to follow a low sodium diet and fluid restriction. You should call your liver doctor or return to the emergency room if you have abdominal pain fever chills confusion or other concerning symptoms. Sincerely Your medical team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: Chief Complaint: altered mental status Major Surgical or Invasive Procedure: none History of Present Illness: Mrs. is a female with HIV on HAART COPD HCV cirrhosis complicated by ascites and hepatic encephalopathy who initially presented to the ED yesterday with hypotension after a paracentesis. The patient has had accelerated decompensation of her cirrhosis recently with worsening ascites and she is maintained on twice weekly paracentesis. She was at her regular session yesterday when she had hypotension to SBP and felt lightheadedness. Per the patient that s when her memory started to get fuzzy. She does not have much recollection of what happened since then. Her outpatient hepatologist saw her and recommended that she go to the ED. In the ED she was evaluated and deemed to have stable blood pressure. She was discharged home. At home she had worsening mental status with her daughter getting concerned and she returned to the ED. In the ED initial vitals were 98.7 77 96/50 16 98 RA. The patient was only oriented to person. Her labs were notable for Na 126 K 6.7 Cr 0.7 baseline 0.4 ALT 153 AST 275 TBili 1.9 Lip 66 INR 1.5. Initial EKG showed sinus rhythm with peaked T waves. Her head CT was negative for any acute processes. She received ceftriaxone 2gm x1 regular insulin 10U calcium gluconate 1g lactulose 30 mL x2 and 25g 5 albumin. On transfer vitals were 99.0 93 84/40 16 95 NC. On arrival to the MICU patient was more alert and conversant. She has no abdominal pain nausea vomiting chest pain or difficulty breathing. She has a chronic cough that is not much changed. She has not had any fever or chills. She reports taking all of her medications except for lactulose which she thinks taste disgusting. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals T: 98.7 BP: 84/48 P: 91 R: 24 O2: 98 NC on 2L GENERAL: Alert oriented no acute distress LUNGS: Decreased air movement on both sides scattered expiratory wheezes CV: Regular rate and rhythm normal S1 S2 no murmurs rubs gallops ABD: Soft non tender distended flank dullness bilaterally bowel sounds present EXT: Warm well perfused 2 pulses no cyanosis or edema DISCHARGE PHYSICAL EXAM: Vitals Tm 99.5 Tc 98.7 79 96/43 58 20 95 on 3L NC 7BM. General Cachectic appearing woman alert oriented no acute distress HEENT Sclera anicteric MMM oropharynx clear poor dentition with partial dentures Neck supple JVP not elevated no LAD Lungs Clear to auscultation bilaterally no wheezes rales ronchi CV Regular rate and rhythm normal S1 S2 no murmurs rubs gallops Abdomen Mildly distended and firm non tender bowel sounds present no rebound tenderness or guarding GU no foley Ext warm well perfused 2 pulses no clubbing cyanosis or edema Neuro AOx3 No asterixis. Pertinent Results: ADMISSION LABS: 06:39AM BLOOD WBC 6.9 RBC 3.98 Hgb 14.1 Hct 41.1 MCV 103 MCH 35.4 MCHC 34.3 RDW 15.8 Plt 06:39AM BLOOD Neuts 72.7 Lymphs 14.7 Monos 9.8 Eos 2.5 Baso 0.3 06:39AM BLOOD PTT 32.4 06:39AM BLOOD Glucose 102 UreaN 49 Creat 0.7 Na 126 K 6.7 Cl 95 HCO3 25 AnGap 13 06:39AM BLOOD ALT 153 AST 275 AlkPhos 114 TotBili 1.9 06:39AM BLOOD Albumin 3.6 IMAGING/STUDIES: CT HEAD: No evidence of acute intracranial process. The left zygomatic arch deformity is probably chronic as there is no associated soft tissue swelling. CXR: No acute intrathoracic process. DISCHARGE LABS: 04:45AM BLOOD WBC 4.8 RBC 3.15 Hgb 11.2 Hct 32.1 MCV 102 MCH 35.4 MCHC 34.8 RDW 15.8 Plt Ct 95 04:45AM BLOOD PTT 37.6 04:45AM BLOOD Glucose 121 UreaN 35 Creat 0.4 Na 130 K 5.2 Cl 97 HCO3 27 AnGap 11 04:45AM BLOOD ALT 96 AST 168 AlkPhos 69 TotBili 1.7 04:45AM BLOOD Calcium 8.6 Phos 2.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities w/ AMS hypotension and hyperkalemia. Altered mental status improved with lactulose. Hypotension was felt to be due to fluid shifts from paracentesis on the day prior to admission as well as low PO intake in the setting of AMS. Hypotension and resolved with IV albumin. Hyperkalemia resolved with insulin and kayexalate. Hypotension: Patient presented with SBP in and improved with albumin in the ED to . It was felt to be due to fluid shifts from paracentesis on as well as likely hypovolemia given AMS and decreased PO intake. No concern for bleeding or sepsis with baseline CBC and lack of fever. She continued to received IV albumin during her hospital course with which her SBP improved to and patient remained asymptomatic. Hyperkalemia: Patient presented with K 6.7 with EKG changes. Given low Na likely the result of low effective arterial volume leading to poor K excretion with likely exacerbation from . AM cortisol was normal. K improved with insulin and kayexalate and K was 5.2 on day of discharge. Bactrim was held during hospital course. : Patient presented with Cr 0.7 from baseline Cr is 0.3 0.4. It was felt to be likely due to volume shift from her paracentesis on the day prior to admission as well as now low effective arterial volume likely poor PO intake AMS. Cr improved to 0.4 with albumin administration. Furosemide and Bactrim were held during hospital course. GOC: The son HCP met with Dr. outpatient hepatologist during hospital course. They discussed that the patient is not a transplant candidate givenevere underlying lung disease FEV1 0.8 hypoxia RV dilation and very low BMI. A more conservative approach was recommended and the patient was transitioned to DNR/DNI. The patient agreed with this plan. She was treated with the goal of treating any any correctable issues. Social work met with the patient prior to discharge. The patient was interested in following up with palliative care for which an outpatient referral was made. Altered Mental Status: Patient presented with confusion that was most likely secondary to hepatic encephalopathy. Based on outpatient records patient has had steady decline in decompensated cirrhosis and mental status. No signs of infection and head CT was negative as well. Mental status improved with lactulose in the ED and patient reports that she has not been taking lactulose regularly at home. Patient was also continued on rifaximin. HCV Cirrhosis: Genotype 3a. Patient is decompensated with increasing ascites and worsening hepatic encephalopathy. She is dependent on twice weekly paracentesis. Spironolactone was recently stopped due to hyperkalemia. Patient is not a transplant candidate given her comorbidities COPD per outpatient hepatologist. The patient would like to continue biweekly paracenteses as an outpatient. HIV: Most recent CD4 count 173 on . HIV viral load on was undetectable. She was continued on her home regimen of raltegravir emtricitabine and tenofovir. Bactrim prophylaxis was held during admission because of hyperkalemia. COPD: Patient on 3L NC at home. She was continued on her home regimen. TRANSITIONAL ISSUES: Follow up with Palliative Care as outpatient Bactrim prophylaxis HIV was held during hospital course due to . Consider restarting as outpatient. Furosemide was held due to consider restarting as outpatient Follow up with hepatology Continue biweekly therapeurtic paracenteses Code status: DNR/DNI Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lactulose 15 mL PO TID 2. Tiotropium Bromide 1 CAP IH DAILY 3. Raltegravir 400 mg PO BID 4. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. TraMADOL Ultram 50 mg PO Q8H:PRN Pain 7. Fluticasone Propionate 110mcg 1 PUFF IH BID 8. Calcium Carbonate 500 mg PO BID 9. Rifaximin 550 mg PO BID 10. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: Hypotension Hyperkalemia Acute Kidney Injury Secondary: HIV Cirrhosis COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. You were admitted to because of confusion low blood pressure and a high potassium value. Your confusion improved with lactulose. Your blood pressure improved with extra fluids and your potassium improved as well. You also had small degree of kidney injury when you came to the hospital and this also improved with fluids. While you were here you discussed changing your goals of care to focusing on symptom management and treatment of reversible processes such as an infection. While you were in the hospital you were seen by one of our social workers. You will also follow up with Palliative Care in their clinic and will continue to have therapeutic paracenteses. It has been a pleasure taking care of you and we wish you all the best Your Care team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: . Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: w/ HIV on HAART COPD on 3L home O2 though sat ing fine on RA on admission HCV cirrhosis c/b ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening girth and abd pain. She d been having pain from her ascites and felt overdue for a paracentesis. She last had paracentesis on the . She reported that she began feeling worsening abdominal pain constant epigastric and radiates to back not a/w food on which increased in severity throughout the course of the day. She was brought to the ED by her son because of this pain. She had no confusion and was alert and oriented x3. The patient also reported she recently ran out of most of her home medications. She denied any fever chills shortness of breath cough dysuria. She reported loose stool a bit more than usual but attributed it to lactulose use. In the ED vitals were: 99.4 105 106/57 18 96 ra. Labs were significant for Na 127 K 5.3 lactate 2.1 INR 1.7. ALT 135 AST 244 AP 123. no leukocytosis. Ascitic fluid showed 220 WBC. She was given Morphine Sulfate 5 mg IV ONCE MR1 and a GI cocktail. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM Vitals T 97 BP 98/65 HR 103 RR 18 O2 94RA Glucose 128. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: distended fluid wave not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes DISCHARGE PHYSICAL EXAM Vitals Tm 98.6 Tc 98.2 BP 82 98/42 68 HR 80 95 RR O2 91 99 RA. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: soft decreased distension not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes Pertinent Results: ADMISSION LABS 09:20PM BLOOD WBC 8.2 RBC 3.48 Hgb 12.3 Hct 36.7 MCV 106 MCH 35.5 MCHC 33.6 RDW 16.5 Plt 09:28PM BLOOD PTT 31.8 09:20PM BLOOD Glucose 118 UreaN 33 Creat 0.6 Na 127 K 5.3 Cl 97 HCO3 24 AnGap 11 09:20PM BLOOD ALT 135 AST 244 AlkPhos 123 TotBili 1.3 09:20PM BLOOD Albumin 3.5 Calcium 8.3 Phos 3.3 Mg 2.3 09:27PM BLOOD Lactate 2.1 NOTABLE LABS 12:30AM ASCITES WBC 220 Polys 17 Lymphs 48 Monos 19 Mesothe 2 Macroph 12 Other 2 12:30AM ASCITES TotPro 0.7 Glucose 129 MICROBIOLOGY 12:30 am PERITONEAL FLUID GRAM STAIN Final : NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. VRE screen: No VRE isolated. IMAGING/STUDIES CXR No acute cardiopulmonary process. RUQUS Cirrhotic mild splenomegaly and ascites. A solid 3cm nodule in the left lobe of the liver is stable in size and appearance. DISCHARGE LABS 06:15AM BLOOD WBC 5.6 RBC 3.27 Hgb 11.6 Hct 33.5 MCV 103 MCH 35.5 MCHC 34.5 RDW 16.1 Plt 06:15AM BLOOD PTT 36.0 06:15AM BLOOD Glucose 87 UreaN 29 Creat 0.4 Na 123 K 5.4 Cl 93 HCO3 24 AnGap 11 06:15AM BLOOD ALT 112 AST 176 AlkPhos 101 TotBili 2.8 06:15AM BLOOD Albumin 3.5 Calcium 8.8 Phos 3.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening abd girth and pain. Goals of care: The patient expressed that her desire to let go and be at peace. She is tired of fighting her end stage liver disease and does not feel that she has a good quality of life. She wished to meet with a representative from hospice which we were able to arrange and she decided that she would like to go home with hospice. A conversation was held with the patient regarding code status. She noted that she would probably be DNR/DNI but would like to discuss it with her son HCP . Therefore at this time she remains full code. We also discussed the possibility of her getting a pleurex catheter placed because of her repeated paracenteses. She was discharged to home with hospice on . Decompensated HCV cirrhosis with ascites: The patient presented with worsening ascites. Her pain was initially managed with tramadol and morphine. She underwent paracentesis on with removal of 3.5L and she received albumin. Studies on the fluid were negative and she reported a significant improvement in her pain. Hyperkalemia: During her hospitalization it was noted that she had hyperkalemia 5.3 5.9 6.9 without EKG changes. After treatment with calcium gluconate 2gm x2 insulin and D50 x 2 and kayexelate her K downtrended to 5.4. Her K has been persistently elevated in the past and should continue to be monitored. Hepatic encephalopathy: The patient s mental status was A Ox3 on admission. She was continued on rifaximin and lactulose in house and at discharge. CHRONIC ISSUES Hyponatremia The patient has a history of asymptomatic hyponatremia. It is most likely hypervolemic hyponatremia related to underlying liver disease as well as aldosterone axis dysfunction related to liver disease. She remained asymptomatic through her hospitalization. Because she was also started on 10mg of furosemide to help prevent fluid re accumulation she will require BMPs twice weekly in the outpatient setting. HIV: Emtricitabine Tenofovir Truvada and Raltegravir were continued in house and at discharge. COPD: fluticasone tiotropium and albuterol were continued in house and at discharge. TRANSITIONAL ISSUES Follow up peritoneal fluid culture New/changed medications: Furosemide 10mg daily new For hyperkalemia and hyponatremia the patient should have biweekly BMPs script written . If K 5.3 she should be given kayexelate once weekly. Lab results will be faxed/sent to Dr. . Continue conversation regarding pleurex catheter placement and code status. She will continue to have twice weekly paracenteses Code: full Emergency Contact: on Admission: The Preadmission Medication list is accurate and complete. 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Medications: 1. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 2. Calcium Carbonate 500 mg PO BID 3. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 4. Fluticasone Propionate 110mcg 1 PUFF IH BID 5. Lactulose 30 mL PO TID 6. Raltegravir 400 mg PO BID 7. Rifaximin 550 mg PO BID 8. Tiotropium Bromide 1 CAP IH DAILY 9. TraMADOL Ultram mg PO Q6H:PRN pain 10. Furosemide 10 mg PO DAILY RX furosemide 20 mg 0.5 One half tablet s by mouth Please take 1 tablet daily. Disp 15 Tablet Refills: 0 11. Outpatient Lab Work Please obtain biweekly BMP to monitor K and Na. Please fax results to Dr. at the at . Discharge Disposition: Home With Service Facility: Discharge Diagnosis: PRIMARY DIAGNOSIS Decompensated HCV cirrhosis Hyperkalemia SECONDARY DIAGNOSES HIV COPD Hyponatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure caring for you during your stay at . You were admitted because of worsening abdominal pain. It is likely that this pain was due to increasing fluid in the abdomen from your cirrhosis. After a paracentesis in which much of this fluid was removed your pain improved significantly. You were noted to have a high potassium during your hospitalization which came down with treatment but this should continue to be followed as an outpatient. You also emphasized your desire to speak with a representative from hospice. Because of your repeated paracenteses we also discussed the possibility of a pleurex catheter placement. We arranged for you to meet with hospice coordinators and you will be discharged home with hospice. We wish you all the best Your care team Followup Instructions:  \n",
            "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: . Chief Complaint: Visual hallucinations Major Surgical or Invasive Procedure: N/A History of Present Illness: male with disease dyslipidemia and a history of prostate cancer s/p prostatectomy who was referred to the ED by his neurologist for worsening gait falls and visual hallucinations. The following history is taken from chart review: The patient was seen by his neurologist on at which time he was noted to have visual hallucinations and worsening gait freezing. For his gait freezing his mirapex was increased by 0.125 mg every week to a goal dose of 0.75 mg t.i.d. He successfully up titrated the medicine to 0.75/0.625/0.625 but began to have visual hallucinations and confusion so on his neurologist recommended decreasing the dose to 0.625 TID. Despite the changes to his Mirapex the patient s daughter has noted progressive gait stiffness and increased difficulty standing. This has resulted in difficulty with simply getting to the bathroom leading to episodes of incontinence. A UA performed on was reassuring. On the day of presentation to the hospital the patient began to experience visual hallucinations of a motor cross race in his backyard. He subsequently had a fall while transferring from the couch to a chair. His wife was unable to get him off the floor. The fall was witnessed and there was no head strike. Per the patient s wife his gait has acutely worsened over the past 24 hours to the point where he has been unable to ambulate on his own. The patient s daughter called his neurologist who recommended presentation to the ED. In the ED the patient was afebrile HRs normotensive and SpO2 100 RA. On exam he was noted to have cogwheeling of upper extremities and decrease strength. Labs were remarkable for a negative urine and serum tox Na 132 K 5.8 hemolyzed and no EKG changes negative troponin normal LFTs unremarkable CBC. Chest Xray showed no acute process and CTH was reassuring. He was evaluated by neurology who recommended admission to medicine for failure to thrive to continue the patient s home medications and complete a toxo metabolic workup. The patient was given his home pramipexole and pravastatin before he was admitted. On arrival to the floor the patient is comfortable in bed. He is not accompanied by family on my interview. He knows that he is in the hospital and that it is . He is not sure why he is here and begins to tell me about a party in his house with a motor cross race in his backyard. When I asked him about his fall he mentions that he has not had a fall for years. He denies any fevers chills cough chest pain abdominal pain nausea diarrhea or dysuria. REVIEW OF SYSTEMS: Per HPI otherwise 10 point review of systems was within normal limits. Past Medical History: disease Body Dementia dyslipidemia prostate cancer s/p prostatectomy Social History: Family History: His mother died at age of old age. His father died of prostate cancer at . He has an older sister age and a younger sister age . He has a younger brother age . As noted he has 2 daughters. There is no family history of neurologic illness or dementia. There is no family history of neurodevelopmental mental disorders such as learning disability or ADHD. There is no family history of psychiatric problems. Physical Exam: ADMISSION PHYSICAL EXAM: VITALS: reviewed in OMR GENERAL: Alert and interactive. In no acute distress. HEENT: PERRL EOMI. Sclera anicteric and without injection. MMM. NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes rhonchi or rales. No increased work of breathing. BACK: No CVA tenderness. ABDOMEN: Normal bowels sounds non distended non tender to deep palpation in all four quadrants. No organomegaly. EXTREMITIES: No clubbing cyanosis or edema. Pulses DP/Radial 2 bilaterally. SKIN: Warm. Cap refill 2s. No rashes. NEUROLOGIC: AOx3. CN2 12 intact. cogwheel UE b/l. Increased tone in LEs strength b/l . Normal sensation. DISCHARGE PHYSICAL EXAM 24 HR Data last updated 2340 Temp: 97.7 Tm 98.4 BP: 130/80 130 153/80 90 HR: 80 80 104 RR: 18 O2 sat: 100 95 100 O2 delivery: Ra GENERAL: In no acute distress. Talking very quietly. CARDIAC: Regular rhythm normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes rhonchi or rales. No increased work of breathing. ABDOMEN: Normal bowels sounds non distended non tender to deep palpation in all four quadrants. EXTREMITIES: No clubbing cyanosis or edema. Pulses DP/Radial 2 bilaterally. SKIN: Warm. NEUROLOGIC: AOx3. CN2 12 intact. cogwheel UE b/l. Increased tone in LEs strength b/l . Normal sensation. Pertinent Results: ADMISSION LABS: 10:30PM BLOOD WBC 8.6 RBC 4.03 Hgb 12.8 Hct 38.2 MCV 95 MCH 31.8 MCHC 33.5 RDW 13.0 RDWSD 45.2 Plt 10:30PM BLOOD Neuts 48.1 Monos 15.9 Eos 2.0 Baso 0.6 Im AbsNeut 4.13 AbsLymp 2.86 AbsMono 1.36 AbsEos 0.17 AbsBaso 0.05 10:30PM BLOOD PTT 23.4 10:30PM BLOOD Glucose 100 UreaN 17 Creat 0.8 Na 132 K 5.8 Cl 98 HCO3 19 AnGap 15 10:30PM BLOOD ALT 18 AST 38 AlkPhos 39 TotBili 0.4 10:30PM BLOOD Lipase 47 10:30PM BLOOD cTropnT 0.01 10:30PM BLOOD Albumin 4.0 Calcium 9.9 Phos 3.7 Mg 2.0 10:30PM BLOOD VitB12 570 10:30PM BLOOD TSH 1.4 07:00AM BLOOD Trep Ab NEG 10:30PM BLOOD ASA NEG Ethanol NEG Acetmnp NEG Tricycl NEG IMAGING: Imaging CT HEAD W/O CONTRAST FINDINGS: There is no evidence of infarction hemorrhage edema or mass. There is prominence of the ventricles and sulci suggestive of involutional changes. There is no evidence of fracture. The visualized portion of the remaining paranasal sinuses and middle ear cavities are clear. The visualized portion of the orbits are unremarkable apart from bilateral lens replacements. IMPRESSION: 1. No acute intracranial abnormality. No hydrocephalus. Imaging CHEST PA LAT IMPRESSION: Mild atelectasis in the lung bases without focal consolidation. Age indeterminate moderate to severe compression deformity of a low thoracic vertebral body. DISCHARGE LABS: 06:21AM BLOOD WBC 7.0 RBC 4.02 Hgb 12.9 Hct 38.1 MCV 95 MCH 32.1 MCHC 33.9 RDW 12.8 RDWSD 44.4 Plt 06:21AM BLOOD Glucose 88 UreaN 10 Creat 0.7 Na 140 K 4.0 Cl 104 HCO3 24 AnGap 12 06:21AM BLOOD Calcium 9.5 Phos 3.2 Mg 1. male with disease dyslipidemia and a history of prostate cancer s/p prostatectomy who was referred to the ED by his neurologist for worsening gait falls and visual hallucinations concerning for progression of his neurologic disorder. ACUTE/ACTIVE ISSUES: disease Body Dementia Visual Hallucinations The patient appears to have acute on chronic progression of his disease. Unclear if this is disease progression or underlying medical cause. Continued mirapex rasagiline and rivastigmine. Neurology recommended started Seroquel for his hallucinations. He was evaluated by physical therapy who recommended rehab. This recommendation was discussed with the family who opted for discharge to home with home physical therapy as this was in line with the patient s goals of care. TRANSITIONAL ISSUES: f/u visual hallucination symptoms on Seroquel f/u physical therapy at home Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Rasagiline 1 mg PO DAILY 2. Pramipexole 0.625 mg PO TID 3. rivastigmine 9.5 mg/24 hr transdermal DAILY 4. Pravastatin 40 mg PO QPM 5. Cyanocobalamin Dose is Unknown PO DAILY 6. Loratadine 10 mg PO DAILY Discharge Medications: 1. QUEtiapine Fumarate 25 mg PO QHS RX quetiapine 25 mg 1 tablet s by mouth AT NIGHT Disp 30 Tablet Refills: 0 2. Loratadine 10 mg PO DAILY 3. Pramipexole 0.625 mg PO TID 4. Pravastatin 40 mg PO QPM 5. Rasagiline 1 mg PO DAILY 6. rivastigmine 9.5 mg/24 hr transdermal DAILY Discharge Disposition: Home With Service Facility: Discharge Diagnosis: Dementia Discharge Condition: Mental Status: Confused sometimes. Level of Consciousness: Alert and interactive. Discharge Instructions: Dear Mr. It was a privilege caring for you at . WHY WAS I IN THE HOSPITAL You were sent to the emergency room by your neurologist who was concerned that you were having visual hallucinations. WHAT HAPPENED TO ME IN THE HOSPITAL You were started on a new medication to help treat your symptoms. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL Continue to take all your medicines and keep your appointments. We wish you the best Sincerely Your Team Followup Instructions:  \n"
          ]
        }
      ],
      "source": [
        "import re\n",
        "\n",
        "# Remove non-alphabetic characters (Data Cleaning)\n",
        "def text_strip(column):\n",
        "    #prefix = 'name unit admission date discharge date date birth'\n",
        "    #column = column.replace(prefix, '').strip()\n",
        "    for row in column:\n",
        "    # Remove . if it occurs more than one time consecutively\n",
        "        row = re.sub(\"(\\.  \\.+)\", \" \", str(row)).lower()\n",
        "\n",
        "        # Remove the characters - <>()|&\"',;?~*!\n",
        "        row = re.sub(r\"[<>()|&\\[\\]\\'\\\",;?=~*!]\", \" \", str(row)).lower()\n",
        "        row = re.sub(r\"\\s+\", \" \", row).strip()\n",
        "\n",
        "        # Remove _ if it occurs more than one time consecutively\n",
        "        row = re.sub(\"(__+)\", \" \", str(row)).lower()\n",
        "\n",
        "        # Remove - if it occurs more than one time consecutively\n",
        "        row = re.sub(\"(--+)\", \" \", str(row)).lower()\n",
        "        #Remove ==\n",
        "        row=re.sub(\"==+\", \" \", str(row)).lower()\n",
        "\n",
        "        # Remove multiple spaces\n",
        "        row = re.sub(\"(\\s+)\", \" \", str(row)).lower()\n",
        "        row = re.sub(r\"\\s+\", \" \", row).strip()\n",
        "\n",
        "        # Remove the single character hanging between any two spaces\n",
        "        row = re.sub(\"(\\s+.\\s+)\", \" \", str(row)).lower()\n",
        "    yield row\n",
        "\n",
        "processed_text = text_strip(raw['text'])\n",
        "print(raw.head(2))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "uL7hGrdB_xQ1",
        "outputId": "576c1754-2209-46a1-cd09-1c038c829d9e"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "\n",
              "  <div id=\"df-b16da52a-8389-4a89-aa66-a97b5f111677\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>subject_id</th>\n",
              "      <th>text</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>10000032</td>\n",
              "      <td>Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: Chief Complaint: Worsening ABD distension and pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week. Pt reports self discontinuing lasix and spirnolactone weeks ago because she feels like they don t do anything and that she doesn t want to put more chemicals in her. She does not follow Na restricted diets. In the past week she notes that she has been having worsening abd distension and discomfort. She denies edema or SOB or orthopnea. She denies f/c/n/v d/c dysuria. She had food poisoning a week ago from eating stale cake n/v 20 min after food ingestion which resolved the same day. She denies other recent illness or sick contacts. She notes that she has been noticing gum bleeding while brushing her teeth in recent weeks. she denies easy bruising melena BRBPR hemetesis hemoptysis or hematuria. Because of her abd pain she went to OSH ED and was transferred to for further care. Per ED report pt has brief period of confusion she did not recall the ultrasound or bloodwork at osh. She denies recent drug use or alcohol use. She denies feeling confused but reports that she is forgetful at times. In the ED initial vitals were 98.4 70 106/63 16 97 RA Labs notable for ALT/AST/AP : Tbili1.6 WBC 5K platelet 77 INR 1.6 Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Her last alcohol consumption was one drink two months ago. No regular alcohol consumption. Last drug use years ago. She quit smoking a couple of years ago. Physical Exam: VS: 98.1 107/61 78 18 97RA General: in NAD HEENT: CTAB anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended mild diffuse tenderness flank dullness cannot percuss liver/spleen edge distension GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 converse normally able to recall 3 times after 5 minutes CN II XII intact Discharge: PHYSICAL EXAMINATION: VS: 98 105/70 95 General: in NAD HEENT: anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended but improved TTP in RUQ GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 CN II XII intact Pertinent Results: 10:25PM GLUCOSE 109 UREA N 25 CREAT 0.3 SODIUM 138 POTASSIUM 3.4 CHLORIDE 105 TOTAL CO2 27 ANION GAP 9 10:25PM estGFR Using this 10:25PM ALT SGPT 100 AST SGOT 114 ALK PHOS 114 TOT BILI 1.6 10:25PM LIPASE 77 10:25PM ALBUMIN 3.3 10:25PM WBC 5.0 RBC 4.29 HGB 14.3 HCT 42.6 MCV 99 MCH 33.3 MCHC 33.5 RDW 15.7 10:25PM NEUTS 70.3 LYMPHS 16.5 MONOS 8.1 EOS 4.2 BASOS 0.8 10:25PM PLT COUNT 71 10:25PM PTT 30.9 10:25PM . CXR: No acute cardiopulmonary process. U/S: 1. Nodular appearance of the liver compatible with cirrhosis. Signs of portal hypertension including small amount of ascites and splenomegaly. 2. Cholelithiasis. 3. Patent portal veins with normal hepatopetal flow. Diagnostic para attempted in the ED unsuccessful. On the floor pt c/o abd distension and discomfort. Brief Hospital Course: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week and confusion. Ascites p/w worsening abd distension and discomfort for last week. likely portal HTN given underlying liver disease though no ascitic fluid available on night of admission. No signs of heart failure noted on exam. This was to med non compliance and lack of diet restriction. SBP negative diuretics: Furosemide 40 mg PO DAILY Spironolactone 50 mg PO DAILY chosen over the usual 100mg dose d/t K of 4.5. CXR was wnl UA negative Urine culture blood culture negative. Pt was losing excess fluid appropriately with stable lytes on the above regimen. Pt was scheduled with current PCP for check upon discharge. Pt was scheduled for new PCP with Dr. at and follow up in Liver clinic to schedule outpatient screening EGD and . Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO DAILY 2. Spironolactone 50 mg PO DAILY 3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 4. Raltegravir 400 mg PO BID 5. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 6. Nicotine Patch 14 mg TD DAILY 7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Furosemide 40 mg PO DAILY RX furosemide 40 mg 1 tablet s by mouth Daily Disp 30 Tablet Refills: 3 4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB 5. Nicotine Patch 14 mg TD DAILY 6. Raltegravir 400 mg PO BID 7. Spironolactone 50 mg PO DAILY 8. Acetaminophen 500 mg PO Q6H:PRN pain Discharge Disposition: Home Discharge Diagnosis: Ascites from Portal HTN Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure taking care of you You came to us with stomach pain and worsening distension. While you were here we did a paracentesis to remove 1.5L of fluid from your belly. We also placed you on you 40 mg of Lasix and 50 mg of Aldactone to help you urinate the excess fluid still in your belly. As we discussed everyone has a different dose of lasix required to make them urinate and it s likely that you weren t taking a high enough dose. Please take these medications daily to keep excess fluid off and eat a low salt diet. You will follow up with Dr. in liver clinic and from there have your colonoscopy and EGD scheduled. Of course we are always here if you need us. We wish you all the best Your Team. Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet Attending: . Chief Complaint: abdominal fullness and discomfort Major Surgical or Invasive Procedure: diagnostic paracentesis therapeutic paracentesis History of Present Illness: with HIV on HAART COPD HCV cirrhosis complicated by ascites and HE admitted with abdominal distention and pain. She was admitted to for the same symptoms recently and had 3L fluid removed no SBP three days ago and felt better. Since discharge her abdomen has become increasingly distended with pain. This feels similar to prior episodes of ascites. Her diuretics were recently decreased on due to worsening hyponatremia 128 and hyperkalemia 5.1. Patient states she has been compliant with her HIV and diuretic medications but never filled out the lactulose prescription. She states she has had BMs daily at home. She has had some visual hallucinations and forgetfulness. Her appetite has been poor. In the ED initial vitals were 98.9 88 116/88 18 97 RA. CBC near baseline INR 1.4 Na 125 Cr 0.6. AST and ALT mildly above baseline 182 and 126 and albumin 2.8. Diagnostic para with 225 WBC 7 PMN total protein 0.3. UA with few bact 6 WBC mod leuk neg nitr but contaminated with 6 epi. CXR clear. RUQ US with no PV thrombus moderate ascites. She was given ondansetron 4mg IV and morphine 2.5mg IV x1 in the ED. On the floor she is feeling improved but still has abdominal distention and discomfort. ROS: Abdominal distention and pain. No black/bloody stools. No pain or swelling. No fevers or chills. Denies chest pain nausea vomiting. No dysuria or frequency. Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: VS: T98.1 105/57 79 20 97RA 44.6kg GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis DISCHARGE PE: VS: T 98.4 BP 95/55 SBP HR 80 RR 18 O2 95RA I/O 240/150 this am GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis Pertinent Results: LABS ON ADMISSION: 04:10PM BLOOD Plt 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:39PM BLOOD LABS ON DISCHARGE: 05:10AM BLOOD Plt 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD MICRO: 10:39 pm URINE Source: . FINAL REPORT URINE CULTURE Final : MIXED BACTERIAL FLORA 3 COLONY TYPES CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. Diagnositc Para: 07:00PM ASCITES 07:00PM ASCITES IMAGING: CXR No acute cardiopulmonary abnormality. RUQ US 1. Extremely coarse and nodular liver echotexture consistent with a history of cirrhosis. 2. Moderate ascites. 3. Patent portal vein. Brief Hospital Course: with HIV on HAART HCV cirrhosis with ascites and HE h/o IVDU COPD bipolar disorder presents with abdominal discomfort due to ascites. ASCITES. Now diuretic refractory given last tap was three days ago with 3L removed and she has already built up moderate ascites. Infectious workup negative with CXR clear UA contaminated but not grossly positive so will f/u culture diagnostic para with only 225 WBC RUQ US with no PV thrombus. Compliant with diuretics but not following low sodium diet or fluid restriction. Dr. discussed possible TIPS in the office but due to lung disease that was on hold pending further cardiac evaluation. Diuretics were recently decreased due to hyponatremia and hyperkalemia. Held spironolactone for now due to K 5.2 and increased lasix 20 40. No evidence of severe hyponatremia Na 120 or renal failure Cr 2.0 to stop diuretics at present. Diagnostic paracentesis negative for infection. Ascitic total protein 0.3 so warrants SBP prophylaxis 1.0 and fortunately already on Bactrim for PCP prophylaxis which would be appropriate for SBP ppx also. Patient did admit to eating pizza and some food prior to admission. She had therapeutic paracentesis with 4.3L removed and received 37.5G albumin IV post procedure. She felt much better with resolution of abdominal discomfort. Patient is scheduled for repeat paracentesis as outpatient on . HEPATIC ENCEPHALOPATHY. History of HE from Hep C cirrhosis. Now with mild encephalopathy hallucinations and forgetfulness due to medication noncompliance but not acutely encephalopathic and without asterixis on exam. Infectious workup negative thus far. Continue lactulose 30mL TID and titrate to 3 BMs daily and continue rifaximin 550mg BID. HYPONATREMIA. Na 125 on admission 128 four days ago and 135 one month ago. Likely due to third spacing from worsening ascites and fluid overload. 1.5L fluid restriction low salt diet. S/p therapeutic paracentesis with albumin replacement. CIRRHOSIS HEPATITIS C. MELD score of 10 and Child s class B on this admission. Now decompensated due to ascites. Hepatitis C genotype IIIB. Dr. starting and with patient in clinic and the insurance process was started by her office. No history of EGD needs this as outpatient for varices screening. NUTRITION. Unclear if truly compliant with low salt diet. Poor oral intake. Low albumin 2.8 on admission. Met with nutrition. COAGULOPATHY. INR 1.4 four days ago. No evidence of active bleeding. Very mild thrombocytopenia with plts 143. HIV. Most recent CD4 173. On HAART. No established ID provider. Continue Truvada and Isentress Bactrim DS daily for PCP . Needs outpatient ID appointment COPD. Stable. States she is on intermittent home O2 for comfort at night and with abdominal distentiom. Continued home COPD meds and home O2 as needed Transitional Issues Discontinued spironolactone elevated potassium Increased furosemide to 40mg daily Please recheck electrolytes at next visit Had paracentesis with 4.3 L removed received 37.5G albumin Needs outpatient ID provider needs more frequent paracentesis Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 2. Truvada 1 TAB PO DAILY 3. Furosemide 20 mg PO DAILY 4. Raltegravir 400 mg PO BID 5. Spironolactone 50 mg PO DAILY 6. Acetaminophen 500 mg PO Q6H:PRN pain fever 7. Tiotropium Bromide 1 CAP IH DAILY 8. Rifaximin 550 mg PO BID 9. Calcium Carbonate 1250 mg PO BID 10. Lactulose 15 mL PO TID 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Acetaminophen 500 mg PO Q6H:PRN pain fever 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 3. Calcium Carbonate 1250 mg PO BID 4. Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. Lactulose 15 mL PO TID 7. Raltegravir 400 mg PO BID 8. Rifaximin 550 mg PO BID 9. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 10. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: diuretic refractory ascites Secondary: HCV cirrhosis HIV hyponatremia COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear was a pleasure to take care of you at . You were admitted with abdominal fullness and pain from your ascites. You had a diagnostic and therapeutic paracentesis with 4.3 L removed. Your spironolactone was discontinued because your potassium was high. Your lasix was increased to 40mg daily. You are scheduled for another paracentesis on prior to your other appointments that day. Please call tomorrow to find out the time of the paracentesis. Please continue to follow a low sodium diet and fluid restriction. You should call your liver doctor or return to the emergency room if you have abdominal pain fever chills confusion or other concerning symptoms. Sincerely Your medical team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: Chief Complaint: altered mental status Major Surgical or Invasive Procedure: none History of Present Illness: Mrs. is a female with HIV on HAART COPD HCV cirrhosis complicated by ascites and hepatic encephalopathy who initially presented to the ED yesterday with hypotension after a paracentesis. The patient has had accelerated decompensation of her cirrhosis recently with worsening ascites and she is maintained on twice weekly paracentesis. She was at her regular session yesterday when she had hypotension to SBP and felt lightheadedness. Per the patient that s when her memory started to get fuzzy. She does not have much recollection of what happened since then. Her outpatient hepatologist saw her and recommended that she go to the ED. In the ED she was evaluated and deemed to have stable blood pressure. She was discharged home. At home she had worsening mental status with her daughter getting concerned and she returned to the ED. In the ED initial vitals were 98.7 77 96/50 16 98 RA. The patient was only oriented to person. Her labs were notable for Na 126 K 6.7 Cr 0.7 baseline 0.4 ALT 153 AST 275 TBili 1.9 Lip 66 INR 1.5. Initial EKG showed sinus rhythm with peaked T waves. Her head CT was negative for any acute processes. She received ceftriaxone 2gm x1 regular insulin 10U calcium gluconate 1g lactulose 30 mL x2 and 25g 5 albumin. On transfer vitals were 99.0 93 84/40 16 95 NC. On arrival to the MICU patient was more alert and conversant. She has no abdominal pain nausea vomiting chest pain or difficulty breathing. She has a chronic cough that is not much changed. She has not had any fever or chills. She reports taking all of her medications except for lactulose which she thinks taste disgusting. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals T: 98.7 BP: 84/48 P: 91 R: 24 O2: 98 NC on 2L GENERAL: Alert oriented no acute distress LUNGS: Decreased air movement on both sides scattered expiratory wheezes CV: Regular rate and rhythm normal S1 S2 no murmurs rubs gallops ABD: Soft non tender distended flank dullness bilaterally bowel sounds present EXT: Warm well perfused 2 pulses no cyanosis or edema DISCHARGE PHYSICAL EXAM: Vitals Tm 99.5 Tc 98.7 79 96/43 58 20 95 on 3L NC 7BM. General Cachectic appearing woman alert oriented no acute distress HEENT Sclera anicteric MMM oropharynx clear poor dentition with partial dentures Neck supple JVP not elevated no LAD Lungs Clear to auscultation bilaterally no wheezes rales ronchi CV Regular rate and rhythm normal S1 S2 no murmurs rubs gallops Abdomen Mildly distended and firm non tender bowel sounds present no rebound tenderness or guarding GU no foley Ext warm well perfused 2 pulses no clubbing cyanosis or edema Neuro AOx3 No asterixis. Pertinent Results: ADMISSION LABS: 06:39AM BLOOD WBC 6.9 RBC 3.98 Hgb 14.1 Hct 41.1 MCV 103 MCH 35.4 MCHC 34.3 RDW 15.8 Plt 06:39AM BLOOD Neuts 72.7 Lymphs 14.7 Monos 9.8 Eos 2.5 Baso 0.3 06:39AM BLOOD PTT 32.4 06:39AM BLOOD Glucose 102 UreaN 49 Creat 0.7 Na 126 K 6.7 Cl 95 HCO3 25 AnGap 13 06:39AM BLOOD ALT 153 AST 275 AlkPhos 114 TotBili 1.9 06:39AM BLOOD Albumin 3.6 IMAGING/STUDIES: CT HEAD: No evidence of acute intracranial process. The left zygomatic arch deformity is probably chronic as there is no associated soft tissue swelling. CXR: No acute intrathoracic process. DISCHARGE LABS: 04:45AM BLOOD WBC 4.8 RBC 3.15 Hgb 11.2 Hct 32.1 MCV 102 MCH 35.4 MCHC 34.8 RDW 15.8 Plt Ct 95 04:45AM BLOOD PTT 37.6 04:45AM BLOOD Glucose 121 UreaN 35 Creat 0.4 Na 130 K 5.2 Cl 97 HCO3 27 AnGap 11 04:45AM BLOOD ALT 96 AST 168 AlkPhos 69 TotBili 1.7 04:45AM BLOOD Calcium 8.6 Phos 2.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities w/ AMS hypotension and hyperkalemia. Altered mental status improved with lactulose. Hypotension was felt to be due to fluid shifts from paracentesis on the day prior to admission as well as low PO intake in the setting of AMS. Hypotension and resolved with IV albumin. Hyperkalemia resolved with insulin and kayexalate. Hypotension: Patient presented with SBP in and improved with albumin in the ED to . It was felt to be due to fluid shifts from paracentesis on as well as likely hypovolemia given AMS and decreased PO intake. No concern for bleeding or sepsis with baseline CBC and lack of fever. She continued to received IV albumin during her hospital course with which her SBP improved to and patient remained asymptomatic. Hyperkalemia: Patient presented with K 6.7 with EKG changes. Given low Na likely the result of low effective arterial volume leading to poor K excretion with likely exacerbation from . AM cortisol was normal. K improved with insulin and kayexalate and K was 5.2 on day of discharge. Bactrim was held during hospital course. : Patient presented with Cr 0.7 from baseline Cr is 0.3 0.4. It was felt to be likely due to volume shift from her paracentesis on the day prior to admission as well as now low effective arterial volume likely poor PO intake AMS. Cr improved to 0.4 with albumin administration. Furosemide and Bactrim were held during hospital course. GOC: The son HCP met with Dr. outpatient hepatologist during hospital course. They discussed that the patient is not a transplant candidate givenevere underlying lung disease FEV1 0.8 hypoxia RV dilation and very low BMI. A more conservative approach was recommended and the patient was transitioned to DNR/DNI. The patient agreed with this plan. She was treated with the goal of treating any any correctable issues. Social work met with the patient prior to discharge. The patient was interested in following up with palliative care for which an outpatient referral was made. Altered Mental Status: Patient presented with confusion that was most likely secondary to hepatic encephalopathy. Based on outpatient records patient has had steady decline in decompensated cirrhosis and mental status. No signs of infection and head CT was negative as well. Mental status improved with lactulose in the ED and patient reports that she has not been taking lactulose regularly at home. Patient was also continued on rifaximin. HCV Cirrhosis: Genotype 3a. Patient is decompensated with increasing ascites and worsening hepatic encephalopathy. She is dependent on twice weekly paracentesis. Spironolactone was recently stopped due to hyperkalemia. Patient is not a transplant candidate given her comorbidities COPD per outpatient hepatologist. The patient would like to continue biweekly paracenteses as an outpatient. HIV: Most recent CD4 count 173 on . HIV viral load on was undetectable. She was continued on her home regimen of raltegravir emtricitabine and tenofovir. Bactrim prophylaxis was held during admission because of hyperkalemia. COPD: Patient on 3L NC at home. She was continued on her home regimen. TRANSITIONAL ISSUES: Follow up with Palliative Care as outpatient Bactrim prophylaxis HIV was held during hospital course due to . Consider restarting as outpatient. Furosemide was held due to consider restarting as outpatient Follow up with hepatology Continue biweekly therapeurtic paracenteses Code status: DNR/DNI Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lactulose 15 mL PO TID 2. Tiotropium Bromide 1 CAP IH DAILY 3. Raltegravir 400 mg PO BID 4. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. TraMADOL Ultram 50 mg PO Q8H:PRN Pain 7. Fluticasone Propionate 110mcg 1 PUFF IH BID 8. Calcium Carbonate 500 mg PO BID 9. Rifaximin 550 mg PO BID 10. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: Hypotension Hyperkalemia Acute Kidney Injury Secondary: HIV Cirrhosis COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. You were admitted to because of confusion low blood pressure and a high potassium value. Your confusion improved with lactulose. Your blood pressure improved with extra fluids and your potassium improved as well. You also had small degree of kidney injury when you came to the hospital and this also improved with fluids. While you were here you discussed changing your goals of care to focusing on symptom management and treatment of reversible processes such as an infection. While you were in the hospital you were seen by one of our social workers. You will also follow up with Palliative Care in their clinic and will continue to have therapeutic paracenteses. It has been a pleasure taking care of you and we wish you all the best Your Care team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: . Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: w/ HIV on HAART COPD on 3L home O2 though sat ing fine on RA on admission HCV cirrhosis c/b ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening girth and abd pain. She d been having pain from her ascites and felt overdue for a paracentesis. She last had paracentesis on the . She reported that she began feeling worsening abdominal pain constant epigastric and radiates to back not a/w food on which increased in severity throughout the course of the day. She was brought to the ED by her son because of this pain. She had no confusion and was alert and oriented x3. The patient also reported she recently ran out of most of her home medications. She denied any fever chills shortness of breath cough dysuria. She reported loose stool a bit more than usual but attributed it to lactulose use. In the ED vitals were: 99.4 105 106/57 18 96 ra. Labs were significant for Na 127 K 5.3 lactate 2.1 INR 1.7. ALT 135 AST 244 AP 123. no leukocytosis. Ascitic fluid showed 220 WBC. She was given Morphine Sulfate 5 mg IV ONCE MR1 and a GI cocktail. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM Vitals T 97 BP 98/65 HR 103 RR 18 O2 94RA Glucose 128. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: distended fluid wave not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes DISCHARGE PHYSICAL EXAM Vitals Tm 98.6 Tc 98.2 BP 82 98/42 68 HR 80 95 RR O2 91 99 RA. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: soft decreased distension not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes Pertinent Results: ADMISSION LABS 09:20PM BLOOD WBC 8.2 RBC 3.48 Hgb 12.3 Hct 36.7 MCV 106 MCH 35.5 MCHC 33.6 RDW 16.5 Plt 09:28PM BLOOD PTT 31.8 09:20PM BLOOD Glucose 118 UreaN 33 Creat 0.6 Na 127 K 5.3 Cl 97 HCO3 24 AnGap 11 09:20PM BLOOD ALT 135 AST 244 AlkPhos 123 TotBili 1.3 09:20PM BLOOD Albumin 3.5 Calcium 8.3 Phos 3.3 Mg 2.3 09:27PM BLOOD Lactate 2.1 NOTABLE LABS 12:30AM ASCITES WBC 220 Polys 17 Lymphs 48 Monos 19 Mesothe 2 Macroph 12 Other 2 12:30AM ASCITES TotPro 0.7 Glucose 129 MICROBIOLOGY 12:30 am PERITONEAL FLUID GRAM STAIN Final : NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. VRE screen: No VRE isolated. IMAGING/STUDIES CXR No acute cardiopulmonary process. RUQUS Cirrhotic mild splenomegaly and ascites. A solid 3cm nodule in the left lobe of the liver is stable in size and appearance. DISCHARGE LABS 06:15AM BLOOD WBC 5.6 RBC 3.27 Hgb 11.6 Hct 33.5 MCV 103 MCH 35.5 MCHC 34.5 RDW 16.1 Plt 06:15AM BLOOD PTT 36.0 06:15AM BLOOD Glucose 87 UreaN 29 Creat 0.4 Na 123 K 5.4 Cl 93 HCO3 24 AnGap 11 06:15AM BLOOD ALT 112 AST 176 AlkPhos 101 TotBili 2.8 06:15AM BLOOD Albumin 3.5 Calcium 8.8 Phos 3.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening abd girth and pain. Goals of care: The patient expressed that her desire to let go and be at peace. She is tired of fighting her end stage liver disease and does not feel that she has a good quality of life. She wished to meet with a representative from hospice which we were able to arrange and she decided that she would like to go home with hospice. A conversation was held with the patient regarding code status. She noted that she would probably be DNR/DNI but would like to discuss it with her son HCP . Therefore at this time she remains full code. We also discussed the possibility of her getting a pleurex catheter placed because of her repeated paracenteses. She was discharged to home with hospice on . Decompensated HCV cirrhosis with ascites: The patient presented with worsening ascites. Her pain was initially managed with tramadol and morphine. She underwent paracentesis on with removal of 3.5L and she received albumin. Studies on the fluid were negative and she reported a significant improvement in her pain. Hyperkalemia: During her hospitalization it was noted that she had hyperkalemia 5.3 5.9 6.9 without EKG changes. After treatment with calcium gluconate 2gm x2 insulin and D50 x 2 and kayexelate her K downtrended to 5.4. Her K has been persistently elevated in the past and should continue to be monitored. Hepatic encephalopathy: The patient s mental status was A Ox3 on admission. She was continued on rifaximin and lactulose in house and at discharge. CHRONIC ISSUES Hyponatremia The patient has a history of asymptomatic hyponatremia. It is most likely hypervolemic hyponatremia related to underlying liver disease as well as aldosterone axis dysfunction related to liver disease. She remained asymptomatic through her hospitalization. Because she was also started on 10mg of furosemide to help prevent fluid re accumulation she will require BMPs twice weekly in the outpatient setting. HIV: Emtricitabine Tenofovir Truvada and Raltegravir were continued in house and at discharge. COPD: fluticasone tiotropium and albuterol were continued in house and at discharge. TRANSITIONAL ISSUES Follow up peritoneal fluid culture New/changed medications: Furosemide 10mg daily new For hyperkalemia and hyponatremia the patient should have biweekly BMPs script written . If K 5.3 she should be given kayexelate once weekly. Lab results will be faxed/sent to Dr. . Continue conversation regarding pleurex catheter placement and code status. She will continue to have twice weekly paracenteses Code: full Emergency Contact: on Admission: The Preadmission Medication list is accurate and complete. 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Medications: 1. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 2. Calcium Carbonate 500 mg PO BID 3. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 4. Fluticasone Propionate 110mcg 1 PUFF IH BID 5. Lactulose 30 mL PO TID 6. Raltegravir 400 mg PO BID 7. Rifaximin 550 mg PO BID 8. Tiotropium Bromide 1 CAP IH DAILY 9. TraMADOL Ultram mg PO Q6H:PRN pain 10. Furosemide 10 mg PO DAILY RX furosemide 20 mg 0.5 One half tablet s by mouth Please take 1 tablet daily. Disp 15 Tablet Refills: 0 11. Outpatient Lab Work Please obtain biweekly BMP to monitor K and Na. Please fax results to Dr. at the at . Discharge Disposition: Home With Service Facility: Discharge Diagnosis: PRIMARY DIAGNOSIS Decompensated HCV cirrhosis Hyperkalemia SECONDARY DIAGNOSES HIV COPD Hyponatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure caring for you during your stay at . You were admitted because of worsening abdominal pain. It is likely that this pain was due to increasing fluid in the abdomen from your cirrhosis. After a paracentesis in which much of this fluid was removed your pain improved significantly. You were noted to have a high potassium during your hospitalization which came down with treatment but this should continue to be followed as an outpatient. You also emphasized your desire to speak with a representative from hospice. Because of your repeated paracenteses we also discussed the possibility of a pleurex catheter placement. We arranged for you to meet with hospice coordinators and you will be discharged home with hospice. We wish you all the best Your care team Followup Instructions:</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-b16da52a-8389-4a89-aa66-a97b5f111677')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-b16da52a-8389-4a89-aa66-a97b5f111677 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-b16da52a-8389-4a89-aa66-a97b5f111677');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ],
            "text/plain": [
              "   subject_id  \\\n",
              "0    10000032   \n",
              "\n",
              "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      text  \n",
              "0  Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: Chief Complaint: Worsening ABD distension and pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week. Pt reports self discontinuing lasix and spirnolactone weeks ago because she feels like they don t do anything and that she doesn t want to put more chemicals in her. She does not follow Na restricted diets. In the past week she notes that she has been having worsening abd distension and discomfort. She denies edema or SOB or orthopnea. She denies f/c/n/v d/c dysuria. She had food poisoning a week ago from eating stale cake n/v 20 min after food ingestion which resolved the same day. She denies other recent illness or sick contacts. She notes that she has been noticing gum bleeding while brushing her teeth in recent weeks. she denies easy bruising melena BRBPR hemetesis hemoptysis or hematuria. Because of her abd pain she went to OSH ED and was transferred to for further care. Per ED report pt has brief period of confusion she did not recall the ultrasound or bloodwork at osh. She denies recent drug use or alcohol use. She denies feeling confused but reports that she is forgetful at times. In the ED initial vitals were 98.4 70 106/63 16 97 RA Labs notable for ALT/AST/AP : Tbili1.6 WBC 5K platelet 77 INR 1.6 Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Her last alcohol consumption was one drink two months ago. No regular alcohol consumption. Last drug use years ago. She quit smoking a couple of years ago. Physical Exam: VS: 98.1 107/61 78 18 97RA General: in NAD HEENT: CTAB anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended mild diffuse tenderness flank dullness cannot percuss liver/spleen edge distension GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 converse normally able to recall 3 times after 5 minutes CN II XII intact Discharge: PHYSICAL EXAMINATION: VS: 98 105/70 95 General: in NAD HEENT: anicteric sclera OP clear Neck: supple no LAD CV: RRR S1S2 no m/r/g Lungs: CTAb prolonged expiratory phase no w/r/r Abdomen: distended but improved TTP in RUQ GU: no foley Ext: wwp no c/e/e clubbing Neuro: AAO3 CN II XII intact Pertinent Results: 10:25PM GLUCOSE 109 UREA N 25 CREAT 0.3 SODIUM 138 POTASSIUM 3.4 CHLORIDE 105 TOTAL CO2 27 ANION GAP 9 10:25PM estGFR Using this 10:25PM ALT SGPT 100 AST SGOT 114 ALK PHOS 114 TOT BILI 1.6 10:25PM LIPASE 77 10:25PM ALBUMIN 3.3 10:25PM WBC 5.0 RBC 4.29 HGB 14.3 HCT 42.6 MCV 99 MCH 33.3 MCHC 33.5 RDW 15.7 10:25PM NEUTS 70.3 LYMPHS 16.5 MONOS 8.1 EOS 4.2 BASOS 0.8 10:25PM PLT COUNT 71 10:25PM PTT 30.9 10:25PM . CXR: No acute cardiopulmonary process. U/S: 1. Nodular appearance of the liver compatible with cirrhosis. Signs of portal hypertension including small amount of ascites and splenomegaly. 2. Cholelithiasis. 3. Patent portal veins with normal hepatopetal flow. Diagnostic para attempted in the ED unsuccessful. On the floor pt c/o abd distension and discomfort. Brief Hospital Course: HCV cirrhosis c/b ascites hiv on ART h/o IVDU COPD bioplar PTSD presented from OSH ED with worsening abd distension over past week and confusion. Ascites p/w worsening abd distension and discomfort for last week. likely portal HTN given underlying liver disease though no ascitic fluid available on night of admission. No signs of heart failure noted on exam. This was to med non compliance and lack of diet restriction. SBP negative diuretics: Furosemide 40 mg PO DAILY Spironolactone 50 mg PO DAILY chosen over the usual 100mg dose d/t K of 4.5. CXR was wnl UA negative Urine culture blood culture negative. Pt was losing excess fluid appropriately with stable lytes on the above regimen. Pt was scheduled with current PCP for check upon discharge. Pt was scheduled for new PCP with Dr. at and follow up in Liver clinic to schedule outpatient screening EGD and . Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO DAILY 2. Spironolactone 50 mg PO DAILY 3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 4. Raltegravir 400 mg PO BID 5. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 6. Nicotine Patch 14 mg TD DAILY 7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing SOB 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Furosemide 40 mg PO DAILY RX furosemide 40 mg 1 tablet s by mouth Daily Disp 30 Tablet Refills: 3 4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB 5. Nicotine Patch 14 mg TD DAILY 6. Raltegravir 400 mg PO BID 7. Spironolactone 50 mg PO DAILY 8. Acetaminophen 500 mg PO Q6H:PRN pain Discharge Disposition: Home Discharge Diagnosis: Ascites from Portal HTN Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure taking care of you You came to us with stomach pain and worsening distension. While you were here we did a paracentesis to remove 1.5L of fluid from your belly. We also placed you on you 40 mg of Lasix and 50 mg of Aldactone to help you urinate the excess fluid still in your belly. As we discussed everyone has a different dose of lasix required to make them urinate and it s likely that you weren t taking a high enough dose. Please take these medications daily to keep excess fluid off and eat a low salt diet. You will follow up with Dr. in liver clinic and from there have your colonoscopy and EGD scheduled. Of course we are always here if you need us. We wish you all the best Your Team. Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet Attending: . Chief Complaint: abdominal fullness and discomfort Major Surgical or Invasive Procedure: diagnostic paracentesis therapeutic paracentesis History of Present Illness: with HIV on HAART COPD HCV cirrhosis complicated by ascites and HE admitted with abdominal distention and pain. She was admitted to for the same symptoms recently and had 3L fluid removed no SBP three days ago and felt better. Since discharge her abdomen has become increasingly distended with pain. This feels similar to prior episodes of ascites. Her diuretics were recently decreased on due to worsening hyponatremia 128 and hyperkalemia 5.1. Patient states she has been compliant with her HIV and diuretic medications but never filled out the lactulose prescription. She states she has had BMs daily at home. She has had some visual hallucinations and forgetfulness. Her appetite has been poor. In the ED initial vitals were 98.9 88 116/88 18 97 RA. CBC near baseline INR 1.4 Na 125 Cr 0.6. AST and ALT mildly above baseline 182 and 126 and albumin 2.8. Diagnostic para with 225 WBC 7 PMN total protein 0.3. UA with few bact 6 WBC mod leuk neg nitr but contaminated with 6 epi. CXR clear. RUQ US with no PV thrombus moderate ascites. She was given ondansetron 4mg IV and morphine 2.5mg IV x1 in the ED. On the floor she is feeling improved but still has abdominal distention and discomfort. ROS: Abdominal distention and pain. No black/bloody stools. No pain or swelling. No fevers or chills. Denies chest pain nausea vomiting. No dysuria or frequency. Past Medical History: 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast which was removed previously and per patient not it was benign. 4. For HIV disease she is being followed by Dr. Dr. . 5. COPD 6. Past history of smoking. 7. She also had a skin lesion which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of s sarcoma the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on and is being monitored by an MRI. 10. History of dysplasia of anus in . 11. Bipolar affective disorder currently manic mild and PTSD. 12. History of cocaine and heroin use. Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: VS: T98.1 105/57 79 20 97RA 44.6kg GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis DISCHARGE PE: VS: T 98.4 BP 95/55 SBP HR 80 RR 18 O2 95RA I/O 240/150 this am GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric MMM no oral lesions HEART: RRR normal S1 S2 no murmurs LUNGS: Clear no wheezes rales or rhonchi ABD: Significant distention with visible veins bulging flanks nontender to palpation tympanitic on percussion normal bowel sounds EXT: no edema 2 DP and pulses NEURO: alert and oriented not confused no asterixis Pertinent Results: LABS ON ADMISSION: 04:10PM BLOOD Plt 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:10PM BLOOD 04:39PM BLOOD LABS ON DISCHARGE: 05:10AM BLOOD Plt 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD 05:10AM BLOOD MICRO: 10:39 pm URINE Source: . FINAL REPORT URINE CULTURE Final : MIXED BACTERIAL FLORA 3 COLONY TYPES CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. 7:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN Final : 1 1 per 1000X FIELD : POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. Diagnositc Para: 07:00PM ASCITES 07:00PM ASCITES IMAGING: CXR No acute cardiopulmonary abnormality. RUQ US 1. Extremely coarse and nodular liver echotexture consistent with a history of cirrhosis. 2. Moderate ascites. 3. Patent portal vein. Brief Hospital Course: with HIV on HAART HCV cirrhosis with ascites and HE h/o IVDU COPD bipolar disorder presents with abdominal discomfort due to ascites. ASCITES. Now diuretic refractory given last tap was three days ago with 3L removed and she has already built up moderate ascites. Infectious workup negative with CXR clear UA contaminated but not grossly positive so will f/u culture diagnostic para with only 225 WBC RUQ US with no PV thrombus. Compliant with diuretics but not following low sodium diet or fluid restriction. Dr. discussed possible TIPS in the office but due to lung disease that was on hold pending further cardiac evaluation. Diuretics were recently decreased due to hyponatremia and hyperkalemia. Held spironolactone for now due to K 5.2 and increased lasix 20 40. No evidence of severe hyponatremia Na 120 or renal failure Cr 2.0 to stop diuretics at present. Diagnostic paracentesis negative for infection. Ascitic total protein 0.3 so warrants SBP prophylaxis 1.0 and fortunately already on Bactrim for PCP prophylaxis which would be appropriate for SBP ppx also. Patient did admit to eating pizza and some food prior to admission. She had therapeutic paracentesis with 4.3L removed and received 37.5G albumin IV post procedure. She felt much better with resolution of abdominal discomfort. Patient is scheduled for repeat paracentesis as outpatient on . HEPATIC ENCEPHALOPATHY. History of HE from Hep C cirrhosis. Now with mild encephalopathy hallucinations and forgetfulness due to medication noncompliance but not acutely encephalopathic and without asterixis on exam. Infectious workup negative thus far. Continue lactulose 30mL TID and titrate to 3 BMs daily and continue rifaximin 550mg BID. HYPONATREMIA. Na 125 on admission 128 four days ago and 135 one month ago. Likely due to third spacing from worsening ascites and fluid overload. 1.5L fluid restriction low salt diet. S/p therapeutic paracentesis with albumin replacement. CIRRHOSIS HEPATITIS C. MELD score of 10 and Child s class B on this admission. Now decompensated due to ascites. Hepatitis C genotype IIIB. Dr. starting and with patient in clinic and the insurance process was started by her office. No history of EGD needs this as outpatient for varices screening. NUTRITION. Unclear if truly compliant with low salt diet. Poor oral intake. Low albumin 2.8 on admission. Met with nutrition. COAGULOPATHY. INR 1.4 four days ago. No evidence of active bleeding. Very mild thrombocytopenia with plts 143. HIV. Most recent CD4 173. On HAART. No established ID provider. Continue Truvada and Isentress Bactrim DS daily for PCP . Needs outpatient ID appointment COPD. Stable. States she is on intermittent home O2 for comfort at night and with abdominal distentiom. Continued home COPD meds and home O2 as needed Transitional Issues Discontinued spironolactone elevated potassium Increased furosemide to 40mg daily Please recheck electrolytes at next visit Had paracentesis with 4.3 L removed received 37.5G albumin Needs outpatient ID provider needs more frequent paracentesis Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 2. Truvada 1 TAB PO DAILY 3. Furosemide 20 mg PO DAILY 4. Raltegravir 400 mg PO BID 5. Spironolactone 50 mg PO DAILY 6. Acetaminophen 500 mg PO Q6H:PRN pain fever 7. Tiotropium Bromide 1 CAP IH DAILY 8. Rifaximin 550 mg PO BID 9. Calcium Carbonate 1250 mg PO BID 10. Lactulose 15 mL PO TID 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Acetaminophen 500 mg PO Q6H:PRN pain fever 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing SOB 3. Calcium Carbonate 1250 mg PO BID 4. Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. Lactulose 15 mL PO TID 7. Raltegravir 400 mg PO BID 8. Rifaximin 550 mg PO BID 9. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 10. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: diuretic refractory ascites Secondary: HCV cirrhosis HIV hyponatremia COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear was a pleasure to take care of you at . You were admitted with abdominal fullness and pain from your ascites. You had a diagnostic and therapeutic paracentesis with 4.3 L removed. Your spironolactone was discontinued because your potassium was high. Your lasix was increased to 40mg daily. You are scheduled for another paracentesis on prior to your other appointments that day. Please call tomorrow to find out the time of the paracentesis. Please continue to follow a low sodium diet and fluid restriction. You should call your liver doctor or return to the emergency room if you have abdominal pain fever chills confusion or other concerning symptoms. Sincerely Your medical team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: Chief Complaint: altered mental status Major Surgical or Invasive Procedure: none History of Present Illness: Mrs. is a female with HIV on HAART COPD HCV cirrhosis complicated by ascites and hepatic encephalopathy who initially presented to the ED yesterday with hypotension after a paracentesis. The patient has had accelerated decompensation of her cirrhosis recently with worsening ascites and she is maintained on twice weekly paracentesis. She was at her regular session yesterday when she had hypotension to SBP and felt lightheadedness. Per the patient that s when her memory started to get fuzzy. She does not have much recollection of what happened since then. Her outpatient hepatologist saw her and recommended that she go to the ED. In the ED she was evaluated and deemed to have stable blood pressure. She was discharged home. At home she had worsening mental status with her daughter getting concerned and she returned to the ED. In the ED initial vitals were 98.7 77 96/50 16 98 RA. The patient was only oriented to person. Her labs were notable for Na 126 K 6.7 Cr 0.7 baseline 0.4 ALT 153 AST 275 TBili 1.9 Lip 66 INR 1.5. Initial EKG showed sinus rhythm with peaked T waves. Her head CT was negative for any acute processes. She received ceftriaxone 2gm x1 regular insulin 10U calcium gluconate 1g lactulose 30 mL x2 and 25g 5 albumin. On transfer vitals were 99.0 93 84/40 16 95 NC. On arrival to the MICU patient was more alert and conversant. She has no abdominal pain nausea vomiting chest pain or difficulty breathing. She has a chronic cough that is not much changed. She has not had any fever or chills. She reports taking all of her medications except for lactulose which she thinks taste disgusting. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals T: 98.7 BP: 84/48 P: 91 R: 24 O2: 98 NC on 2L GENERAL: Alert oriented no acute distress LUNGS: Decreased air movement on both sides scattered expiratory wheezes CV: Regular rate and rhythm normal S1 S2 no murmurs rubs gallops ABD: Soft non tender distended flank dullness bilaterally bowel sounds present EXT: Warm well perfused 2 pulses no cyanosis or edema DISCHARGE PHYSICAL EXAM: Vitals Tm 99.5 Tc 98.7 79 96/43 58 20 95 on 3L NC 7BM. General Cachectic appearing woman alert oriented no acute distress HEENT Sclera anicteric MMM oropharynx clear poor dentition with partial dentures Neck supple JVP not elevated no LAD Lungs Clear to auscultation bilaterally no wheezes rales ronchi CV Regular rate and rhythm normal S1 S2 no murmurs rubs gallops Abdomen Mildly distended and firm non tender bowel sounds present no rebound tenderness or guarding GU no foley Ext warm well perfused 2 pulses no clubbing cyanosis or edema Neuro AOx3 No asterixis. Pertinent Results: ADMISSION LABS: 06:39AM BLOOD WBC 6.9 RBC 3.98 Hgb 14.1 Hct 41.1 MCV 103 MCH 35.4 MCHC 34.3 RDW 15.8 Plt 06:39AM BLOOD Neuts 72.7 Lymphs 14.7 Monos 9.8 Eos 2.5 Baso 0.3 06:39AM BLOOD PTT 32.4 06:39AM BLOOD Glucose 102 UreaN 49 Creat 0.7 Na 126 K 6.7 Cl 95 HCO3 25 AnGap 13 06:39AM BLOOD ALT 153 AST 275 AlkPhos 114 TotBili 1.9 06:39AM BLOOD Albumin 3.6 IMAGING/STUDIES: CT HEAD: No evidence of acute intracranial process. The left zygomatic arch deformity is probably chronic as there is no associated soft tissue swelling. CXR: No acute intrathoracic process. DISCHARGE LABS: 04:45AM BLOOD WBC 4.8 RBC 3.15 Hgb 11.2 Hct 32.1 MCV 102 MCH 35.4 MCHC 34.8 RDW 15.8 Plt Ct 95 04:45AM BLOOD PTT 37.6 04:45AM BLOOD Glucose 121 UreaN 35 Creat 0.4 Na 130 K 5.2 Cl 97 HCO3 27 AnGap 11 04:45AM BLOOD ALT 96 AST 168 AlkPhos 69 TotBili 1.7 04:45AM BLOOD Calcium 8.6 Phos 2.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities w/ AMS hypotension and hyperkalemia. Altered mental status improved with lactulose. Hypotension was felt to be due to fluid shifts from paracentesis on the day prior to admission as well as low PO intake in the setting of AMS. Hypotension and resolved with IV albumin. Hyperkalemia resolved with insulin and kayexalate. Hypotension: Patient presented with SBP in and improved with albumin in the ED to . It was felt to be due to fluid shifts from paracentesis on as well as likely hypovolemia given AMS and decreased PO intake. No concern for bleeding or sepsis with baseline CBC and lack of fever. She continued to received IV albumin during her hospital course with which her SBP improved to and patient remained asymptomatic. Hyperkalemia: Patient presented with K 6.7 with EKG changes. Given low Na likely the result of low effective arterial volume leading to poor K excretion with likely exacerbation from . AM cortisol was normal. K improved with insulin and kayexalate and K was 5.2 on day of discharge. Bactrim was held during hospital course. : Patient presented with Cr 0.7 from baseline Cr is 0.3 0.4. It was felt to be likely due to volume shift from her paracentesis on the day prior to admission as well as now low effective arterial volume likely poor PO intake AMS. Cr improved to 0.4 with albumin administration. Furosemide and Bactrim were held during hospital course. GOC: The son HCP met with Dr. outpatient hepatologist during hospital course. They discussed that the patient is not a transplant candidate givenevere underlying lung disease FEV1 0.8 hypoxia RV dilation and very low BMI. A more conservative approach was recommended and the patient was transitioned to DNR/DNI. The patient agreed with this plan. She was treated with the goal of treating any any correctable issues. Social work met with the patient prior to discharge. The patient was interested in following up with palliative care for which an outpatient referral was made. Altered Mental Status: Patient presented with confusion that was most likely secondary to hepatic encephalopathy. Based on outpatient records patient has had steady decline in decompensated cirrhosis and mental status. No signs of infection and head CT was negative as well. Mental status improved with lactulose in the ED and patient reports that she has not been taking lactulose regularly at home. Patient was also continued on rifaximin. HCV Cirrhosis: Genotype 3a. Patient is decompensated with increasing ascites and worsening hepatic encephalopathy. She is dependent on twice weekly paracentesis. Spironolactone was recently stopped due to hyperkalemia. Patient is not a transplant candidate given her comorbidities COPD per outpatient hepatologist. The patient would like to continue biweekly paracenteses as an outpatient. HIV: Most recent CD4 count 173 on . HIV viral load on was undetectable. She was continued on her home regimen of raltegravir emtricitabine and tenofovir. Bactrim prophylaxis was held during admission because of hyperkalemia. COPD: Patient on 3L NC at home. She was continued on her home regimen. TRANSITIONAL ISSUES: Follow up with Palliative Care as outpatient Bactrim prophylaxis HIV was held during hospital course due to . Consider restarting as outpatient. Furosemide was held due to consider restarting as outpatient Follow up with hepatology Continue biweekly therapeurtic paracenteses Code status: DNR/DNI Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lactulose 15 mL PO TID 2. Tiotropium Bromide 1 CAP IH DAILY 3. Raltegravir 400 mg PO BID 4. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. TraMADOL Ultram 50 mg PO Q8H:PRN Pain 7. Fluticasone Propionate 110mcg 1 PUFF IH BID 8. Calcium Carbonate 500 mg PO BID 9. Rifaximin 550 mg PO BID 10. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY Discharge Medications: 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: Hypotension Hyperkalemia Acute Kidney Injury Secondary: HIV Cirrhosis COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. You were admitted to because of confusion low blood pressure and a high potassium value. Your confusion improved with lactulose. Your blood pressure improved with extra fluids and your potassium improved as well. You also had small degree of kidney injury when you came to the hospital and this also improved with fluids. While you were here you discussed changing your goals of care to focusing on symptom management and treatment of reversible processes such as an infection. While you were in the hospital you were seen by one of our social workers. You will also follow up with Palliative Care in their clinic and will continue to have therapeutic paracenteses. It has been a pleasure taking care of you and we wish you all the best Your Care team Followup Instructions: Sex: F Service: MEDICINE Allergies: Percocet / Vicodin Attending: . Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: Paracentesis History of Present Illness: w/ HIV on HAART COPD on 3L home O2 though sat ing fine on RA on admission HCV cirrhosis c/b ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening girth and abd pain. She d been having pain from her ascites and felt overdue for a paracentesis. She last had paracentesis on the . She reported that she began feeling worsening abdominal pain constant epigastric and radiates to back not a/w food on which increased in severity throughout the course of the day. She was brought to the ED by her son because of this pain. She had no confusion and was alert and oriented x3. The patient also reported she recently ran out of most of her home medications. She denied any fever chills shortness of breath cough dysuria. She reported loose stool a bit more than usual but attributed it to lactulose use. In the ED vitals were: 99.4 105 106/57 18 96 ra. Labs were significant for Na 127 K 5.3 lactate 2.1 INR 1.7. ALT 135 AST 244 AP 123. no leukocytosis. Ascitic fluid showed 220 WBC. She was given Morphine Sulfate 5 mg IV ONCE MR1 and a GI cocktail. Past Medical History: HCV Cirrhosis: genotype 3a HIV: on HAART CD4 count 173 HIV viral load undetectable COPD: PFT showed FVC 1.95 65 FEV1 0.88 37 FEFmax 2.00 33 Bipolar Affective Disorder PTSD Hx of cocaine and heroin abuse Hx of skin cancer per patient report Social History: Family History: She a total of five siblings but she is not talking to most of them. She only has one brother that she is in touch with and lives in . She is not aware of any known GI or liver disease in her family. Physical Exam: ADMISSION PHYSICAL EXAM Vitals T 97 BP 98/65 HR 103 RR 18 O2 94RA Glucose 128. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: distended fluid wave not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes DISCHARGE PHYSICAL EXAM Vitals Tm 98.6 Tc 98.2 BP 82 98/42 68 HR 80 95 RR O2 91 99 RA. GENERAL: NAD lying on her right side. HEENT: AT/NC EOMI PERRL anicteric sclera pink conjunctiva MMM good dentition NECK: nontender supple neck no LAD no JVD CARDIAC: RRR S1/S2 no murmurs gallops or rubs LUNG: CTAB no wheezes rales rhonchi breathing comfortably without use of accessory muscles ABDOMEN: soft decreased distension not tense. NABS nontender EXTREMITIES: no cyanosis clubbing or edema moving all 4 extremities with purpose PULSES: 2 DP pulses bilaterally NEURO: CN II XII intact AAO3 no asterxis SKIN: warm and well perfused no excoriations or lesions no rashes Pertinent Results: ADMISSION LABS 09:20PM BLOOD WBC 8.2 RBC 3.48 Hgb 12.3 Hct 36.7 MCV 106 MCH 35.5 MCHC 33.6 RDW 16.5 Plt 09:28PM BLOOD PTT 31.8 09:20PM BLOOD Glucose 118 UreaN 33 Creat 0.6 Na 127 K 5.3 Cl 97 HCO3 24 AnGap 11 09:20PM BLOOD ALT 135 AST 244 AlkPhos 123 TotBili 1.3 09:20PM BLOOD Albumin 3.5 Calcium 8.3 Phos 3.3 Mg 2.3 09:27PM BLOOD Lactate 2.1 NOTABLE LABS 12:30AM ASCITES WBC 220 Polys 17 Lymphs 48 Monos 19 Mesothe 2 Macroph 12 Other 2 12:30AM ASCITES TotPro 0.7 Glucose 129 MICROBIOLOGY 12:30 am PERITONEAL FLUID GRAM STAIN Final : NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE Final : NO GROWTH. ANAEROBIC CULTURE Preliminary : NO GROWTH. VRE screen: No VRE isolated. IMAGING/STUDIES CXR No acute cardiopulmonary process. RUQUS Cirrhotic mild splenomegaly and ascites. A solid 3cm nodule in the left lobe of the liver is stable in size and appearance. DISCHARGE LABS 06:15AM BLOOD WBC 5.6 RBC 3.27 Hgb 11.6 Hct 33.5 MCV 103 MCH 35.5 MCHC 34.5 RDW 16.1 Plt 06:15AM BLOOD PTT 36.0 06:15AM BLOOD Glucose 87 UreaN 29 Creat 0.4 Na 123 K 5.4 Cl 93 HCO3 24 AnGap 11 06:15AM BLOOD ALT 112 AST 176 AlkPhos 101 TotBili 2.8 06:15AM BLOOD Albumin 3.5 Calcium 8.8 Phos 3.4 Mg 2. w/ HIV on HAART COPD on 3L home O2 HCV cirrhosis decompensated ascites requiring biweekly therapeutic paracenteses hepatic encephalopathy not on transplant list comorbidities p/w worsening abd girth and pain. Goals of care: The patient expressed that her desire to let go and be at peace. She is tired of fighting her end stage liver disease and does not feel that she has a good quality of life. She wished to meet with a representative from hospice which we were able to arrange and she decided that she would like to go home with hospice. A conversation was held with the patient regarding code status. She noted that she would probably be DNR/DNI but would like to discuss it with her son HCP . Therefore at this time she remains full code. We also discussed the possibility of her getting a pleurex catheter placed because of her repeated paracenteses. She was discharged to home with hospice on . Decompensated HCV cirrhosis with ascites: The patient presented with worsening ascites. Her pain was initially managed with tramadol and morphine. She underwent paracentesis on with removal of 3.5L and she received albumin. Studies on the fluid were negative and she reported a significant improvement in her pain. Hyperkalemia: During her hospitalization it was noted that she had hyperkalemia 5.3 5.9 6.9 without EKG changes. After treatment with calcium gluconate 2gm x2 insulin and D50 x 2 and kayexelate her K downtrended to 5.4. Her K has been persistently elevated in the past and should continue to be monitored. Hepatic encephalopathy: The patient s mental status was A Ox3 on admission. She was continued on rifaximin and lactulose in house and at discharge. CHRONIC ISSUES Hyponatremia The patient has a history of asymptomatic hyponatremia. It is most likely hypervolemic hyponatremia related to underlying liver disease as well as aldosterone axis dysfunction related to liver disease. She remained asymptomatic through her hospitalization. Because she was also started on 10mg of furosemide to help prevent fluid re accumulation she will require BMPs twice weekly in the outpatient setting. HIV: Emtricitabine Tenofovir Truvada and Raltegravir were continued in house and at discharge. COPD: fluticasone tiotropium and albuterol were continued in house and at discharge. TRANSITIONAL ISSUES Follow up peritoneal fluid culture New/changed medications: Furosemide 10mg daily new For hyperkalemia and hyponatremia the patient should have biweekly BMPs script written . If K 5.3 she should be given kayexelate once weekly. Lab results will be faxed/sent to Dr. . Continue conversation regarding pleurex catheter placement and code status. She will continue to have twice weekly paracenteses Code: full Emergency Contact: on Admission: The Preadmission Medication list is accurate and complete. 1. Calcium Carbonate 500 mg PO BID 2. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 3. Fluticasone Propionate 110mcg 1 PUFF IH BID 4. Lactulose 30 mL PO TID 5. Raltegravir 400 mg PO BID 6. Rifaximin 550 mg PO BID 7. TraMADOL Ultram mg PO Q6H:PRN pain 8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 9. Tiotropium Bromide 1 CAP IH DAILY Discharge Medications: 1. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing 2. Calcium Carbonate 500 mg PO BID 3. Emtricitabine Tenofovir Truvada 1 TAB PO DAILY 4. Fluticasone Propionate 110mcg 1 PUFF IH BID 5. Lactulose 30 mL PO TID 6. Raltegravir 400 mg PO BID 7. Rifaximin 550 mg PO BID 8. Tiotropium Bromide 1 CAP IH DAILY 9. TraMADOL Ultram mg PO Q6H:PRN pain 10. Furosemide 10 mg PO DAILY RX furosemide 20 mg 0.5 One half tablet s by mouth Please take 1 tablet daily. Disp 15 Tablet Refills: 0 11. Outpatient Lab Work Please obtain biweekly BMP to monitor K and Na. Please fax results to Dr. at the at . Discharge Disposition: Home With Service Facility: Discharge Diagnosis: PRIMARY DIAGNOSIS Decompensated HCV cirrhosis Hyperkalemia SECONDARY DIAGNOSES HIV COPD Hyponatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory Independent. Discharge Instructions: Dear Ms. It was a pleasure caring for you during your stay at . You were admitted because of worsening abdominal pain. It is likely that this pain was due to increasing fluid in the abdomen from your cirrhosis. After a paracentesis in which much of this fluid was removed your pain improved significantly. You were noted to have a high potassium during your hospitalization which came down with treatment but this should continue to be followed as an outpatient. You also emphasized your desire to speak with a representative from hospice. Because of your repeated paracenteses we also discussed the possibility of a pleurex catheter placement. We arranged for you to meet with hospice coordinators and you will be discharged home with hospice. We wish you all the best Your care team Followup Instructions:  "
            ]
          },
          "execution_count": 10,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "raw.head(1)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "_SCx5WVl8yNh"
      },
      "outputs": [],
      "source": [
        "import spacy\n",
        "from time import time\n",
        "\n",
        "nlp = spacy.load('en_core_web_sm', disable=['ner', 'parser'])\n",
        "\n",
        "# Process text as batches and yield Doc objects in order\n",
        "text = [str(doc) for doc in nlp.pipe(processed_text, batch_size=5000)]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "W1TamTuTixg3",
        "outputId": "a2fca836-0500-40d7-f30e-a92d957c9eb2"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "(331794, 8)"
            ]
          },
          "execution_count": 8,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "raw.shape"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 472
        },
        "id": "Lo64DrzI83Xj",
        "outputId": "3aaf3c85-90b5-4d07-fb71-769254eb8381"
      },
      "outputs": [
        {
          "data": {
            "image/png": "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",
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import matplotlib.pyplot as plt\n",
        "\n",
        "text_count = []\n",
        "\n",
        "for sent in raw['text']:\n",
        "    text_count.append(len(sent.split()))\n",
        "\n",
        "\n",
        "graph_df = pd.DataFrame()\n",
        "\n",
        "graph_df['text'] = text_count\n",
        "\n",
        "graph_df.hist(bins = 12, color='gray')\n",
        "plt.ylabel('No of documents')\n",
        "plt.xlabel(\"Word count\")\n",
        "plt.show()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "KJEc0h0b87_f",
        "outputId": "f0661a66-4516-47eb-c2ff-cd630eb9401b"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0.82328\n"
          ]
        }
      ],
      "source": [
        "# Check how much % of text have 0-5000 words\n",
        "cnt = 0\n",
        "for i in raw['text']:\n",
        "    if len(i.split()) <= 5000:\n",
        "        cnt = cnt + 1\n",
        "print(cnt / len(raw['text']))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Lwez4W0p8-n0"
      },
      "outputs": [],
      "source": [
        "# Model to summarize the text between 0-500 words for Text\n",
        "max_text_len = 5000\n",
        "max_summary_len=500"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "lg7jshP09AuE",
        "outputId": "97cadcf3-adf3-49a3-f5de-8e7d34bd4efd"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "(41164, 1)\n"
          ]
        }
      ],
      "source": [
        "# Select the Text which fall below max length\n",
        "\n",
        "import numpy as np\n",
        "\n",
        "cleaned_text = np.array(raw['text'])\n",
        "\n",
        "short_text = []\n",
        "\n",
        "for i in range(len(cleaned_text)):\n",
        "    if len(cleaned_text[i].split()) <= max_text_len:\n",
        "        short_text.append(cleaned_text[i])\n",
        "\n",
        "post_pre = pd.DataFrame({'text': short_text})\n",
        "print(post_pre.shape)"
      ]
    }
  ],
  "metadata": {
    "accelerator": "GPU",
    "colab": {
      "gpuType": "T4",
      "machine_shape": "hm",
      "provenance": []
    },
    "gpuClass": "standard",
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}
